Revised In Commerce List tracking table
Revised In Commerce List (R-ICL) tracking table (Excel version – 215.8 K)
In the table below, a bold font and an asterisk (*) indicates that the entry's identifier is one which has been updated by Chemical Abstracts Service Registry Number (CAS RN).
The following acronyms are used throughout the table:
- R-ICL: Revised In Commerce List
- DSL: Domestic Substances List
- TBD: To be determined
Read more information about the Results of prioritization, status and outcome for substances on the Revised In Commerce List.
If the substance status is “no commercial activity identified” in the R-ICL tracking table below, see the Canada Gazette, Part I: Vol. 156, No 8 – February 19, 2022: Notice of removal of substances with no commercial activity from the Revised In Commerce List.
| Substances identifier | Substance name | Prioritization results | Status | Outcome |
|---|---|---|---|---|
| ICLCN 001 | Confidential name | Higher priority based on available information - Human health concern | Confidential names are not eligible for listing on R-ICL | Removed from R-ICL |
| 1.13.11.12 | linoleate:oxygen 13-oxidoreductase | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | To be determined (TBD) |
| 100085-35-6 | Protein hydrolyzates, fibronectin | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 100085-62-9 | Protein hydrolyzates, microorganism | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 1001439-91-3 | Amylopectin, enzyme-hydrolyzed | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 100209-19-6 | Almond, ext., hydrolyzed | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 100209-41-4 | Protein hydrolyzates, corn | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 100209-42-5 | Protein hydrolyzates, cottonseed | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 100231-68-3 | D-Glucoside, eicosyl | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 10025-06-6 | Glycine, N-methyl-, (9Z)-9-octadecen-1-yl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 10028-15-6 | Ozone | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 100286-90-6 | [1,4'-Bipiperidine]-1'-carboxylic acid, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 10031-23-9 | Radium bromide (RaBr2) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 10031-59-1 | Sulfuric acid, thallium(1+) salt (1:?) | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 100358-63-2 | .alpha.-D-Glucopyranoside, .beta.-D-fructofuranosyl, [R-(Z)]-12-hydroxy-9-octadecenoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 10036-64-3 | .alpha.-D-Glucopyranose, 2-(acetylamino)-2-deoxy- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 100403-19-8 | Ceramides | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 100418-33-5 | Ethanol, 2-[(4-methyl-2-nitrophenyl)amino]- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 10043-83-1 | Phosphoric acid, magnesium salt (1:?) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 100568-02-3 | Benzenepropanamine, N-methyl-.gamma.-[4-(trifluoromethyl)phenoxy]-, (.gamma.S)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 100684-25-1 | Protein hydrolyzates, wheat gluten | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 100684-29-5 | Glycerides, vegetable-oil, hydrogenated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 100684-33-1 | Petrolatum (petroleum), clay-treated | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 100684-38-6 | Residual oils (petroleum), clay-treated solvent-dewaxed | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 100684-49-9 | Slack wax (petroleum), carbon-treated | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 1007304-55-3 | Poly(oxy-1,2-ethanediyl), .omega.'-hydroxy-.omega.-[(1- oxoisooctadecyl)oxy]-.omega."-[[(5-oxo-2-pyrrolidinyl)carbonyl]oxy]- .alpha.,.alpha.',.alpha."-1,2,3-propanediyltris- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 1007-42-7 | L-Histidine, hydrochloride (1:?) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 100843-69-4 | Saccharide isomerate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 100986-85-4 | 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (3S)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 10101-63-0 | Lead iodide (PbI2) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 10118-90-8 | 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 101227-09-2 | Fatty acids, C16-18, 2-hexyldecyl esters | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 1012317-71-3 | L-Lysinamide, N2-(1-oxohexyl)-L-lysylglycyl-L-histidyl-, acetate (1:?) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 10124-48-8 | Mercury amide chloride (Hg(NH2)Cl) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 10124-49-9 | Sulfuric acid, iron salt (1:?) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 101-26-8 | Pyridinium, 3-[[(dimethylamino)carbonyl]oxy]-1-methyl-, bromide (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 101-31-5 | Benzeneacetic acid, .alpha.-(hydroxymethyl)-, (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, (.alpha.S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 10139-47-6 | Zinc iodide (ZnI2) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 101403-98-9 | Fatty acids, palm kernel-oil | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 10161-34-9 | Estra-4,9,11-trien-3-one, 17-(acetyloxy)-, (17.beta.)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 101827-46-7 | 1-Naphthalenemethanamine, N-[[4-(1,1-dimethylethyl)phenyl]methyl]-N-methyl-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 101831-37-2 | Benzeneacetonitrile, 2,6-dichloro-.alpha.-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 10192-46-8 | Boric acid (H3BO3), zinc salt (2:3) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 101993-72-0 | Octadecanoic acid, ester with triglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 102051-00-3 | 9-Octadecenoic acid (9Z)-, triester with decaglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 102-29-4 | 1,3-Benzenediol, 1-acetate | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 10233-14-4 | 9-Octadecenoic acid (9Z)-, 2-[2-(2-hydroxyethoxy)ethoxy]ethyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 102397-69-3 | .beta.-D-Mannopyranuronic acid, 1-O-(dihydroxymethylsilyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 102625-70-7 | 1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1026525-47-4 | L-Glutamine, glycyl-L-arginylglycyl-L-.alpha.,-aspartyl-L-tyrosyl-L-isoleucyl-L-tryptophyl-L-seryl-L-leucyl-L-,.alpha.-aspartyl-L-threonyl | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 102785-61-5 | Glauconite-1M | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 102785-62-6 | Glauconite-2M1 | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 102785-63-7 | Glauconite-1Md | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 10279-59-1 | Phosphoric acid, aluminum sodium salt (8:2:3) | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 102868-96-2 | Zinc, bis[N-(acetyl-.kappa.O)-L-methioninato-.kappa.O]-, (T-4)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 10294-31-2 | Gold iodide (AuI) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 10294-70-9 | Tin iodide (SnI2) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 102-98-7 | Mercurate(2-), [orthoborato(3-)-.kappa.O]phenyl-, hydrogen (1:2) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 103055-07-8 | Benzamide, N-[[[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]amino]carbonyl]-2,6-difluoro- | Higher priority based on available information - Environmental concern | Environmental concern | Removed from the R-ICL |
| 10305-76-7 | Phosphoric acid, aluminum sodium salt (8:3:1), tetrahydrate | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 103129-82-4 | 3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester, (4S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 103-16-2 | Phenol, 4-(phenylmethoxy)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 103213-20-3 | Fatty acids, C18-unsatd., dimers, hydrogenated, di-iso-Pr esters | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 10326-21-3 | Chloric acid, magnesium salt (2:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 1033319-29-7 | Pichia anomala, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 1034-01-1 | Benzoic acid, 3,4,5-trihydroxy-, octyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1034015-50-3 | Polysaccharides, sugarcane,3-(dimethyloctadecylammonio)-2-hydroxypropyl ethers,chlorides | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 103577-45-3 | 1H-Benzimidazole, 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 10361-76-9 | Peroxymonosulfuric acid, potassium salt (1:2) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 103622-85-1 | 3,6,9,12-Tetraoxatriacont-21-en-1-ol | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 103628-46-2 | 1H-Indole-5-methanesulfonamide, 3-[2-(dimethylamino)ethyl]-N-methyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 103628-48-4 | Butanedioic acid, compd. with 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 103639-04-9 | 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-, hydrochloride, hydrate (1:1:2) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 103667-50-1 | 2-Thiopheneacetic acid, 5-benzoyl-.alpha.-methyl-, (.alpha.S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 103810-94-2 | Methanone, diphenyl-, dihydroxy deriv. | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 103819-44-9 | Fats and Glyceridic oils, avocado, ethoxylated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 103819-46-1 | Olive oil, ethoxylated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 103980-44-5 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-[[(2-furanylcarbonyl)thio]methyl]-8-oxo-, hydrochloride (1:1), (6R,7R)- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 104075-48-1 | 1H-Imidazole, 5-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 10417-86-4 | Pregnane-3,11,20-trione, 21-hydroxy-, (5.beta.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 10417-94-4 | 5,8,11,14,17-Eicosapentaenoic acid, (5Z,8Z,11Z,14Z,17Z)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 10418-03-8 | 2'H-Androst-2-eno[3,2-c]pyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 104226-19-9 | 3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 104227-87-4 | 1,3-Propanediol, 2-[2-(2-amino-9H-purin-9-yl)ethyl]-, 1,3-diacetate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 104333-00-8 | 1,2-Propanediol, 3-[[2-nitro-4-(trifluoromethyl)phenyl]amino]- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 104344-23-2 | 2-Propanol, 1-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-, (2E)-2-butenedioate (2:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 104365-75-5 | 2-Propenoic acid, homopolymer, ester with 1,2,3-propanetriol | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 104486-81-9 | L-talo-Non-2-enonic acid, 5,9-anhydro-2,3,4,8-tetradeoxy-8-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methylpropyl]-2-oxiranyl]methyl]-3-methyl-, 8-carboxyoctyl ester, calcium salt (2:1), (2E)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 104632-25-9 | 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, hydrochloride (1:2), (6S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 104673-29-2 | Chitosan, N-(2-hydroxypropyl) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 10476-84-3 | Octadecanoic acid, manganese salt (1:?) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 10476-86-5 | Strontium iodide (SrI2) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 104-98-3 | 2-Propenoic acid, 3-(1H-imidazol-5-yl)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 104987-11-3 | 15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-, (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| *105613-48-7/ 10051-63-1 | 2-Butanone, 3,3'-[(2,2-dimethyl-1,3-propanediyl)diimino]bis-,2,2'-dioxime, (2E,2'E,3R,3'R)-rel- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 105618-03-9 | 3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, ethyl methyl ester, (4S)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 10578-34-4 | Benzoic acid, octadecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 105816-04-4 | D-Phenylalanine, N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 105857-23-6 | Plasminogen activator (human tissue-type protein moiety) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 105859-93-6 | Propanoic acid, 2,2-dimethyl-, tridecyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 105883-45-2 | L-Tyrosine, N-acetyl-, dihydroxymethylsilyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 105883-49-6 | Magnesium, bis[N-(acetyl-.kappa.O)-L-methioninato-.kappa.O]-, (T-4)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 105883-50-9 | Manganese, bis[N-(acetyl-.kappa.O)-L-methioninato-.kappa.O]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 105883-51-0 | Copper, bis[N-(acetyl-.kappa.O)-L-methioninato-.kappa.O]- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 105883-52-1 | Cobalt, bis[N-(acetyl-.kappa.O)-L-methioninato-.kappa.O]- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 106233-09-4 | Poly(oxy-1,2-ethanediyl),alpha.-hydro-.omega.-hydroxy-,mono-C16-18-alkyl ethers, phosphates | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 106266-06-2 | 4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 106392-12-5 | Oxirane, 2-methyl-, polymer with oxirane, block | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 106436-39-9 | Propanoic acid, 2,2-dimethyl-, tridecyl ester, branched | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 106463-17-6 | Benzenesulfonamide, 5-[(2R)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxy-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 106483-04-9 | Octanoic acid, diester with 5-hydroxy-6-methyl-3,4-pyridinedimethanol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 106631-38-3 | 1-Naphthalenepropanol, .alpha.-ethenyldecahydro-.alpha.,5,5,8a-tetramethyl-2-methylene- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 106685-40-9 | 2-Naphthalenecarboxylic acid, 6-(4-methoxy-3-tricyclo[3.3.1.13,7]dec-1-ylphenyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 107133-36-8 | 1H-Indole-2-carboxylic acid, 1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)butyl]amino]-1-oxopropyl]octahydro-, (2S,3aS,7aS)-, compd. with 2-methyl-2-propanamine (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1072005-10-7 | Decanoic acid, mixed diesters with octanoic acid and 1,3-propanediol | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 107615-51-0 | 9-Octadecenoic acid, 12-hydroxy-, monoester with hexaglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 107628-04-6 | Poly(oxy-1,2-ethanediyl), .alpha.-[2-[(2-hydroxyethyl)amino]-2-oxoethyl]-.omega.-hydroxy-, mono-C13-15-alkyl ethers | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 107709-25-1 | Starch, polymer with sodium 2-propenoate (1:1), graft | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1077-27-6 | 1,2-Dithiolane-3-pentanoic acid, (3S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 107753-78-6 | Carbamic acid, N-[3-[[2-methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]-, cyclopentyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 107868-30-4 | Androsta-1,4-diene-3,17-dione, 6-methylene- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 108050-54-0 | Tylosin, 4A-O-de(2,6-dideoxy-3-C-methyl-.alpha.-L-ribo-hexopyranosyl)-20-deoxo-20-[(3R,5S)-3,5-dimethyl-1-piperidinyl]- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 108347-90-6 | Poly[oxy(methyl-1,2-ethanediyl)], .alpha.-benzoyl-.omega.-(octadecyloxy)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 108777-93-1 | 1,2,3-Propanetriol, homopolymer, octanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 108778-82-1 | Beractant | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 1093-16-9 | Spiro[naphthalene-2(1H),2'-oxirane]-1-propanol, .alpha.-ethenyloctahydro-.alpha.,5,5,8a-tetramethyl- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 109423-22-5 | Benzoic acid, 2-hydroxy-, 5-methyl-2-(1-methylethyl)cyclohexyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 109485-61-2 | Nonane, 2,2,4,4,6,6,8-heptamethyl- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 1095-90-5 | 3-Heptanone, 6-(dimethylamino)-4,4-diphenyl-, hydrochloride (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 109884-54-0 | Isooctadecanoic acid, 2,2-dimethyl-1,3-propanediyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 109889-09-0 | 1H-Indazole-3-carboxamide, 1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 11029-12-2 | Anthocyanins, grape | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 110332-91-7 | Oxirane, methyl-,polymer with oxirane, monoacetate, isohexadecyl ether, block | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 11061-68-0 | Insulin (human) | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 110780-72-8 | Biotite-3A1 ((Fe0.4-0.8Mg0.2-0.6)3K(Si3Al)[(OH)0.5-1F0-0.5]2O10) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 1109-11-1 | 2,4,6,8,10,12,14,16-Heptadecaoctaenoic acid, 2,6,11,15-tetramethyl-17-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, ethyl ester, (2E,4E,6E,8E,10E,12E,14E,16E)- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 11092-32-3 | Aluminum oxide (AlO2) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 110942-02-4 | 2-133-Interleukin 2 (human reduced), 125-L-serine- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 111025-46-8 | 2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 11108-73-9 | Uranium alloy, base, U,Nb,Zr (Mulberry) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 11116-97-5 | Calcium, (D-gluconato)(2-hydroxypropanoato)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 1112-38-5 | Phosphorothioic acid, O,O-dimethyl ester | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 11128-98-6 | Boric acid, ammonium salt | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 11140-04-8 | Octanoic acid, ester with 1,2,3-propanetriol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 111470-99-6 | 3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester, benzenesulfonate (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1115-47-5 | Methionine, N-acetyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 1115-70-4 | Imidodicarbonimidic diamide, N,N-dimethyl-, hydrochloride (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 1118558-33-0 | Bidens pilosa, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 1119-33-1 | L-Glutamic acid, 5-ethyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 111974-69-7 | Ethanol, 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 111974-72-2 | Ethanol, 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-, (2E)-2-butenedioate (2:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1119-87-5 | 1,2-Dodecanediol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1120-16-7 | Dodecanamide | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 112362-50-2 | 3H-21,18-Nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, 26-[[2-(diethylamino)ethyl]sulfonyl]-8,9,14,15,24,25,26,26a-octahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-, (3R,4R,5E,10E,12E,14S,26R,26aS)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 112385-09-8 | 2-Butenedioic acid (2Z)-, diisooctadecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 112529-15-4 | 2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-, hydrochloride (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 112593-95-0 | Biotite-1M ((Fe0.4-0.8Mg0.2-0.6)3K(Si3Al)[(OH)0.5-1F0-0.5]2O10) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 112708-25-5 | Tetraglycerol, mono-(9Z)-9-octadecen-1-yl ether | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 112809-51-5 | Benzonitrile, 4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 112811-59-3 | 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 112887-68-0 | L-Glutamic acid, N-[[5-[[(3,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]methylamino]-2-thienyl]carbonyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 112965-21-6 | 1,3-Cyclohexanediol, 5-[(2E)-2-[(1R,3aS,4E,7aR)-1-[(1R,2E)-4-cyclopropyl-4-hydroxy-1-methyl-2-butenyl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-, (1R,3S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 113010-52-9 | Benzoic acid, 4-amino-, ethyl ester, polymer with oxirane | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 113-07-5 | 2-Pyrrolidinone, 1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-, monohydrochloride | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 113089-59-1 | Collagens, hydrolyzates, reaction products with 3-chloro-2-hydroxy-N,N,N-trimethyl-1-propanaminium chloride | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| *113170-55-1/108910-78-7 | L-Ascorbic acid, 2-(dihydrogen phosphate), magnesium salt (2:3) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 113-21-3 | Propanoic acid, 2-hydroxy-, ion(1-) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 113221-73-1 | 2-Naphthalenecarboxaldehyde, 5,6,7,8-tetrahydro-5,5,7,8,8-pentamethyl- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 113427-24-0 | 1-165-Erythropoietin (human clone .lambda.HEPOFL13 protein moiety), glycoform .alpha. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 113431-53-1 | 2-Butenedioic acid (2E)-, diisooctadecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 113431-54-2 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, triisooctadecyl ester | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 113507-06-5 | Milbemycin B, 5-O-demethyl-28-deoxy-25-[(1E)-1,3-dimethyl-1-butenyl]-6,28-epoxy-23-(methoxyimino)-, (6R,23E,25S)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 1135-24-6 | 2-Propenoic acid, 3-(4-hydroxy-3-methoxyphenyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 113617-63-3 | 3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-5,6,8-trifluoro-1,4-dihydro-4-oxo-, rel- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 113665-84-2 | Thieno[3,2-c]pyridine-5(4H)-acetic acid, .alpha.-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (.alpha.S)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 113806-05-6 | Dibenz[b,e]oxepin-2-acetic acid, 11-[3-(dimethylamino)propylidene]-6,11-dihydro-, (11Z)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 113956-14-2 | C.I. Pigment Red 259 | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 114040-31-2 | L-Ascorbic acid, mono(dihydrogen phosphate), magnesium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 114355-43-0 | 9-Octadecenoic acid, 12-hydroxy-, (9Z,12R)-, ester with hexaglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 114733-90-3 | Biotite-2M1 ((Fe0.4-0.8Mg0.2-0.6)3K(Si3Al)[(OH)0.5-1F0-0.5]2O10) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 114-80-7 | Benzenaminium, 3-[[(dimethylamino)carbonyl]oxy]-N,N,N-trimethyl-, bromide (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 114870-03-0 | .alpha.-D-Glucopyranoside, methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)- .alpha.-D-glucopyranosyl-(1→4)-O-.beta.-D-glucopyranuronosyl- (1→4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-.alpha.-D- glucopyranosyl-(1→4)-O-2-O-sulfo-.alpha.-L-idopyranuronosyl- (1→4)-2-deoxy-2-(sulfoamino)-, 6-(hydrogen sulfate), sodium salt (1:10) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 114977-28-5 | Benzenepropanoic acid, .beta.-[[(1,1-dimethylethoxy)carbonyl]amino]-.alpha.-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (.alpha.R,.beta.S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1151559-87-3 | Protein hydrolyzates, Candida saitoana | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 115340-78-8 | 1-Propanaminium, 3-amino-N-ethyl-N,N-dimethyl-, N-apricot-oil acyl derivs., Et sulfates | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 115436-72-1 | Phosphonic acid, P,P'-[1-hydroxy-2-(3-pyridinyl)ethylidene]bis-, sodium salt (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 115550-35-1 | 7H-Pyrido[3,2,1-ij][4,1,2]benzoxadiazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 115-76-4 | 1,3-Propanediol, 2,2-diethyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 115956-13-3 | 1H-Indole-3-carboxylic acid, (6R,9aS)-octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, rel-, methanesulfonate (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 116-38-1 | Benzenaminium, N-ethyl-3-hydroxy-N,N-dimethyl-, chloride (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 116655-76-6 | 10H-Benzo[4,5]cyclohepta[1,2-b]thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-, (S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 116768-20-8 | Biotite-3T ((Fe0.4-0.8Mg0.2-0.6)3K(Si3Al)[(OH)0.5-1F0-0.5]2O10)) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 117522-93-7 | L-Proline, 5-oxo-, compd. with chitosan | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1176-08-5 | Ethanamine, N,N-dimethyl-2-[2-(phenylmethyl)phenoxy]-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 1176232-55-5 | Mimosa tenuiflora, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 117704-25-3 | Avermectin A1a, 25-cyclohexyl-5-O-demethyl-25-de(1-methylpropyl)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 117976-90-6 | 1H-Benzimidazole, 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-, sodium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 118072-93-8 | Phosphonic acid, P,P'-[1-hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 118292-40-3 | 3-Pyridinecarboxylic acid, 6-[2-(3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]-, ethyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 118390-30-0 | Interferon .alpha.1 (human lymphoblast reduced), N-L-methionyl-22-L-arginine-76-L-alanine-78-L-aspartic acid-79-L-glutamic acid-86-L-tyrosine-90-L-tyrosine-156-L-threonine-157-L-asparagine-158-L-leucine- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 119068-77-8 | 2H-Pyran-2-acetic acid, tetrahydro-2,4-dihydroxy-6-[(1R)-1-[(2S,5R,7S,8R,9S)-9-hydroxy-2,8-dimethyl-2-[(2S,2'R,3'S,5R,5'R)-octahydro-2-methyl-5'-[(2S,3S,5R,6S)-tetrahydro-6-hydroxy-3,5,6-trimethyl-2H-pyran-2-yl]-3'-[[(2S,5S,6R)-tetrahydro-5-methoxy-6-methyl-2H-pyran-2-yl]oxy][2,2'-bifuran]-5-yl]-1,6-dioxaspiro[4.5]dec-7-yl]ethyl]-5-methoxy-3-methyl-, monosodium salt, (2R,3S,4S,5R,6S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 119068-78-9 | Cholestane-3,7,12,24,26,27-hexol, 26-(hydrogen sulfate), sodium salt (1:1), (3.alpha.,5.beta.,7.alpha.,12.alpha.,24R,25S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 119141-88-7 | 1H-Benzimidazole, 6-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 119302-91-9 | Pyrrolidinium, 1-[(2.beta.,3.alpha.,5.alpha.,16.beta.,17.beta.)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl]-1-(2-propenyl)-, bromide | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 119413-54-6 | 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, hydrochloride (1:1), (4S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 119481-72-0 | Poly(oxy-1,2-ethanediyl), .alpha.-[2-(1-methylethoxy)-2-oxoethyl]-.omega.-hydroxy-, C12-15-alkyl ethers | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 119691-49-5 | 1-Eicosanol, 2-tetradecyl- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 1197-18-8 | Cyclohexanecarboxylic acid, 4-(aminomethyl)-, trans- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 119831-19-5 | Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, ether with methyl D-glucopyranoside (4:1), dioctadecanoate | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 120011-70-3 | 1H-Inden-1-one, 2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-, hydrochloride (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 1200-22-2 | 1,2-Dithiolane-3-pentanoic acid, (3R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 120066-54-8 | Gadolinium, [10-[2-(hydroxy-.kappa.O)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-.kappa.N1,.kappa.N4,.kappa.N7,.kappa.N10,.kappa.O1,.kappa.O4,.kappa.O7]- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 120138-50-3 | Virginiamycin S1, 4-[4-(dimethylamino)-N-methyl-L-phenylalanine]-5-[(2S,5R)-5-[[[(3S)-1-azabicyclo[2.2.2]oct-3-yl]thio]methyl]-4-oxo-2-piperidinecarboxylic acid]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 12018-01-8 | Chromium oxide (CrO2) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 120202-66-6 | Thieno[3,2-c]pyridine-5(4H)-acetic acid, .alpha.-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (.alpha.S)-, sulfate (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 120279-96-1 | 4H-Thieno[2,3-b]thiopyran-2-sulfonamide, 4-(ethylamino)-5,6-dihydro-6-methyl-, 7,7-dioxide, (4S,6S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 120373-24-2 | 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxodecyl)cyclopentyl]-, 1-methylethyl ester, (5Z)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 120486-24-0 | Isooctadecanoic acid, triester with oxybis[propanediol] | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 120511-73-1 | 1,3-Benzenediacetonitrile, .alpha.1,.alpha.1,.alpha.3,.alpha.3-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 12068-50-7 | Halloysite (Al2(Si2O7).2H2O) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 121032-29-9 | 9-(.beta.-D-Arabinofuranosyl)-6-methoxy-9H-purin-2-amine | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 121181-53-1 | Colony-stimulating factor (human clone 1034), N-L-methionyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 12122-15-5 | Nickel carbonate hydroxide (Ni5(CO3)2(OH)6) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 12126-59-9 | Estrogens, conjugates | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 121268-17-5 | Phosphonic acid, 2,2'-(4-amino-1-hydroxybutylidene)bis-, sodium salt, hydrate (1:1:3) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 121440-30-0 | Isooctadecanoic acid, tetraester with oxybis[propanediol] | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 121546-77-8 | Alcohols, C12-15 ethoxylate, sulfonate, sodium salt | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 121679-13-8 | 1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 121684-92-2 | .alpha.-D-Glucopyranoside, .beta.-D-fructofuranosyl, acetate dioctadecanoate | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 121734-19-8 | 1,3-Benzenediamine, 4-methoxy-, sulfate | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| *12174-11-7/ 1337-76-4 | Palygorskite ([Mg(Al0.5-1Fe0-0.5)]Si4(OH)O10.4H2O) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 121888-66-2 | Quaternary ammonium compounds benzylbis(hydrogenated tallow alkyl)methyl, benzoate lauryl sulfate, salts with bentonite | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 121888-67-3 | Quaternary ammonium compounds, benzylbis(hydrogenated tallow alkyl)methyl, bis(hydrogenated tallow alkyl)dimethylammonium salt with hectorite | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 121888-68-4 | Quaternary ammonium compounds, benzyl(hydrogenated tallow alkyl)dimethyl, stearates, salts with bentonite | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 1219683-77-8 | 9-Octadecenoic acid, 12-hydroxy-, (9Z,12R)-, homopolymer, ester with pentaglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1220882-73-4 | Kappaphycus alvarezii, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 122111-03-9 | Cytidine, 2'-deoxy-2',2'-difluoro-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 122-11-2 | Benzenesulfonamide, 4-amino-N-(2,6-dimethoxy-4-pyrimidinyl)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 12211-28-8 | Proteinase, Bacillus subtilis, sutilains | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 12217-41-3 | C.I. Basic Blue 22 | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 12217-43-5 | 9,10-Anthracenedione, 1-amino-4-[[4-[(dimethylamino)methyl]phenyl]amino]- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 12221-52-2 | C.I. Basic Red 22 | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 12222-04-7 | C.I. Direct Blue 199 | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 122320-73-4 | 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 12244-16-5 | Endellite (Al2(Si2O7).4H2O) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 122647-32-9 | Methanesulfonamide, N-[4-[4-(ethylheptylamino)-1-hydroxybutyl]phenyl]-, (2E)-2-butenedioate (2:1) (salt) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 122703-32-6 | D-Glucopyranoside, methyl, di-(9Z)-9-octadecenoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 12298-43-0 | Halloysite (Al2(Si2O7).xH2O) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 123005-57-2 | Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, ether with methyl D-glucopyranoside (3:1), ether with .alpha.-[3-(dodecyldimethylammonio)-2-hydroxypropyl]-.omega.-hydroxypoly(oxy-1,2-ethanediyl) chloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 123441-03-2 | Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 1236-99-3 | 10H-Phenothiazine-10-propanamine, 2-methoxy-N,N,.beta.-trimethyl-, hydrochloride (1:1), (.beta.R)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 123776-54-5 | Butanedioic acid, sulfo-, 1-dodecyl ester, diammonium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 123776-56-7 | 1-Propanaminium, 3-(acetylamino)-N,N,N-trimethyl-, chloride (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 123-78-4 | 4-Octadecene-1,3-diol, 2-amino-, (2S,3R,4E)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 1239011-60-9 | Phenylalaninamide, N2-acetyl-D-lysyl-L-alpha-aspartyl-L-valyl-3-hydroxy- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 123948-87-8 | 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (4S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 123997-26-2 | Avermectin B1, 4"-(acetylamino)-4"-deoxy-, (4"R)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 124046-05-5 | Benzenemethanaminium, N-(3-aminopropyl)-N,N-dimethyl-, N-babassu-oil acyl derivs., chlorides | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 124046-09-9 | Benzenemethanaminium, N-(3-aminopropyl)-N,N-dimethyl-, N-wheat-oil acyl derivs., chlorides | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 124046-21-5 | Amides, avocado-oil, N,N-bis(hydroxyethyl) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 124046-24-8 | Amides, babassu-oil, N,N-bis(hydroxyethyl) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 124046-40-8 | Amides, wheat germ-oil, N-[3-(dimethylamino)propyl], lactates | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 124046-50-0 | Oils, almond, ethoxylated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 124046-52-2 | Palm kernel oil, ethoxylated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 12417-86-6 | Stevensite ((Ca0.33-0.5Na0-0.33)0.33Mg3(Si3.67Al0.33)(OH)2O10) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 1242417-48-6 | Luffa cylindrica, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 124-43-6 | Urea, compd. with hydrogen peroxide (H2O2) (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 124750-99-8 | 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, potassium salt (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 124832-26-4 | L-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 124832-27-5 | L-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 124937-52-6 | Phenol, 2-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-methyl-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 124-94-7 | Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11.beta.,16.alpha.)- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 125-02-0 | Pregna-1,4-diene-3,20-dione, 11,17-dihydroxy-21-(phosphonooxy)-, disodium salt, (11.beta.)- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 125-04-2 | Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, sodium salt (1:1), (11.beta.)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 125109-85-5 | Benzenepropanal, .beta.-methyl-3-(1-methylethyl)- | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 125317-39-7 | Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-15-[(2R,6R,8S)-4-ethyl-1,3,6,7,8,9-hexahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2.beta.,3.beta.,4.beta.,5.alpha.,12R,19.alpha.)-, (2R,3R)-2,3-dihydroxybutanedioate (1:2) (salt) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 125494-59-9 | Cyclobutanemethanamine, 1-(4-chlorophenyl)-N,N-dimethyl-.alpha.-(2-methylpropyl)-, hydrochloride, hydrate (1:1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 125687-22-1 | Poly (oxy-1,2-ethanediyl) ,.alpha.,.alpha.'-(2- carboxy-2-methyl-1,3- propanediyl) bis [.omega.-hydroxy-, polymer with 2,4-diisocyanato-1- methylbenzene | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 125-71-3 | Morphinan, 3-methoxy-17-methyl-, (9.alpha.,13.alpha.,14.alpha.)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 1257857-19-4 | Furcellaran, ammonium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 1257964-88-7 | Flavones, isoflavones, soya | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 12584-58-6 | Insulin (swine) | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 125804-04-8 | Docosanoic acid, compd. with N-[3-(dimethylamino)propyl]docosanamide (1:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 125804-08-2 | Docosanoic acid, 2-octyldodecyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 125804-10-6 | 9,12-Octadecadienoic acid (9Z,12Z)-, dimer, compd. with (9Z,12Z)-N-[3-(dimethylamino)propyl]-9,12-octadecadienamide (1:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 125804-16-2 | Docosanoic acid, isooctadecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 125804-18-4 | Isononanoic acid, tridecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1259528-20-5 | Syrups, 4-O-.alpha.-D-glucopyranosyl-D-glucitol-high hydolyzed starch, hydrogenated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 1259528-21-6 | Syrups, sorbitol-high hydrolyzed starch, hydrogenated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 126094-21-1 | D-Gluconamide, N-(3-methoxypropyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 126121-35-5 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,2-bis(2-octyldodecyl) 3-(2-octyl-7-pentylheptyl) ester | Higher priority based on available information - Human health concern | Commercial activity identified | To be assessed |
| 126139-79-5 | L-Tyrosine, N-(3-carboxy-2-hydroxy-1-oxopropyl)-, disodium salt, (S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 12619-70-4 | Cyclodextrin | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 126-27-2 | Acetamide, 2,2'-[(2-hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 12629-01-5 | Somatotropin (human) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 12640-40-3 | Bismuth oxide | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 126-44-3 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, ion(3-) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 1264-72-8 | Colistin, sulfate (salt) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 12650-69-0 | Nonanoic acid, 9-[[(2Z)-3-methyl-1-oxo-4-[(2S,3R,4R,5S)-tetrahydro-3,4-dihydroxy-5-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methylpropyl]-2-oxiranyl]methyl]-2H-pyran-2-yl]-2-buten-1-yl]oxy]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 126506-93-2 | 1,3,2-Dioxastibolane-4,5-dicarboxylic acid, 2-hydroxy-, 2-oxide | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 12651-23-9 | Titanium hydroxide | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 126595-07-1 | Propanoic acid, 3,3'-(1,3-dioxo-1,3-digermoxanediyl)bis-, homopolymer | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 12684-19-4 | Lead iodide | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 126928-07-2 | Isooctadecanoic acid, monoester with hexaglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 127061-56-7 | L-Ascorbic acid, 2-[(2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-YL hydrogen phosphate], potassium salt (1:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 127281-18-9 | Glycerides, mixed decanoyl and octanoyl, reaction products with oxirane | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 127311-98-2 | 1-Propanaminium, 3-[[(9Z,12R)-12-hydroxy-1-oxo-9-octadecenyl]amino]-N,N,N-trimethyl-, chloride | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 12737-61-0 | 2-Propenoic acid, 2-methyl-, ester with 1,2,3-propanetriol, homopolymer | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 127-40-2 | .beta.,.epsilon.-Carotene-3,3'-diol, (3R,3'R,6'R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 127474-91-3 | 2,6-Naphthalenedicarboxylic acid, 2,6-bis(2-ethylhexyl) ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 127502-06-1 | 3,12-Dioxa-6,9-diphosphatetradecane, 6,9-bis(2-ethoxyethyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 127512-63-4 | Isooctadecanoic acid, monoester with triglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 12768-44-4 | 4H-1-Benzopyran-4-one, 3-[[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-beta-d-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-,hydrogen sulfate, sodium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 127770-27-8 | Hexadecanoic acid, isohexadecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 127779-20-8 | Butanediamide, N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-, (2S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 128-13-2 | Cholan-24-oic acid, 3,7-dihydroxy-, (3.alpha.,5.beta.,7.beta.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 128446-33-3 | .alpha.-Cyclodextrin, 2-hydroxypropyl ethers | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 128665-25-8 | Sorbitan, octadecanoate (2:3), poly(oxy-1,2-ethanediyl) derivs. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 128729-28-2 | 2-Propanol, 1,3-bis[(4-aminophenyl)(2-hydroxyethyl)amino]-, hydrochloride (1:4) | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 128794-94-5 | 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 128895-87-4 | Triglycerol, monohexadecyl ether | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 128973-71-7 | Siloxanes and Silicones, .alpha.-D-mannopyranuronoyloxy Me, hydroxy-terminated | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 128973-73-9 | Siloxanes and Silicones, Me[1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)acetyl]oxy, hydroxy-terminated | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 128973-74-0 | Siloxanes and Silicones, (2S-trans)-[[4-hydroxy-2-pyrrolidinyl)carbonyl]oxy] Me, hydroxyl-terminated | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 129-06-6 | 2H-1-benzopyran-2-one, 4-Hydroxy-3-(-oxo-1-phenylbutyl)-sodium salt (1:1) |
Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 129101-54-8 | Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 129318-43-0 | Phosphonic acid, P,P'-(4-amino-1-hydroxybutylidene)bis-, sodium salt (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 129423-55-8 | Dodecanedioic acid, 1,12-bis(2-octyldodecyl) ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 129426-19-3 | Hexadecanamide, N-[2-hydroxy-1-(hydroxymethyl)pentadecyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 129496-10-2 | Milbemycin, oxime | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 129497-78-5 | 24H,26H-Benzo[b]porphine-9,13-dipropanoic acid, 18-ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-, monomethyl ester, (4R,4aS)-rel- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 129499-78-1 | L-Ascorbic acid, 2-O-.alpha.-D-glucopyranosyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 129521-66-0 | Lignite | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 129541-40-8 | Tetradecanamide, N-[3-(dimethylamino)propyl]-, phosphate (1:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 129618-40-2 | 6H-Dipyrido[2,3-b:3',2'-e][1,4]diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 129691-05-0 | 5,8,11,14-Eicosatetraenoic acid, 2,3-dihydroxypropyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 129722-12-9 | 2(1H)-Quinolinone, 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 129757-76-2 | 2-Oxepanone, polymer with 1,6-diisocyanatohexane and 2-ethyl-2-(hydroxymethyl)-1,3-propanediol | Higher priority based on available information - Human health concern | Commercial activity identified | To be assessed |
| 1300-94-3 | Phenol, 5-methyl-2-pentyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 130169-63-0 | Siloxanes and Silicones, di-Me, [(1-oxooctadecyl)oxy]-terminated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 130209-82-4 | 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-, 1-methylethyl ester, (5Z)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1302-27-8 | Biotite ((Fe0.4-0.8Mg0.2-0.6)3K(Si3Al)[(OH)0.5-1F0-0.5]2O10) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 130291-58-6 | 2-Propenoic acid, 2-methyl-, 2-(dimethylamino)ethyl ester, homopolymer, compd. with bromomethane | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 130328-22-2 | 1,2,3- Propanetricarboxylic acid, 2-hydroxy-, esters with octadecanol,fatty acids,C12-18 and 1,3 propanediol,2,2-bis (hydroxymethyl) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 130353-64-9 | Quaternary ammonium compounds, coco alkyl(2,3-dihydroxypropyl)dimethyl, 3-ethers with cellulose 2-hydroxyethyl ether, chlorides | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 130381-02-1 | Protein hydrolyzates, soya, [3-(dodecyldimethylammonio)-2-hydroxypropyl], chlorides | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 130381-04-3 | Protein hydrolyzates, wheat germ, [3-(coco alkyldimethylammonio)-2-hydroxypropyl], chlorides | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 130381-05-4 | Protein hydrolyzates, wheat germ, [3-(dimethyloctadecylammonio)-2-hydroxypropyl], chlorides | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 130381-06-5 | Protein hydrolyzates, wheat germ, [3-(dodecyldimethylammonio)-2-hydroxypropyl], chlorides | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 130381-07-6 | Protein hydrolyzates, wheat germ, polymers with vinylpyrrolidone | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 130498-24-7 | Limnanthes alba, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 130501-87-0 | Stearalkonium Bentonite (Quaternary ammonium compound, Benzyl (hydrogenated C4-C18 alkyl) dimethyl, salts with Montmorillonite clay) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1306-04-3 | Chlorapatite (Ca5Cl(PO4)3) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 1306-05-4 | Fluorapatite (Ca5F(PO4)3) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 13078-36-9 | Glycine, N,N,-bis[2-bis(carboxymethyl)amino]ethyl]-, sodium salt (1:3) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 130905-60-1 | Hexanedioic acid, mixed esters with decanoic acid, 12-hydroxyoctadecanoic acid, isostearic acid, octanoic acid, 3,3'oxybis[1,2-propanediol] and stearic acid | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 13092-66-5 | Phosphoric acid, magnesium salt (2:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 130929-57-6 | 2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-, (2E)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 130-95-0 | Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)- | Higher priority based on available information - Human health concern | Commercial activity identified | To be assessed |
| 130986-04-8 | 2H-1-Benzopyran, 3,4-dihydro-2,5,7,8-tetramethyl-6-[[methylbis(9-octadecen-1-yloxy)silyl]oxy]-2-(4,8,12-trimethyltridecyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 13103-34-9 | Androsta-1,4-dien-3-one, 17-[(1-oxo-10-undecenyl)oxy]-, (17.beta.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 13103-75-8 | Benzenamine, N,N-dimethyl-4-[2-(2-pyridinyl)diazenyl]- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 131044-77-4 | Copper, N-acetyl-L-tyrosine hydroxy-terminated (S)-[2-(acetylamino)-3-(4-hydroxyphenyl)-1-oxopropoxy] Me siloxanes | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 131044-78-5 | Copper, hydroxy-terminated Me (S)-[[(5-oxo-2-pyrrolidinyl) carbonyl]oxy] siloxanes 5-oxo-L-proline complexes | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 131216-83-6 | Siloxanes and Silicones, 2-(acetylamino)-4-(methylthio)-1-oxobutyoxyMe, hydroxy-terminated | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 131252-83-0 | Dodecanedioic acid, diisohexadecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 131276-37-4 | Hexadecanamide, 9,10,16-trihydroxy-N-[2-hydroxy-3-(tetradecyloxy)propyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 131410-48-5 | Gadolinium, [5,8-bis[(carboxy-.kappa.O)methyl]-11-[2-(methylamino)-2-(oxo-.kappa.O)ethyl]-3-(oxo-.kappa.O)-2,5,8,11-tetraazatridecan-13-oato(3-)-.kappa.N5,.kappa.N8,.kappa.N11,.kappa.O13]- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 131410-50-9 | Calciate(1-), [5,8-bis[(carboxy-.kappa.O)methyl]-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oato(3-)-.kappa.N5,.kappa.N8,.kappa.N11,.kappa.O13]-, sodium (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1314-84-7 | Zinc phosphide (Zn3P2) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 13149-68-3 | D-Gluconic acid, 6-ester with N,N-bis(1-methylethyl)glycine | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 13149-69-4 | D-Gluconic acid, 6-[bis[bis(1-methylethyl)amino]acetate] | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1315-04-4 | Antimony sulfide (Sb2S5) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 1317-26-6 | Aluminum magnesium hydroxide (AlMg2(OH)7), monohydrate | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 1317-57-3 | Glauconite ([(Al0-1Fe0-1)1.33Mg0.67]K(Si3.67Al0.33)(OH)2O10) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 1318-02-1 | Zeolites | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 131812-48-1 | 1,3-Dioxolane, 2,4-dimethyl-2-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthalenyl)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 131812-49-2 | Naphthalene, 7-(diethoxymethyl)-1,2,3,4-tetrahydro-1,1,2,4,4-pentamethyl- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 131812-51-6 | 1,3-Dioxolane, 2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-, cis- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 131812-52-7 | 1,3-Dioxolane, 2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-, trans- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 131812-67-4 | 1,3-Dioxolane,2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 1319-53-5 | Malachite (Cu2(CO3)(OH)2) | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 131954-48-8 | 1-Propanaminium, N,N,N-trimethyl-3-[(2-methyl-1-oxo-2-propen-1-yl)amino]-, chloride (1:1), polymer with 1-ethenyl-2-pyrrolidinone | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 1321-57-9 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, mono(1-methylethyl) ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 132207-31-9 | Polysiloxanes, di-Me, 3-hydroxypropyl Me, ethers with polyethylene glycol dihydrogen phosphate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1322-14-1 | 10-Undecenoic acid, calcium salt (2:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 132259-10-0 | Air | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1323-66-6 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, monooctadecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 132467-76-6 | 1-Octadecanaminium, N-[2-hydroxy-3-[3-hydroxy-4-[(3-hydroxypropyl)amino]-2,2-dimethyl-4-oxobutoxy]propyl]-N,N-dimethyl-, chloride | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 132539-06-1 | 10H-Thieno[2,3-b][1,5]benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 132539-07-2 | 1-Piperidinepropanoic acid, 4-(methoxycarbonyl)-4-((1-oxopropyl)phenylamino)-, methyl ester, hydrochloride | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 132-69-4 | 1-Propanamine, N,N-dimethyl-3-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-, hydrochloride (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 132875-61-7 | 1-Piperidinepropanoic acid, 4-(methoxycarbonyl)-4-[(1-oxopropyl)phenylamino]-, methyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 132-98-9 | 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(2-phenoxyaxetyl)amino]-,potassium salt (1:1), (2S,5R,6R)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 133029-32-0 | Imidodicarbonimidic diamide, N-(3-aminopropyl)-, homopolymer | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 133040-01-4 | 2-Thiophenepropanoic acid, .alpha.-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-, (.alpha.E)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 133098-04-1 | Ethane, 2-chloro-2-(difluoromethoxy)-1,1,1-trifluoro-, (2R)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 133099-07-7 | 3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-.alpha., .alpha.-diphenyl-, hydrobromide (1 :1), (3S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 133101-79-8 | Elastins, esters with hydroxy-terminated hydroxy Me siloxanes | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 133107-64-9 | Insulin (human), 28B-L-lysine-29B-L-proline- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 1332-25-8 | C.I. Pigment Red 102 | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 133448-16-5 | Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, ethers with polyethylene glycol monoisostearate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1335-26-8 | Magnesium peroxide | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 1335-36-0 | 1,2,3-Propanetriol, mono(dihydrogen phosphate), manganese salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1335-56-4 | .alpha.-D-Glucopyranoside, .beta.-D-fructofuranosyl, mixt. with iron(2+) carbonate (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1336-17-0 | 2-Propanone, peroxide | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 133652-38-7 | 173-527-Plasminogen activator (human tissue-type), 173-L-serine-174-L-tyrosine-175-L-glutamine- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 133654-02-1 | Decanoic acid, ester with triglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 1337-20-8 | Chlorophyllins, copper potassium sodium | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 1337-89-9 | 1-Phenanthrenecarboxylic acid, 1,2,3,4,4a,4b,5,6,10,10a-decahydro-1,4a-dimethyl-7-(1-methylethyl)-, (1R,4aR,4bR,10aR)-, ester with 1,2,3-propanetriol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 133814-18-3 | Isoquinolinium, 2,2'-[(1,4-dioxo-1,4-butanediyl)bis(oxy-3,1-propanediyl)]bis[1,2,3,4-tetrahydro-6,7,8-trimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-, (1R,1'S,2S,2'R)-rel- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 133814-19-4 | Isoquinolinium, 2,2'-[[(4E)-1,8-dioxo-4-octene-1,8-diyl]bis(oxy-3,1-propanediyl)]bis[1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-, (1R,1'R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 1338929-66-0 | Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, ether with methyl D-glucopyranoside 2,6-di-(9Z)-9 octadecenoate (2:1),mono-(9Z)-9-octadecenoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 133934-09-5 | 1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-wheat-oil acyl derivs., inner salts | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 1340-06-3 | Ichthyolic acid, sodium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 134017-12-2 | Octadecanoic acid, 12-[(1- oxoisooctadecyl) oxy]-, isooctadecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 13408-62-3 | Ferrate(3-), hexakis(cyano-.kappa.C)-, (OC-6-11)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 134112-42-8 | 1-Propanaminium, N-[2-(dodecyloxy)-2-oxoethyl]-N,N-dimethyl-3-[(1-oxoisooctadecyl)amino]-,chloride | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 13412-64-1 | 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-, monosodium salt, monohydrate, (2S,5R,6R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 134134-87-5 | Proteins, oat | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 13429-07-7 | 2-Propanol, 1-(2-methoxypropoxy)- | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 134324-28-0 | Lactoferrin (cattle clone PM-8/PM-7 protein moiety reduced) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 134375-99-8 | Aluminum Zirconium Trichlorohydrex Gly | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 134523-00-5 | 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, (.beta.R,.delta.R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 134523-03-8 | 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, calcium salt (2:1), (.beta.R,.delta.R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 13460-51-0 | Boric acid (H3B3O6) | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 134678-17-4 | 2(1H)-Pyrimidinone, 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 134737-05-6 | Siloxanes and Silicones, di-Me, 3-[3-[(3-coco amidopropyl)dimethylammonio]-2-hydroxypropoxy]propyl group-terminated, acetates (salts) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 134774-45-1 | Oxidase, urate (Aspergillus flavus clone 9C/9A reduced) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 135062-02-1 | Benzoic acid, 2-ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 135236-72-5 | Butanoic acid, 3-hydroxy-3-methyl-, calcium salt (2:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 135322-32-6 | L-Ascorbic acid, compd. with chitosan | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 135326-54-4 | Propanol, (tetradecyloxy)-, acetate | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 1353675-54-3 | Lindera aggregata aggregata, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 1355047-06-1 | .alpha.-D-Glucopyranoside, methyl, isooctadecanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 135507-00-5 | Hyaluronic acid, dimethylsilyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 13552-80-2 | Undecanoic acid, 1,1',1"-(1,2,3-propanetriyl) ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 13557-75-0 | Dodecanoic acid, 2-(1-carboxyethoxy)-1-methyl-2-oxoethyl ester, sodium salt (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 136097-93-3 | Fatty acids, beeswax, monoesters with polyglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 136097-96-6 | Fatty Acids, C16-22, C>14-alkyl esters, reaction products with polyethylene | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 13614-98-7 | 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, hydrochloride (1:1), (4S,4aS,5aR,12aS)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 136207-49-3 | 3,6,9,12,15-Pentaoxaheptatriacontan-1-ol | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 136279-32-8 | Interleukin 2 (human), N-L-methionyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 136434-34-9 | 2-Thiophenepropanamine, N-methyl-.gamma.-(1-naphthalenyloxy)-, hydrochloride (1:1), (.gamma.S) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 136470-78-5 | 2-Cyclopentene-1-methanol, 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-, (1S,4R)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 136504-87-5 | 1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-soya acyl derivs., inner salts | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 136505-01-6 | 2-Propenenitrile, homopolymer, hydrolyzed, block, reaction products with N,N-dimethyl-1,3-propanediamine | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 136591-59-8 | Methanesulfonamide, N-[4-[(1S)-4-(ethylheptylamino)-1-hydroxybutyl]phenyl]-, (2E)-2-butenedioate (2:1) (salt) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 13682-92-3 | Aluminum, (glycinato-.kappa.N,.kappa.O)dihydroxy-, (T-4)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 136920-08-6 | 1-Propanaminium, N-(3-aminopropyl)-2,3-dihydroxy-N,N-dimethyl-, N-cocoacyl derivs., chlorides | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 137028-15-0 | Propanoic acid, 2,2-dimethyl-, isoeicosyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 137044-11-2 | 1-Propanaminium, 3-[2-(acetylamino)ethoxy]-N,N,N-trimethyl-, chloride | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 13710-19-5 | Benzoic acid, 2-[(3-chloro-2-methylphenyl)amino]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 137330-13-3 | Tylosin, 4A-O-de(2,6-dideoxy-3-C-methyl-a-L-ribo-hexopyranosyl)-20-deoxo-20-[(3R,5S)-3,5-dimethyl-1-piperidinyl]-, phosphate (1:1)(salt) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 13779-98-1 | Plumbane, tetraiodo- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 137862-53-4 | L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 137-88-2 | Pyridinium, 1-[(4-amino-2-propyl-5-pyrimidinyl)methyl]-2-methyl-, chloride, hydrochloride (1:1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 138068-37-8 | Hirudin (Hirudo medicinalis isoform HV1), 1-L-leucine-2-L-threonine-63-desulfo- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 138-14-7 | Butanediamide, N4-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N1-(5-aminopentyl)-N1-hydroxy-, methanesulfonate (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 138148-35-3 | Butanamide, N,N'-[dithiobis[2,1-ethanediylimino(3-oxo-3,1-propanediyl)]]bis[2,4-dihydroxy-3,3-dimethyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 138208-67-0 | Decanoic acid, 4-methylpentyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 13832-70-7 | Olean-12-en-29-oic acid, 3-hydroxy-11-oxo-, octadecyl ester, (3.beta.,20.beta.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 13837-60-0 | 2H-Pyran, 2-ethynyltetrahydro-2,6,6-trimethyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 13838-16-9 | Ethane, 2-chloro-1-(difluoromethoxy)-1,1,2-trifluoro- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 138-39-6 | Benzenesulfonamide, 4-(aminomethyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 138402-11-6 | 1,3-Diazaspiro[4.4]non-1-en-4-one, 2-butyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 1384982-80-2 | Quaternary Ammonium Compounds, dimethylbis (mixed C12-15-alkyl and cetyl and stearyl), chlorides | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 138530-95-7 | 1H-Benzimidazole, 2-[(S)-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 138680-08-7 | 1-Piperazinecarboxylic acid, 4-methyl-, (5R)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 13870-90-1 | Cobinamide, Co-(5'-deoxyadenosin-5'-yl)-, f-(dihydrogen phosphate), inner salt, 3'-ester with (5,6-dimethyl-1-.alpha.-D-ribofuranosyl-1H-benzimidazole-.kappa.N3) | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 138786-67-1 | 1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, sodium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 13887-98-4 | Acetic acid, 2,2'-[oxybis(2,1-ethanediyloxy)]bis- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 138890-62-7 | 2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide, 4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-, 1,1-dioxide, (4R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 60662-14-8 | Indate(2-)-111In, [N,N-bis[2 [bis(carboxymethyl)amino]ethyl]glycinato(5-)]-, disodium | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 139110-80-8 | D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 139247-28-2 | Poly(oxy-1,2-ethanediyl), .alpha.,.alpha.',.alpha."-1,2,3-propanetriyltris[.omega.-hydroxy-, benzoate | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 139264-17-8 | 2-Oxazolidinone, 4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-, (4S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 13945-76-1 | Dodecanoic acid, dodecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 139639-23-9 | Plasminogen activator, tissue-type | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1396764-55-8 | Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, lauryl Me, ethoxylated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 139755-83-2 | 7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-[2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1397-89-3 | [1R (1R ,3S ,5R ,6R ,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)]-33-[(3-Amino-3,6-dideoxy-.beta.-D-mannopyranosyl)oxy]-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1398-61-4 | Chitin | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 1399-80-0 | Benzenedimethanaminium, ar-dodecyl-ar,N,N,N,N',N',N'-heptamethyl-, dichloride, mixt. with ar-dodecyl-ar,N,N,N-tetramethylbenzenemethanaminium chloride | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 1401-54-3 | Naphtho[1,2-b]furan-2(3H)-one, decahydro-6,9a-dihydroxy-5a-methyl-3,9-bis(methylene)-, (3aS,5aS,6R,9aR,9bS)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 140207-93-8 | 4-O-Methyl-.alpha.-D-glucurono-.beta.-D-xylan, hydrogen sulfate, sodium salt | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 14028-44-5 | Dibenz[b,f][1,4]oxazepine, 2-chloro-11-(1-piperazinyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 1404-90-6 | 22H-8,11:18,21-Dietheno-23,36-(iminomethano)-13,16:31,35-dimetheno-1H,16H-[1,6,9]oxadiazacyclohexadecino[4,5-m][10,2,16]benzoxadiazacyclotetracosine, vancomycin deriv. | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 1404-93-9 | Vancomycin, hydrochloride | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 1405-41-0 | Gentamicin, sulfate (salt) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 1405-89-6 | Bacitracin Zinc | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 1405-97-6 | Gramicidin | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1406-66-2 | Tocopherols | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 140678-14-4 | Manganate(6-), [[N,N'-1,2-ethanediylbis[N-[[3-(hydroxy-.kappa.O)-2-methyl-5-[(phosphonooxy)methyl]-4-pyridinyl]methyl]glycinato-.kappa.N,.kappa.O]](8-)]-, trisodium trihydrogen, (OC-6-13)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 140-99-8 | Butanedioic acid, calcium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 141-02-6 | 2-Butenedioic acid (2E)-, 1,4-bis(2-ethylhexyl) ester | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 141121-11-1 | Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, ether with methyl .beta.-D-glucopyranoside (4:1), benzoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 141250-39-7 | Fatty acids, coco, diesters with polyethylene glycol hydrogen citrate, monosodium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 141464-42-8 | D-Glucopyranose, oligomeric, C8-16-alkyl glycosides | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1415-73-2 | 9(10H)-Anthracenone, 10-.beta.-D-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-, (10S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 141-86-6 | 2,6-Pyridinediamine | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 141-94-6 | 5-Pyrimidinamine, 1,3-bis(2-ethylhexyl)hexahydro-5-methyl- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 142104-11-8 | 2-Butenedioic acid (2E)-, di-C12-15-alkyl esters | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 142164-39-4 | Nickel carbonate hydroxide | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 142340-99-6 | Propanoic acid, 2,2-dimethyl-, 1,1'-[[[[2-(6-amino-9H-purin-9-yl)ethoxy]methyl] phosphinylidene]bis(oxymethylene)] ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 14246-53-8 | Glycine, N-(1-oxooctyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 142-55-2 | 2-hydroxypropyl laurate | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 142657-60-1 | Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, ethers with polyethylene glycol mono[[(3-coco amidopropyl)dimethylammonio]acetate],chlorides | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 142678-35-1 | 1H-Benzimidazole, 6-(difluoromethoxy)-2-[(S)-[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 142891-20-1 | 2-Propenoic acid, 2-chloro-3-[2-chloro-5-(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)phenyl]-, ethyl ester, (2Z)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 14289-32-8 | Propanamide, N-(2-methylphenyl)-2-(propylamino)-, (2R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1429320-75-1 | Butanedioic acid, 2-sulfo-, 1(or 4)-C10-16-alkyl esters, disodium salts | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 14307-43-8 | Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, ammonium salt (1:?) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 143110-73-0 | D-Glucose, 2-deoxy-6-O-[2-deoxy-2-[[(3R)-1-oxo-3-[(1-oxododecyl)oxy]tetradecyl]amino]-3-O-[(3R)-1-oxo-3-[(1-oxotetradecyl)oxy]tetradecyl]-4-O-phosphono-.beta.-D-glucopyranosyl]-2-[[(3R)-1-oxo-3-[(1-oxohexadecyl)oxy]tetradecyl]amino]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 143193-85-5 | 1H-1,2,4-Triazole-1-ethanol, .alpha.-(2-fluorophenyl)-.alpha.-(4-fluorophenyl)-, mixt. with guazatine acetate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 143201-11-0 | 6-Heptenoic acid, 7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-, sodium salt (1:1), (3R,5S,6E)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 143388-64-1 | 1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-, monohydrochloride | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1434719-44-4 | Protein hydrolyzates, saccharomyces cerevisiae zinc complexes | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 1434721-25-1 | Protein hydrolyzates, Saccharomyces cerevisiae magnesium complexes | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 1434722-94-7 | Protein hydrolyzates, Saccharomyces cerevisiae calcium complexes | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 1434729-64-2 | Protein hydrolyzates, saccharomyces cerevisiae calcium iron magnesium potassium sodium complexes | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 143485-69-2 | 13-Docosenoic acid, 9-octadecen-1-yl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 143491-57-0 | 2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 143653-53-6 | Immunoglobulin G1, anti-(human integrin .alpha.IIb.beta.3) Fab fragment (human-mouse monoclonal c7E3 clone p7E3VHhC.gamma.1 .gamma.1-chain), disulfide with human-mouse monoclonal c7E3 clone p7E3V.kappa.hC.kappa. .kappa.-chain | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 143-67-9 | Vincaleukoblastine, sulfate (1:1) (salt) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 143831-71-4 | Nuclease, deoxyribo- (human clone 18-1 protein moiety) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 144025-09-2 | 1H-Imidazole, 1-[2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-, (-)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 144034-80-0 | 1H-Indole-3-ethanamine, N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 144143-96-4 | 2-Thiophenepropanoic acid, .alpha.-((2-butyl-1-((4-carboxyphenyl)methyl)-1H-imidazol-5-yl)methylene)-, (.alpha.E)-, methanesulfonate (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 144377-73-1 | 4,6-Dioxa-14-aza-10-azonia-5-phosphadotriaconta-23,26-dien-1-aminium, 5-[3-[dimethyl[3-[[(9Z,12Z)-1-oxo-9,12-octadecadien-1-yl]amino]propyl]ammonio]-2-hydroxypropoxy]-2,8-dihydroxy-N,N,10,10-tetramethyl-15-oxo-N-[3-[[(9Z,12Z)-1-oxo-9,12-octadecadien-1-yl]amino]propyl]-, 5-oxide, chloride (1:3), (23Z,26Z)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 144470-58-6 | Octadecanoic acid, 12-hydroxy-, homopolymer, ester with 1,2,3-propanetriol homopolymer | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 144494-65-5 | L-Tyrosine, N-(butylsulfonyl)-O-[4-(4-piperidinyl)butyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 144514-51-2 | Waxes and waxy substance, derived from Citrus sinensis or Citrus aurantium, Rutaceae | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 144514-54-5 | Fatty acids, beeswax, mixed docosyl and 6-hydroxyhexyl esters | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 14452-57-4 | Magnesium peroxide (Mg(O2)) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 144610-93-5 | Propanoic acid, 2,2-dimethyl-, tetradecyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 144635-07-4 | Glycerides, butter-fat mono-, di- and tri-, oxidized | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 14465-68-0 | 9,12,15-Octadecatrienoic acid, 1,1',1"-(1,2,3-propanetriyl) ester, (9Z,9'Z,9"Z,12Z,12'Z,12"Z,15Z,15'Z,15"Z)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 144701-48-4 | [1,1'-Biphenyl]-2-carboxylic acid, 4'-[(1,4'-dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 1448790-48-4 | Soybean, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 145040-37-5 | 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 145-13-1 | Pregn-5-en-20-one, 3-hydroxy-, (3.beta.)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 145155-23-3 | 2-166-Interferon .beta.1 (human fibroblast reduced), 17-L-serine- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 145202-66-0 | 1H-Indole-3-ethanamine,N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-,benzoate (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 145269-34-7 | Hydrolyzed wheat protein hydroxypropyltriammonium | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 1460304-48-6 | Lactylic Esters of fatty acids Fatty acids, vegetable-oil, 1-carboxyethyl esters |
Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 1460307-26-9 | Lactylic Esters of fatty acids Fatty acids, tall-oil, 1-carboxyethyl esters |
Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 1460305-62-7 | Monosodium salts of Phosphorylated Mono and Diglycerides Glycerides, vegetable-oil mono- and di-, mono(dihydrogen phosphates), monosodium salts |
Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1460306-77-7 | Monosodium salts of Phosphorylated Mono and Diglycerides Glycerides, animal mono- and di-, mono(dihydrogen phosphates), monosodium salts |
Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 14611-52-0 | Benzeneethanamine, N,.alpha.-dimethyl-N-2-propyn-1-yl-, hydrochloride (1:1), (.alpha.R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 146-14-5 | Riboflavin 5'-(trihydrogen diphosphate), P'→5'-ester with adenosine | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 146192-98-5 | 2-Butenedioic acid (2Z)-, monobutyl ester, polymer with ethenyl acetate and 1,7,7-trimethylphenylbicyclo[2.2.1]hept-2-yl 2-propenoate | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 14639-25-9 | 2-Pyridinecarboxylic acid, chromium(3+) salt (3:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 1463-95-2 | Pyridinium, 2-[2-[(5-bromo-2-pyridinyl)amino]ethenyl]-1-ethyl-6-methyl-, iodide (1:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 146479-72-3 | Follicle-stimulating hormone (human .alpha.-subunit reduced), complex with follicle-stimulating hormone (human .beta.-subunit reduced) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 146632-08-8 | Siloxanes and Silicones, di-Me, Bu group- and 3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl group-terminated, polymers with 2-[[(heptadecafluorooctyl)sulfonyl]methylamino]ethyl acrylate and iso-Bu methacrylate | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 14663-23-1 | 2,4-Imidazolidinedione, 1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-, sodium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 147059-72-1 | 1,8-Naphthyridine-3-carboxylic acid, 7-[(1.alpha.,5.alpha.,6.alpha.)-6-amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 147221-93-0 | Methanesulfonamide, N-[2-[[4-[3-[(1-methylethyl)amino]-2-pyridinyl]-1-piperazinyl]carbonyl]-1H-indol-5-yl]-, methanesulfonate (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 147245-92-9 | L-Glutamic acid, polymer with L-alanine, L-lysine and L-tyrosine, acetate (salt) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 147398-77-4 | Ethanaminium, N-(carboxymethyl)-N,N-dimethyl-2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]-, inner salt, polymer with methyl 2-methyl-2-propenoate | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 147550-61-6 | Copper carbonate hydroxide | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 1476-53-5 | Benzamide, N-[7-[[3-O-(aminocarbonyl)-6-deoxy-5-C-methyl-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl]oxy]-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl]-4-hydroxy-3-(3-methyl-2-buten-1-yl)-, sodium salt (1:1) | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 14769-73-4 | Imidazo[2,1-b]thiazole, 2,3,5,6-tetrahydro-6-phenyl-, (6S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 147732-56-7 | L-Lysine, N-(1-oxohexadecyl)glycyl-L-histidyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 147732-57-8 | L-Tyrosine, N-[(9Z)-1-oxo-9-octadecenyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 14783-68-7 | bis(glycinato-N,O)magnesium | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 14798-03-9 | Ammonium | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 148-01-6 | Benzamide, 2-methyl-3,5-dinitro- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 14832-91-8 | Amethyst (SiO2) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 148506-50-7 | Poly[oxy-1,2-ethanediyl(dimethyliminio)-1,3-propanediylimino(1,6-dioxo-1,6-hexanediyl)imino-1,3-propanediyl(dimethyliminio)-1,2-ethanediyl chloride (1:2)] | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 148-79-8 | 1H-Benzimidazole, 2-(4-thiazolyl)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 148812-63-9 | Protein hydrolyzates, wheat, reaction products with palmitoyl chloride | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 149144-85-4 | Butanedioic acid, hydroxy-, di-C12-13-branched alkyl esters | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1492-18-8 | L-Glutamic acid, N-[4-[[(2-amino-5-formyl-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-, calcium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 14932-42-4 | Xenon, isotope of mass 133 | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 14982-50-4 | Galacturonic acid | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 14984-34-0 | D-Glucuronic acid, monosodium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 149845-06-7 | Butanediamide,N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1- dimethylethyl) amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl) propyl]-2-[(2-quinolinylcarbonyl)amino]-,(2S)-, methanesulfonate (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 150378-17-9 | D-erythro-Pentonamide, 2,3,5-trideoxy-N-[(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]-5-[(2S)-2-[[(1,1-dimethylethyl)amino]carbonyl]-4-(3-pyridinylmethyl)-1-piperazinyl]-2-(phenylmethyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 150399-23-8 | L-Glutamic acid, N-[4-[2-(2-amino-4, 7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, sodium salt (1:2) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 150599-70-5 | 1H-Imidazolium, 1-ethenyl-3-methyl-, methyl sulfate (1:1), polymer with 1-ethenyl-2-pyrrolidinone | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 150824-47-8 | 1,1-Ethenediamine, N-[(6-chloro-3-pyridinyl)methyl]-N-ethyl-N'-methyl-2-nitro-, (1E)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1508-65-2 | Benzeneacetic acid, .alpha.-cyclohexyl-.alpha.-hydroxy-, 4-(diethylamino)-2-butyn-1-yl ester, hydrochloride (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 151030-83-0 | Octadecanoic acid, 12-hydroxy-, ester with 2,2'-[oxybis(methylene)]bis[2-(hydroxymethyl)-1,3-propanediol] | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 151096-09-2 | 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 151186-19-5 | Lactoferrin (human precursor reduced) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 151319-34-5 | Acetamide, N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 151661-87-9 | Protein hydrolyzates, oat | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 151661-97-1 | Siloxanes and Silicones, di-Me, 3-hydroxypropyl group-terminated, ethers with polyethylene glycol monoester with beeswax | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 151-73-5 | Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, sodium salt (1:2), (11.beta.,16.beta.)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 151767-02-1 | Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, sodium salt (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 152459-95-5 | Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 152751-57-0 | 2-Propen-1-amine, hydrochloride (1:1), polymer with 2-(chloromethyl)oxirane | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 152887-30-4 | Protein hydrolyzates, wheat, [2-hydroxy-3-[3-trimethoxysilyl)propoxy]propyl], hydrolyzed | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 152923-56-3 | Immunoglobulin G1, anti-(human interleukin 2 receptor) (human-mouse monoclonal clone 1H4 .gamma.1-chain), disulfide with human-mouse monoclonal clone 1H4 light chain, dimer | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 153065-40-8 | Glycerides, Limnanthes alba | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 15307-81-0 | Benzeneacetic acid, 2-[(2,6-dichlorophenyl)amino]-, potassium salt (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 153190-98-8 | Oxirane, 2-methyl-, polymer with oxirane, monobenzoate, block | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 153259-65-5 | Cyclohexanecarboxylic acid, 4-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]-, cis- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| *153439-40-8/ 138452-21-8 | Benzeneacetic acid, 4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-.alpha.,.alpha.-dimethyl-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 153559-49-0 | Benzoic acid, 4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 153-61-7 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-, (6R,7R)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 154248-97-2 | Ceramidase, glucosyl- (human placenta isoenzyme protein moiety) 495-L-histidine- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 154248-98-3 | Glycols, 1,2-,C12-16,ethoxylated propoxylated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 154361-50-9 | Cytidine, 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 154-45-0 | Benzenemethanol, .alpha.-[1-(methylamino)ethyl]-, (R*,S*)-, sulfate (2:1) (salt) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 15454-75-8 | Zinc, bis(5-oxo-L-prolinato-.kappa.N1,.kappa.O2)-, (T-4)- | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 154598-52-4 | 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 15475-56-6 | L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, sodium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 15500-66-0 | Piperidinium, 1,1'-[(2.beta.,3.alpha.,5.alpha.,16.beta.,17.beta.)-3,17-bis(acetyloxy)androstane-2,16-diyl]bis[1-methyl-, dibromide | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 155-09-9 | Cyclopropanamine, 2-phenyl-, (1R,2S)-rel- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 155141-29-0 | 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (2Z)-2-butenedioate (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 155213-67-5 | 2,7,10,12-Tetraazatridecanoic acid, 4-hydroxy-12-methyl-9-(1-methylethyl)-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3S,4S,6S,9S)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 1553-41-9 | 5,8,11,14,17-Eicosapentaenoic acid | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 1555-53-9 | 9-Octadecenoic acid (9Z)-, magnesium salt (2:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 155601-30-2 | 1H-Pyrazole-1-ethanol,4,5-diamino-,sulfate (1:1) | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 155683-77-5 | Oxirane, 2-methyl-, polymer with oxirane, monoisodecyl ether | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 155715-93-8 | Gelatins, polymers with keratin hydrolyzates and L-lysine, hydroxy-N,N,N-trimethyl-1 propanaminium chloride-quaternized | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 155715-94-9 | Lactoglobulins, reaction products with succinic anhydride mono-C8-16-isoalkyl derivs., sulfonated, sodium salts | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 156028-14-7 | 1H-Imidazolium, 1-(carboxymethyl)-4,5-dihydro-1-(2-hydroxyethyl)-2-undecyl-, inner salt, sodium salt (1:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 156042-32-9 | L-Serine, N-(1-oxohexadecyl)-, tetradecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 15663-27-1 | Platinum, diamminedichloro-, (SP-4-2)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 156679-41-3 | N-dodecyl-[3-(4-dimethylamino)benzamido)-propyl]dimethylammonium tosylate | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 156715-43-4 | Protein hydrolyzates, soya, [3-(cocoalklydimethylammonio)-2-hydroxypropyl], chlorides | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 156715-50-3 | Collagens, pro- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 156798-09-3 | Keratins, hydrolyzates, [3-(coco alkyldimethylammonio)-2-hydroxypropyl], chlorides | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 156798-11-7 | Protein hydrolyzates, wheat, [2-hydroxy-3-(trimethylammonio)propyl] chlorides | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 156798-12-8 | Olive oil, unsaponifiables | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 15686-51-8 | Pyrrolidine, 2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methyl-, (2R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 15687-14-6 | Butanamide, N-[2-ethyl-2-(3-methoxyphenyl)butyl]-4-hydroxy- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 157009-77-3 | 9,12-Octadecadienoic acid (9Z,12Z)-, dimer, diisoeicosyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 1570-64-5 | Phenol, 4-chloro-2-methyl- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 157140-89-1 | 2,7-Dimethyl-4-oxa-octanitrile | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 157148-07-7 | 2-Pyrrolidinone, 1-ethenyl-, polymer with 1-triacontene | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 157479-51-1 | Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, ethers with polyethylene glycol monoeicosanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 157627-95-7 | Poly (oxy-1,2-ethanediyl), ,.alpha.-sulfo-.omega.-hydroxy-,C16-18 and C18-unsatd.alkyl ethers,sodium salts | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 15763-02-7 | Butanedioic acid, 2-hydroxy-, 1,4-dioctyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 15792-51-5 | Benzenesulfonic acid, 2,5-dichloro-4-[4,5-dihydro-3-methyl-5-oxo-4-[[3-[(phenylamino)sulfonyl]phenyl]azo]-1H-pyrazol-1-yl]-, monosodium salt | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 158112-80-2 | Oxiranemethanol,homopolymer,2-hydroxydodecyl ether | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 158483-23-9 | Poly(oxy-1,2-ethanediyl),.alpha.,.alpha.',.alpha."-1,2,3-propanetriyltris[.omega.-hydroxy-,2-hydroxypropanoate | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 158563-45-2 | L-Valinamide, L-methionyl-L-prolyl-D-phenylalanyl-L-arginyl-D-tryptophyl-L-phenylalanyl-L-lysyl-L-prolyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 158567-66-9 | Propanoic acid, 2,2-dimethyl-, 2-octyldodecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 158570-96-8 | Fats and Glyceridic oils, emu, Dromaius novaehollandiae | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 15876-39-8 | Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one,2',4',5',7'-tetrabromo-3',6'-dihydroxy, aluminum salt (3:2) | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 158765-79-8 | Micrococcus luteus, lysate | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 158966-92-8 | Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 15905-81-4 | Sulfuric acid, nickel salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 15905-86-9 | Nitric acid, uranium salt | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 159317-32-5 | Acetic acid, hydroxy-, isooctadecyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 159351-69-6 | Rapamycin, 42-O-(2-hydroxyethyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 159666-35-0 | 2-Propenoic acid, 2-methyl-, polymer with 1, 1-dimethylethyl 2-propenoate and ethyl 2-propenoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 159989-64-7 | 3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 159989-65-8 | 3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)-, methanesulfonate (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 160337-95-1 | Insulin (human), 21A-glycine-30Ba-L-arginine-30Bb-L-arginine- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 16040-38-3 | Phosphoric acid, lead salt | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 16051-77-7 | D-Glucitol, 1,4:3,6-dianhydro-, 5-nitrate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 16057-43-5 | Ethanol,2{2-(octadecyloxy)ethoxy}- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 160965-04-8 | Brazil nut, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 161074-67-5 | Glutens, hydrolyzates, reaction products with lauroyl chloride, sodiumsalts | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 161074-97-1 | D-Glucopyranose, oligomeric, C8-10-alkyl glycosides | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 161308-02-7 | Hexanedioic acid, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol, decanoate isooctadecanoate octanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 161756-30-5 | Poly(oxy-1,2-ethanediyl), .alpha.-dodecyl-.omega.-hydroxy-,2-hydroxy-1,2,3-propanetricarboxylate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 161814-49-9 | Carbamic acid, N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3S)-tetrahydro-3-furanyl ester | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 161973-10-0 | Magnesium, bis[6-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl-.kappa.O]-1H-benzimidazolato-.kappa.N3]-, (T-4)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 162011-90-7 | 2(5H)-Furanone, 4-[4-(methylsulfonyl)phenyl]-3-phenyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 162030-43-5 | Mannopyranuronic acid, 1-O-[hydroxymethyl [[(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)acetyl]oxy]silyl]- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 162353-59-5 | Quaternary ammonium compounds, (C10-20 and C10-20-unsatd. alkyl) (3-chloro-2-ydroxypropyl) dimethyl, chlorides, reaction products with silk protein hydrolyzates | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 162353-60-8 | Protein hydrolyzates, wheat, reaction products with cocoyl chloride, potassium salts | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 162359-56-0 | 1,3 Propanediol, 2-amino-2-[2-(4-octylphenyl)ethyl]-, hydrochloride (1 :1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 162888-05-3 | Octadecanoic acid, 12-hydroxy-, 16-methylheptadecyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 163545-26-4 | 1-165-Hematopoietic cell growth factor KL (human clone V19.8:hSCF162), N-L-methionyl-, dimer | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 163661-75-4 | Lipids, sunflower | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 16389-88-1 | Dolomite (CaMg(CO3)2) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 16391-75-6 | 29-Nordammara-17(20),24-dien-21-oic acid, 16-(acetyloxy)-3,11-dihydroxy-, (3.alpha.,4.alpha.,8.alpha.,9.beta.,11.alpha.,13.alpha.,14.beta.,16.beta.,17Z)-, compd. with 2,2'-iminobis[ethanol] (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1641-17-4 | Methanone, (2-hydroxy-4-methoxyphenyl)(4-methylphenyl)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 164250-88-8 | Sunflower oil, oleic acid-high | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 164288-56-6 | 1-Propanaminium, 3-amino-N-[2-[(2-hydroxyethyl)amino]-2-oxoethyl]-N,N-dimethyl-, N-C12-18 acyl derivs., chlorides | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 16455-61-1 | Ferrate(1-), [[.alpha.,.alpha.'-[1,2-ethanediyldi(imino-.kappa.N)]bis[2-(hydroxy-.kappa.O)benzeneacetato-.kappa.O]](4-)]-, sodium (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 16456-36-3 | Octanoic acid, tetradecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 164656-23-9 | 1H-Indeno[5,4-f]quinoline-7-carboxamide, N-[2,5-bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1649-18-9 | 1-Butanone, 1-(4-fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 16508-79-5 | 2-Naphthalenecarboxylic acid, 3-hydroxy-4-(2-phenyldiazenyl)-, barium salt (2:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 16508-80-8 | Benzoic acid, 2-(2,4,5,7-tetrabromo-6-hydroxy-3-oxo-3H-xanthen-9-yl)-, aluminum salt (1:?) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 165101-51-9 | Becaplermin | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 16561-29-8 | Tetradecanoic acid, (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9-yl ester | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 165745-27-7 | Carbamic acid, N-butyl-, 3-iodo-2-propyn-1-yl ester, mixt. with N-[1,3-bis(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl]-N,N'-bis(hydroxymethyl)urea | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 165800-03-3 | Acetamide, N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 16676-29-2 | Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, hydrochloride (1:1), (5.alpha.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 16693-53-1 | Glycine, N-methyl-N-(1-oxododecyl)-, compd. with 2,2',2"-nitrilotris[ethanol] (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 16761-12-9 | Heptanoic acid, potassium salt (1:1) | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 167747-36-6 | Fats and Glyceridic oils, mango kernel | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 167817-58-5 | D-Glucose, homopolymer, dodecyl ether | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1680-31-5 | Carbonic Acid, Dioctyl Ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 16816-67-4 | Butanamide, N,N'-[dithiobis[2,1-ethanediylimino(3-oxo-3,1-propanediyl)]]bis[2,4-dihydroxy-3,3-dimethyl-, (2R,2'R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 16824-78-5 | Phenol, 2,4,6-trinitro-, calcium salt | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 16830-15-2 | Urs-12-en-28-oic acid, 2,3,23-trihydroxy-, O-6-deoxy-.alpha.-L-mannopyranosyl-(1→4)-O-.beta,-D-glucopyranosyl-1→6)-.beta,-D-glucopyranosy ester, (2.alpha.,3.beta.,4.alpha.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 168456-53-9 | Poria cocos, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 168677-75-6 | Poly(oxy-1,2-ethanediyl), .alpha.,.alpha.'-[[(9Z,12Z)-(2,3-dihydroxypropyl)-9,12-octadecadien-1-yliminio]di-2,1-ethanediyl]bis[.omega.-hydroxy-, chloride (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 16887-00-6 | Chloride | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 16899-10-8 | Decanoic acid, 6-hydroxy- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 169105-05-9 | Starch, 2-[N,N-bis(2-carboxyethyl)amino]ethyl ether | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 169107-13-5 | Fats and Glyceridic oils, Limnanthes alba seed | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 16941-32-5 | Glucagon | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 169590-42-5 | Benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 169590-61-8 | Protein hydrolyzates, silk, [2-hydroxy-3-(trimethylammonio)propyl], chlorides | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 169590-62-9 | Caseins, hydrolyzates, [2-hydroxy-3-(trimethylammonio)propyl], chlorides | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 169590-80-1 | Protein hydrolyzates, silk, Et esters | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 16984-36-4 | D-Glucopyranose, 4-O-.alpha.-D-glucopyranosyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 17026-85-6 | 1-Hexadecanol, 1-(dihydrogen phosphate), potassium salt (1:?) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 170277-31-3 | Immunoglobulin G, anti-(human tumor necrosis factor) (human-mouse monoclonal cA2 heavy chain), disulfide with human-mouse monoclonal cA2 light chain, dimer | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 17121-12-9 | 1,3,5,7,2,4,6,8-Tetroxatetraphosphocane, 2,4,6,8-tetrahydroxy-,2,4,6,8-tetraoxide,ion(4-) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 171263-26-6 | Glycine, N-(1-oxohexadecyl)-L-valylglycyl-L-valyl-L-alanyl-L-prolyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1715-33-9 | Pregna-1,4-diene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11.beta.)- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 171596-29-5 | Pyrazino[1', 2' :1,6]pyrido[3, 4-b]indole-1,4-dione,6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R,12aR)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 171599-83-0 | 7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-[2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 172046-58-1 | Poly[oxy(methyl-1,2-ethanediyl)], .alpha.-hydro-.omega.-(tetradecyloxy)-, ester with 2-hydroxy-1,2,3-propanetricarboxylic acid (3:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 172275-79-5 | Starch, 1,3-dimethyl-2-oxo-4,5-imidazolidinediyl ether | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 172376-82-8 | 6,10-Dodecadienal, 3,7,11-trimethyl-, (6Z)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 1724-14-7 | erythro-Pentose, 2-deoxy- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 173010-79-2 | Quaternary ammonium compounds, coco alkyl(2,3-dihydroxypropyl)dimethyl, 3-phosphates (esters), chlorides, sodium salts | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 17375-37-0 | Carbonic acid, manganese salt | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 173763-15-0 | Aluminum Sesquichlorohydrate | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 173937-91-2 | 3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)- 2-oxoethyl]-2-(4-methoxyphenyl)-, (2R,3R,4S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 17407-37-3 | Butanedioic acid, 1-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl] ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 1744-22-5 | 2-Benzothiazolamine, 6-(trifluoromethoxy)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 174722-31-7 | Immunoglobulin G1, anti-(human CD20 (antigen)) (human-mouse monoclonal IDEC-C2B8 .gamma.1-chain), disulfide with human-mouse monoclonal IDEC-C2B8 .kappa.-chain, dimer | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 174761-16-1 | 1H-Imidazolium, 1-ethenyl-3-methyl-, methyl sulfate (1:1), polymer with 1-ethenylhexahydro-2H-azepin-2-one and 1-ethenyl-2-pyrrolidinone | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 17482-42-7 | Butanedioic acid, 2-hydroxy-, calcium salt (1:?) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 175357-18-3 | L-Phenylalanine, N-(1-oxo-10-undecen-1-yl)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 175893-70-6 | Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, diesters with caroboxymethyl wheat protein hydrolyzates | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 175893-71-7 | 2-Propenamide, N-[3-(dimethylamino)propyl]-2-methyl-, polymer with 1-ethenyl-2-pyrrolidinone, sulfate | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 17618-45-0 | Octadecanoic acid, 2-hexyldecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 17619-86-2 | Ethanol, 2-amino-, sulfite (salt) | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 17627-10-0 | L-Cystine, N,N'-bis(1-oxohexadecyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 17671-27-1 | Docosanoic acid, docosyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 17672-22-9 | Phenol, 2-amino-6-methyl- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 177080-35-2 | Phenol, 4-[(3-hydroxypropyl)amino]-2-nitro- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 177190-98-6 | 1-Propanaminium, N,N,N-trimrthyl-3-[(1-oxo-3-phenyl-2-propen-1-yl)amino]-,chloride (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 1778-02-5 | Pregn-5-en-20-one, 3-(acetyloxy)-, (3.beta.)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 17879-97-9 | Benzenepropanoic acid, 3-amino-.alpha.-ethyl-2,4,6-triiodo-, (R)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 179005-04-0 | Siloxanes and Silicones, 3-[4-[[[3-[(2,3-dihydroxypropyl)dimethylammonio]propyl]amino]carbonyl]-2-oxo-1-pyrrolidinyl]propyl Me, di-Me, 3-[3-[[3-(C8-22-acylamino)propyl]dimethylammonio]-2-hydroxypropyl phosphates], chlorides, sodium salts | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 179045-86-4 | Immunoglobulin G1, anti-(human interleukin 2 receptor) (human-mouse monoclonal CHI621 .gamma.1-chain), disulfide with human-mouse monoclonal CHI621 light chain, dimer | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 179268-62-3 | Isooctahexacontane | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 179268-63-4 | Isohexapentacontahectane | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 17941-34-3 | Hexadecanoic acid, 9,10,16-trihydroxy-, (9R,10R)-rel- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 17949-65-4 | Zinc, bis(2-pyridinecarboxylato-.kappa.N1,.kappa.O2-, (T-4)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 17955-88-3 | Trisiloxane, 1,1,1,3,5,5,5-heptamethyl-3-octyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 179911-08-1 | Propanamide, N-ethyl-N-(3-methylphenyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 180254-52-8 | Glycerides,sunflower-oil mono-and-di,ethoxylated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 180288-69-1 | Immunoglobulin G1, anti-(human p185neu receptor) (human-mouse monoclonal rhuMab HER2 .gamma.1-chain), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimer | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 18089-54-8 | Silanol, methyl- | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 182162-80-7 | Dodecanoic acid, 2-octyl-, 2-octyldodecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 182298-52-8 | Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, ethers with polyethylene glycol monolaurate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 182700-78-3 | Siloxanes and Silicones,3-[(3-aminopropyl)amino]propyl Me, di-Me, 3-hydroxypropyl Me, ethoxylated, [(hydroxydimethylsilyl)oxy]-terminated | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 183476-82-6 | L-Ascorbic acid, 2,3,5,6-tetrakis(2-hexyldecanoate) | Higher priority based on available information - Human health concern | Clarification required | TBD |
| 18358-13-9 | 2-Propenoic acid, 2-methyl-, ion(1-) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 185018-43-3 | L-Ascorbic acid, 2-[(3.beta.)-cholest-5-en-3-yl hydrogen phosphate], monosodium salt | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 18507-89-6 | 3-Quinolinecarboxylic acid, 6-(decyloxy)-7-ethoxy-4-hydroxy-, ethyl ester | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 185243-69-0 | 1-235-Tumor necrosis factor receptor (human) fusion protein with 236-467-immunoglobulin G1 (human .gamma.1-chain Fc fragment) | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 185429-83-8 | Ethanone, 1-[(1R,2S)-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethyl-2-naphthalenyl]-, rel- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 185630-77-7 | Fats and Glyceridic oils, Limnanthes alba seed, ethoxylated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 186511-05-7 | Sunflower oil, ethoxylated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 1867-66-9 | Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 186826-86-8 | 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 187175-42-4 | Silsesquioxanes, Me, hydroxy-terminated, alginate, compds. with caffeine | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 187339-62-4 | 1,2,3-Propanetriol, homopolymer, ether with methyl D-glucopyranoside dioctadecanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 187547-43-9 | Fatty Acids, C18-Unsatd., Dimers, Hydrogenated, Esters with Polyglycerol Diisostearate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 187991-39-5 | L-ascorbic acid, 6-O-(dihydroxymethylsilyl)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 188039-54-5 | Immunoglobulin G1, anti (respiratory syncytial virus protein F) (human-mouse monoclonal MEDI- 493.gamma.1-chain), disulfide with human-mouse monoclonal MEDI-493.kappa.-chain, dimer | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 188062-50-2 | 2-Cyclopentene-1-methanol, 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-, (1S,4R)-, sulfate (2:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 188627-80-7 | L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-.alpha.-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→6)-disulfide | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 188928-66-7 | Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, ethers with polyethylene glycol monoesters with beeswax fatty acids | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 18917-91-4 | Aluminum, tris[2-(hydroxy-.kappa.O)propanoato-.kappa.O]- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 18917-93-6 | Magnesium, bis[2-(hydroxy-.kappa.O)propanoato-.kappa.O]-, (T-4)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 189440-77-5 | 4,7-Octadienoic acid, methyl ester, (4E)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 190270-74-7 | L-Lysine dihydroxymethylsilyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 19035-79-1 | 1-Hexadecanol, 1-(dihydrogen phosphate), potassium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 190454-07-0 | Phosphoric acid, mono- and di-C9-15-alkyl esters | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 190524-47-1 | Inulin, octadecanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 191114-48-4 | 2H-Oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(1H,7H,9H)-tetrone, 4-ethyloctahydro-11-methoxy-3.alpha.-7,9,11,13,15-hexamethyl-1-[4-[4-(3- pyridinyl)-1H-imidazol-1-yl]butyl]-10-[[3,4,6-trideoxy-3-(dimethylamino)- .beta.-D-xylo-hexopyranosyl]oxy]-, (3.alpha.-S,4R,7R,9R,10R,11R,13R,15R,15aR)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 192230-28-7 | Irvingia gabonensis, extract | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 19237-84-4 | Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-furanyl-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 19248-94-3 | 2-Buten-1-ol, 2-methyl-, 1-acetate, (2E)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 192725-17-0 | 1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-.alpha.-(1-methylethyl)-2-oxo-, (.alpha.S)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 1929-30-2 | 2-Propenoic acid, 3-(4-methoxyphenyl)-, ethyl ester | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 1935-18-8 | 1-Butanaminium, 4-hydroxy-N,N,N-trimethyl-4-oxo-2-[(1-oxohexadecyl)oxy]-, inner salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 193888-44-7 | 1-Propanaminium, N-(carboxymethyl)-2-hydroxy-N-(2-hydroxyethyl)-N-[2-[(1-oxododecyl)amino]ethyl]-3-(phosphonooxy)-, inner salt, monosodium salt | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 193892-43-2 | Poly[oxy(dimethylsilylene)], .alpha.-docosyl-.omega.-(docosyloxy)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 194810-88-3 | Amylopectin, hydrogen dodecenylbutanedioate, calcium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1953-02-2 | Glycine, N-(2-mercapto-1-oxopropyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 1953-04-4 | 10H-Benzofuro[3a,3,2-ef][2]benzazepin-10-ol, 1,2,3,4,8a,9-hexahydro-7-methoxy-3-methyl-, hydrobromide (1:1), (8aS,10R,12aS)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 196618-13-0 | 1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R,4R,5S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 19666-16-1 | Benzoic acid, 2-hydroxy-, tridecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1972-08-3 | 6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR,10aR)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 1976-28-9 | 3-Pyridinecarboxylic acid, aluminum salt (3:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 19767-45-4 | Ethanesulfonic acid, 2-mercapto-, sodium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 1977-10-2 | Dibenz[b,f][1,4]oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 19774-82-4 | Methanone, (2-butyl-3-benzofuranyl)[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]-, hydrochloride (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 19794-93-5 | 1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one, 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 197969-51-0 | 1-Propanaminium, N,N,N-trimethyl-3-[(2-methyl-1-oxo-2-propen-1-yl)amino]-, chloride (1:1), polymer with methyl 2-propenoate and 2-propenoic acid | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 198404-98-7 | Cyclopropanemethanol, 1-methyl-2-[(1,2,2-trimethylbicyclo[3.1.0]hex-3-y)methyl]- | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 19881-18-6 | Benzene, 1-isothiocyanato-4-(4-nitrophenoxy)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 199277-69-5 | Octadecanoic acid, 12-(benzoyloxy)-, 2-ethylhexyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 2013-12-9 | D-Norvaline | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 2016-45-7 | 1-Hexadecanamine, N,N-dimethyl-, hydrochloride (1:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 202138-50-9 | 2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, 1,9-bis(1-methylethyl) ester, 5-oxide, (2E)-2-butenedioate (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 202148-87-6 | Acacia concinna, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 2040-10-0 | Ethanone, 1-[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 2040-64-4 | Tetradecanoic acid, dodecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 204206-44-0 | Hexanedioic acid, polymer with 1,2,3-propanetriol, 2-ethylhexanoate octadecanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 204255-11-8 | 1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1- ethylpropoxy)-, ethyl ester, (3R,4R,5S)-, phosphate (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 2043-43-8 | Propanamide, 2-hydroxy- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 20537-88-6 | Ethanethiol, 2-[(3-aminopropyl)amino]-, 1-(dihydrogen phosphate) | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 205537-77-5 | Poly[oxy(dimethylsilylene)], .alpha.-hydro-.omega.-hydroxy-, mixt. with dimethicone | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 20559-55-1 | Carbamic acid, (5-propoxy-1H-benzimidazol-2-yl)-, methyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 206354-95-2 | Isononanoic acid, 1,2,3-propanetriyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 20636-48-0 | 3,6,9,12-Tetraoxatetradecan-1-ol, 14-(4-nonylphenoxy)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 206555-98-8 | 5-Heptenoic acid, 7-[(1S,2S,3S,5R)-2-[(1E,3S)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-, (5Z)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 2068-78-2 | Vincaleukoblastine, 22-oxo-, sulfate (1:1) (salt) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 2068-80-6 | L-Aspartic acid, magnesium salt (2:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 208054-84-6 | 1,3-Benzenedicarboxylic acid, polymer with 2,2-dimethyl-1,3-propanediol, hexanedioic acid, 1,6-hexanediol, 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoic acid and 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, compd. with 2-amino-2-methyl-1-propanol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 208126-52-7 | Resin acids and Rosin acids, mixed esters with dipentaerythritol and 12-hydroxyoctadecanoic acid and stearic acid | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 208126-56-1 | Octadecanoic acid, 12-hydroxy-, mixed esters with dipentaerythritoland isostearic acid | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 208265-92-3 | Colony-stimulating factor (human), 3-hydroxypropyl-N-methionyl-, 1-ether with .alpha.-methyl-.omega.-hydroxypoly(oxy-1,2-ethanediyl) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 20858-25-7 | 3,6,9,12-Tetraoxatetracosanoic acid | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 20858-86-0 | D-Gluconic acid, 6-ester with N,N-dimethylglycine | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 20882-75-1 | 9H-Xanthen-9-one, 1,2,8-trihydroxy-6-methoxy- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 209216-23-9 | 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]- 6H-purin-6-one,monohydrate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 20938-62-9 | .beta.-Alanine, N-[(2R)-2,4-dihydroxy-3,3-dimethyl-1-oxobutyl]-, ion(1-) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 209802-43-7 | Isooctadecanoic acid, 1-methylheptyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 209810-58-2 | Erythropoietin [30-asparagine,32-threonine,87-valine, 88-asparagine,90-threonine] (human) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 21034-17-3 | Oxazolium, 3,4-dimethyl-2-[2-(phenylamino)ethenyl]-, iodide | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 21062-37-3 | Adenosine, thymidylyl-(3'→5')- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 21109-95-5 | Barium sulfide (BaS) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 21127-45-7 | 3,6,9,12,15-Pentaoxaheptacosanoic acid | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 21187-98-4 | Benzenesulfonamide, N-[[(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]-4-methyl- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 21245-01-2 | Benzoic acid, 4-(dimethylamino)-, 3-methylbutyl ester | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 2124-57-4 | 1,4-Naphthalenedione,2-[(2E,6E,10E,14E,18E,22E)-3,7,11,15,19,23,27-heptamethly-2,6,10,14,18,22,26-octacosaheptaen-1-yl]-3-mthly- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 21256-18-8 | 2-Oxazolepropanoic acid, 4,5-diphenyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 213127-10-7 | 2-Propen-1-aminium, N,N-dimethyl-N-2-propenyl-, chloride, polymer with 2-propenoic acid, sodium salt | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 2135-17-3 | Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,17,21-trihydroxy-16-methyl-, (6.alpha.,11.beta.,16.alpha.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 213629-14-2 | Siloxanes and Silicones, di-Me, Me hydrogen, reaction products with 1,5-hexadiene | On Domestic Substances List (DSL) | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 2136-71-2 | Ethanol, 2-(hexadecyloxy)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 214047-00-4 | L-Serine, N2-(1-oxohexadecyl)-L-lysyl-L-threonyl-L-threonyl-L-lysyl- | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 215231-33-7 | Cyclohexanol, 1-methyl-3-(2-methylpropyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 2152-34-3 | 2-amino-5-phenyl-1,3-oxazol-4-one | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 215322-01-3 | Eicosanedioic acid, ester with 1,2,3-propanetriol docosanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 21539-58-2 | .beta.-Alanine, N-methyl-N-(1-oxododecyl)-, sodium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 21542-96-1 | 1-Docosanamine, N,N-dimethyl- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 215647-85-1 | Interferon .alpha.-2b (human), pegylated | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 21593-23-7 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[[(4-pyridinylthio)acetyl]amino]-, (6R,7R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 217969-86-3 | 2-Methyl-2-propylcyclohexanone | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 2180-18-9 | Acetic acid, manganese salt | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 2197-63-9 | 1-Hexadecanol, 1,1'-(hydrogen phosphate) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 219861-08-2 | 5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-, (1S)-, ethanedioate (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 219989-84-1 | (1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2 (2-methylthiazol-4-yl)ethenyl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 220119-17-5 | Avermectin A1a, 25-cyclohexyl-4'-O-de(2,6-dideoxy-3-O-methyl-.alpha.-L-arabino-hexopyranosyl)-5-demethoxy-25-de(1-methylpropyl)-22,23-dihydro-5-(hydroxyimino)-, (5Z)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 220326-00-1 | Oxirane, 2-methyl-, polymer with oxirane, diisooctadecanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 220622-96-8 | Poly(oxy-1,2-ethanediyl),.alpha.-(carboxymethyl)-.omega.-hydroxy-, C12-14-alkyl ethers | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 220714-63-6 | Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, ethers with polyethylene glycol mono[3-(dimethyloctadecylammonio)-2-hydroxypropyl hydrogen phosphate], inner salts | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 220828-91-1 | 1-Propanaminium, N-(2-hydroxyethyl)-N,N-dimethyl-3-[(1-oxodocosyl)amino]-, chloride (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 221227-05-0 | L-Arginine, N-(1-oxohexadecyl)glycyl-L-glutaminyl-L-prolyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 22194-22-5 | Ethane, 2-chloro-1-(difluoromethoxy)-1,1,2-trifluoro-, (2R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 22204-24-6 | 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, compd. with 1,4,5,6-tetrahydro-1-methyl-2-[(1E)-2-(2-thienyl)ethenyl]pyrimidine (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 222400-35-3 | Protein hydrolyzates, wheat, isostearoyl, compds. With 2-amino-2-methyl-1-propanol | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 222400-43-3 | Protein hydrolyzates, oat, reaction products with lauroyl chloride, sodium salts | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 2224-49-9 | Dodecanoic acid, compd. with 2,2',2"-nitrilotris[ethanol] (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 22260-51-1 | Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'.alpha.)-, monomethanesulfonate (salt) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 22316-47-8 | 1H-1,5-Benzodiazepine-2,4(3H,5H)-dione, 7-chloro-1-methyl-5-phenyl- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 223266-93-1 | .alpha.-D-Galacturono-6-deoxy-.alpha.-L-galacto-.beta.-D-galactan | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 22366-99-0 | 9,10-Anthracenedione, 1-[(3-aminopropyl)amino]-4-(methylamino)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 223705-57-5 | Fatty acids, coco, 2-sulfoethyl esters, ammonium salts | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 223705-79-1 | Honey, 2-hydroxy-3-(trimethylammonio) propyl ethers, chlorides | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 223717-75-7 | Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, ether with methyl D-glucopyranoside (4:1), tri-(9Z)-9-octadecenoate | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 223747-87-3 | Argania spinosa, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 223748-41-2 | Sapindus Trifoliatus Fruit Extract | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 223748-90-1 | Lentinula edodes, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 223748-92-3 | Cyperus esculentus, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 223749-33-5 | Kigelia africana, ext | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 223749-71-1 | Quinoa, Chenopodium quinoa, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 223749-75-5 | Ahnfeltia concinna, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 223749-83-5 | chlorella vulgaris extract | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 223749-88-0 | Enteromorpha compressa, extract | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 223751-71-1 | Hypnea musciformis, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 223751-74-4 | Rhodymenia palmata, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 223751-76-6 | Porphyra umbilicalis, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 223751-78-8 | Sargassum filipendula, ext | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 223751-82-4 | Ganoderma lucidum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 224948-78-1 | Poly(oxy-1,2-ethanediyl), .alpha.-[2-[methylbis[2-[[(9Z)-1-oxo-9-octadecenyl]amino]ethyl]ammonio]ethyl]-.omega.-hydroxy-, methyl sulfate (salt) | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 225234-03-7 | Fats and Glyceridic oils, sea buckthorn, Hippophae rhamnoides | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 225234-07-1 | Fats and Glyceridic oils, Lupinus Alba | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 225234-12-8 | Fats and Glyceridic oils, borage seed | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 225234-14-0 | Fats and Glyceridic oils, shea butter, unsaponifiable fraction | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 22613-51-0 | 2-acetoxyethyl stearate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 226700-81-8 | Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl]-, C-[(3S)-tetrahydro-3-furanyl] ester, calcium salt (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 226708-41-4 | Fatty acids, olive-oil, ethoxylated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 22694-75-3 | Boric acid (H3BO3), triammonium salt | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 226995-92-2 | Poly(oxy-1,2-ethanediyl), .alpha.-[2-[bis(2- aminoethyl)methylammonio]ethyl]-.omega.-hydroxy-, N,N'-di-Limnanthes alba seed-oil acyl derivs., Me sulfates (salts) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 227025-08-3 | Oat, hydrolyzed | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 227025-35-6 | Protein hydrolyzates, egg shell membrane | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 227200-22-8 | L-Ascorbic acid, reaction products with methylsilanetriol and pectin | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 227605-22-3 | Lithium magnesium sodium oxide silicate (Li0.03Mg0.39Na0.07O0.15(Si2O5)0.28) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 22766-83-2 | Tetradecanoic acid, 2-octyldodecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 22794-26-9 | L-Proline, 5-oxo-, dodecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 22801-45-2 | 9-Octadecenoic acid (9Z)-, 2-octyldodecyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 22916-47-8 | 1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 229975-97-7 | 2,5,6,10,13-Pentaazatetradecanedioic acid, 3-12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[-4-(2-pyridinyl)phenyl]methyl]-, dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1) (salt) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 23031-32-5 | 1,3-Benzenediol, 5-[2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-, sulfate (2:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 23059-38-3 | Cyclohexanecarboxylic acid, 1,4-dimethyl-, methyl ester, cis- | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 2307-68-8 | Pentanamide, N-(3-chloro-4-methylphenyl)-2-methyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 23155-02-4 | Phosphonic acid, P-[(2R,3S)-3-methyl-2-oxiranyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 2315-66-4 | 3,6,9,12,15,18,21,24,27-Nonaoxanonacosan-1-ol, 29-[4-(1,1,3,3-tetramethylbutyl)phenoxy]- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 23250-42-2 | Cyclohexanecarboxylic acid, 1,4-dimethyl-, methyl ester, trans- | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 23277-43-2 | Morphinan-3,6,14-triol, 17-(cyclobutylmethyl)-4,5-epoxy-, hydrochloride, (5.alpha.,6.alpha.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 23288-49-5 | Phenol, 4,4'-[(1-methylethylidene)bis(thio)]bis[2,6-bis(1,1-dimethylethyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 23312-56-3 | 4H-Pyrano[2,3-b][1,4]benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, (2R,4aR,5aR,6S,7S,8R,9S,9aR,10aS)-, sulfate (1:1) | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 233603-23-1 | Fatty acids, lanolin, 2-octyldodecyl esters | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| *23444-65-7/ 8001-98-7 | 1,4-Naphthoquinone, 5,8-dihydroxy-6-(1-hydroxy-4-methyl-3-pentenyl)-, (-)- ) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 234447-17-7 | 1-Propanone, 1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-, hydrochloride, (-)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 235783-76-3 | 9-Octadecenoic acid, 12-hydroxy-, (9Z,12R)-, homopolymer, ester with triglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 2364-67-2 | 1-Propanaminium, 3-carboxy-N,N,N-trimethyl-2-[(1-oxohexadecyl)oxy]-, inner salt, (2R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 2370-64-1 | Dodecanoic acid, 17-hydroxy-3,6,9,12,15-pentaoxaheptadec-1-yl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 23736-58-5 | 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)-, compd. with N,N'-bis(phenylmethyl)-1,2-ethanediamine (2:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 2375-03-3 | Pregna-1,4-diene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, monosodium salt, (6.alpha.,11.beta.)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 2380-86-1 | 1H-Indol-6-ol | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 23964-57-0 | 2-Thiophenecarboxylic acid, 4-methyl-3-[[1-oxo-2-(propylamino)propyl]amino]-, methyl ester, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 241148-25-4 | Oils, Calophyllum inophyllum | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 2420-29-3 | 3,6,9,12,15,18-Hexaoxahexatriacontan-1-ol | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 2420-56-6 | 10,12-Octadecadienoic acid, (10E,12Z)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 242138-07-4 | Immunoglobulin G1, anti-(human immunoglobulin E Fc region) (human-mouse monoclonal E25 clone pSVIE25. gamma.-chain), disulfide with human-mouse monoclonal E25 clone pSVIE25 .kappa.-chain, dimer | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 24292-52-2 | 2-Propen-1-one, 1-[4-[[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-2-hydroxy-6-methoxyphenyl]-3-(3-hydroxy-4-methoxyphenyl)-, (2E)- | Higher priority based on available information - Human health concern | Clarification required | TBD |
| 24305-27-9 | L-Prolinamide, 5-oxo-L-prolyl-L-histidyl- | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 243133-67-7 | Poly(oxy-1,2-ethanediyl), .alpha.-(2-hydroxytetradecyl)-.omega.-hydroxy-,.omega. -C16-18-alkyl ethers | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 243137-53-3 | Siloxanes and Silicones, di-Me, polymers with mono[(ethenyldimethylsilyl)oxy]-terminated di-Me siloxanes | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 244023-79-8 | Carrageen, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 244058-54-6 | Pseudopterogorgia elisabethae, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 2451-01-6 | Cyclohexanemethanol, 4-hydroxy-.alpha.,.alpha.,4-trimethyl-, monohydrate, cis- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 245443-07-6 | L-Glutamic acid, N-(1-oxododecyl)-, mixed (3β)-cholest-5-en-3-yl 2-octyldodecyl esters | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 245443-08-7 | L-Glutamic acid, N-(1-oxododecyl)-, mixed (3β)-cholest-5-en-3-yldocosyl 2-octyldodecyl esters | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 24545-86-6 | Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 3',6'-dihydroxy-4',5'-dinitro- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 24584-09-6 | 2,6-Piperazinedione, 4,4'-[(1S)-1-methyl-1,2-ethanediyl]bis- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 246159-33-1 | D-Glucopyranose, C16-18-alkyl glycosides | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 246864-39-1 | Decanoic acid, 1,2,3-propanetriyl ester, reaction products with polyethylene glycol and 1,2,3-propanetriyl trioctanoate | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 246865-89-4 | Fats and Glyceridic oils, coriander seed | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 24729-96-2 | L-threo-.alpha.-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, 2-(dihydrogen phosphate) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 247588-54-1 | Fats and Glyceridic oils, Pongamia glabra | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 248596-59-0 | Siloxanes and Silicones, di-Me, 3-[[(9Z,12R)-12-hydroxy-1-oxo-9- octadecenyl]oxy]propyl group-terminated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 24871-34-9 | 3,6,9,12,15,18,21,24,27,30-Decaoxaoctatetracont-39-en-1-ol, (39Z)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 2487-40-3 | 6H-Purin-6-one, 1,2,3,9-tetrahydro-2-thioxo- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 24905-87-1 | Ethanol, 2-[(4-amino-3-nitrophenyl)amino]- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 2490-97-3 | L-Glutamine, N2-acetyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 24936-74-1 | Poly[imino-1,6-hexanediylimino(1,12-dioxo-1,12-dodecanediyl)] | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 2495-84-3 | L-Ascorbic acid, 6-(9Z)-9-octadecenoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 24967-93-9 | Chondroitin, 4-(hydrogen sulfate) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 24967-94-0 | Dermatan, hydrogen sulfate (ester) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 25014-12-4 | 2-Propenamide, 2-methyl-, homopolymer | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 25104-18-1 | L-Lysine, homopolymer | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 25126-32-3 | 3-10-Caerulein, 5-L-methionine- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 25136-75-8 | 2-Propen-1-aminium, N,N-dimethyl-N-2-propen-1-yl-, chloride (1:1), polymer with 2-propenamide and 2-propenoic acid | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 25167-62-8 | Docosahexaenoic acid | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 25212-15-1 | 1,3-Pentadiene, homopolymer | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 25248-42-4 | Poly[oxy(1-oxo-1,6-hexanediyl)] | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 25249-06-3 | D-Galacturonic acid, homopolymer | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 25316-40-9 | 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, hydrochloride (1:1), (8S,10S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 25339-99-5 | .alpha.-D-Glucopyranoside, .beta.-D-fructofuranosyl, monododecanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 25378-27-2 | Eicosapentaenoic acid | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 25395-66-8 | L-Ascorbic acid, monooctadecanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 2540-56-9 | 9,11-Octadecadienoic acid, (9Z,11E)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 25482-78-4 | Peroxymonosulfuric acid, potassium salt | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 25497-28-3 | Ethane, difluoro- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 25513-46-6 | L-Glutamic acid, homopolymer | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 25568-84-7 | 1,3-Cyclopentadiene, homopolymer | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 25637-91-6 | Dodecanoic acid, diester with 5-hydroxy-6-methyl-3,4-pyridinedimethanol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 2565-36-8 | Ethanol, 2,2'-[methylenebis(oxy)]bis- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 2568-33-4 | 1,3-Butanediol, 3-methyl- | Higher priority based on available information - Human health concern | Clarification required | TBD |
| 25709-83-5 | Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one,2',4',5'-tribromo-3',6'-dihydroxy- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 25709-84-6 | Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one,2',4',7'-tribromo-3',6'-dihydroxy- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 25852-45-3 | Poly (oxy-1, 2-ethanediyl), .alpha.-phosphono-.omega.-(dodecyloxy)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 25905-73-1 | 9-Octadecenoic acid, 2-hydroxyethyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 25999-20-6 | Benzoic acid, 6-[(3R,4S,5S,7R)-7-[(2S,3S,5S)-5-ethyl-5-[(2R,5R,6S)-5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]tetrahydro-3-methyl-2-furanyl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methyl-, monosodium salt | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 26085-09-6 | 9,12-Octadecadienoic acid, dimer | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 26086-33-9 | Hexanoic acid, 2-ethyl-, 1,1'-[2-ethyl-2-[[(2-ethyl-1-oxohexyl)oxy]methyl]-1,3-propanediyl] ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 26100-51-6 | Propanoic acid, 2-hydroxy-, homopolymer | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 26124-25-4 | Propanoic acid, ethenyl ester, polymer with ethenyl acetate and 1-ethenyl-2-pyrrolidinone | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 261-31-4 | 9H-Thioxanthene | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 2615-15-8 | 3,6,9,12,15-Pentaoxaheptadecane-1,17-diol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 26159-34-2 | 2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, sodium salt (1:1), (.alpha.S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 261713-82-0 | Poly(oxy-1,2-ethanediyl), .alpha.-(2-hydroxypropyl)-.omega.-[1-methyl-2-[1-methyl-2-[(1-oxododecyl)oxy]ethoxy]ethoxy]- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 26264-02-8 | 3,6,9,12-Tetraoxatetradecan-1-ol, 14-(nonylphenoxy)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 26317-27-1 | Cuprate(3-), [(7S,8S)-3-carboxy-5-(carboxymethyl)-13-ethenyl-18-ethyl-7,8-dihydro-2,8,12,17-tetramethyl-21H,23H-porphine-7-propanoato(5-)-.kappa.N21,.kappa.N22,.kappa.N23,.kappa.N24]-, trihydrogen, (SP-4-2)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 2638-43-9 | 3,6,9,12,15,18,21-Heptaoxatricosan-1-ol, 23-[4-(1,1,3,3-tetramethylbutyl)phenoxy]- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 26402-22-2 | Decanoic acid, monoester with 1,2,3-propanetriol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 26402-26-6 | Octanoic acid, monoester with 1,2,3-propanetriol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 26446-38-8 | .alpha.-D-Glucopyranoside,.beta.-D-fructofuranosyl,monohexadecanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 26499-65-0 | Plaster of Paris (Ca(SO4).1/ 2H2O) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 26538-44-3 | 1H-2-Benzoxacyclotetradecin-1-one, 3,4,5,6,7,8,9,10,11,12-decahydro-7,14,16-trihydroxy-3-methyl-, (3S,7R)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 26545-51-7 | Benzamide, N,N-diethylmethyl- | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 26566-61-0 | Galactose | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 26636-40-8 | Poly(oxy-1,2-ethanediyl), .alpha.-docosyl-.omega.-hydroxy- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 26658-83-3 | 2-Propenoic acid, 2-methyl-, butyl ester, polymer with 2-(dimethylamino)ethyl 2-methyl-2-propenoate | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 26675-46-7 | Ethane, 2-chloro-2-(difluoromethoxy)-1,1,1-trifluoro- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 26699-71-8 | Hexanedioic acid, monoester with 1,2,3-propanetriol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 26780-50-7 | 1,4-Dioxane-2,5-dione, 3,6-dimethyl-, polymer with 1,4-dioxane-2,5-dione | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 26787-65-5 | Octacosanoic acid, 2-hydroxyethyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 26793-35-1 | 2-Propenoic acid, polymer with N,N-dimethyl-2-propenamide | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 26826-30-2 | Ethanol, 2-[2-[2-(tetradecyloxy)ethoxy]ethoxy]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| *26874-89-5/ 53906-28-8/ 28651-01-6 | .beta.-D-Glucopyranose,homopolymer | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 26915-12-8 | Benzenamine, ar-methyl- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 26920-62-7 | 1-Docosanaminium, N-(carboxymethyl)-N,N-dimethyl-, inner salt | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 26942-95-0 | Isooctadecanoic acid, 1,1',1"-(1,2,3-propanetriyl) ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 2709-56-0 | 1-Piperazineethanol, 4-[3-[2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 27164-46-1 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[2-(1H-tetrazol-1-yl)acetyl]amino]-, sodium salt (1:1), (6R,7R)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 27177-03-3 | 3,6,9,12,15,18-Hexaoxaeicosan-1-ol, 20-(nonylphenoxy)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 27177-07-7 | 3,6,9,12,15,18,21,24,27-Nonaoxanonacosan-1-ol, 29-(octylphenoxy)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 27214-38-6 | Tetradecanoic acid, monoester with 1,2,3-propanetriol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 27216-37-1 | .alpha.-D-Glucopyranoside, .beta.-D-fructofuranosyl, diacetate hexakis(2-methylpropanoate) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 27233-34-7 | Poly(oxy-1,2-ethanediyl), .alpha.-sulfo-.omega.-[(9Z)-9-octadecen-1-yloxy]-, sodium salt (1:1) | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 27299-12-3 | D-Glucitol, 1,4-anhydro- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 27306-90-7 | Poly (oxy-1,2-ethanediyl), .alpha.-(carboxymethyl)-.omega.-(dodecyloxy)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 27321-72-8 | Stearic Acid, Monoester with Triglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 2748-88-1 | Pyridinium, 4-methyl-1-tetradecyl-, chloride (1:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 27522-09-4 | Boric acid (H3BO3), ammonium salt (1:?) | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 27636-82-4 | 2,4-Imidazolidinedione, (hydroxymethyl)-5,5-dimethyl- | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 27640-89-7 | 13-Docosenoic acid, (13Z)-13-docosen-1-yl ester, (13Z)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 27707-45-5 | .alpha. -D-Glucopyranose, homopolymer | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 27836-64-2 | D-Glucopyranoside, dodecyl | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 27836-65-3 | D-Glucopyranoside, octadecyl | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 27841-04-9 | Heptanoic acid, 1,1'-(2,2-dimethyl-1,3-propanediyl) ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 27841-06-1 | Decanoic acid, 1,1'-(2,2-dimethyl-1,3-propanediyl) ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 2784-94-3 | Ethanol, 2,2'-[[4-(methylamino)-3-nitrophenyl]imino]bis- | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 27871-49-4 | Propanoic acid, 2-hydroxy-, methyl ester, (2S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 27876-94-4 | 2,4,6,8,10,12,14-Hexadecaheptaenedioic acid, 2,6,11,15-tetramethyl-, (2E,4E,6E,8E,10E,12E,14E)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 27923-63-3 | .alpha.-D-Glucopyranoside, .beta.-D-fructofuranosyl, trioctadecanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 28088-63-3 | Benzenesulfonic acid, dimethyl-, calcium salt (2:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 28212-44-4 | Poly(oxy-1,2-ethanediyl),.alpha.-(carboxymethyl)-.omega.-(4-nonylphenoxy)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 282527-44-0 | Hexanedioic acid, polymer with 1,2,3-propanetriol and 2,2,4-trimethyl-1,3-pentanediol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 28261-54-3 | Pyrrolidinone | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 28302-36-5 | Cuprate(3-), [(7S,8S)-3-carboxy-5-(carboxymethyl)-13-ethenyl-18-ethyl-17-formyl-7,8-dihydro-2,8,12-trimethyl-21H,23H-porphine-7-propanoato(5-)-.kappa.N21,.kappa.N22,.kappa.N23,.kappa.N24]-, sodium (1:3), (SP-4-2)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 28305-25-1 | Propanoic acid, 2-hydroxy-, calcium salt (2:1), (2S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 2835-98-5 | Phenol, 2-amino-5-methyl- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 2835-99-6 | Phenol, 4-amino-3-methyl- | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 28371-16-6 | 9(10H)-Anthracenone, 10-.beta.-D-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-, (10R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 28395-03-1 | Benzoic acid, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 28474-90-0 | L-Ascorbic acid, dihexadecanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 28523-86-6 | Propane, 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 28602-69-9 | Diphosphoric acid, ammonium manganese(2+) salt (2:2:3) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 28633-45-6 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, iron(3+) salt (1:?) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 287115-59-7 | 2,4,6-Octatriene, 2,6-dimethyl-, hydrogenated, acid-hydrated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 287115-61-1 | 3-Penten-2-one, 4-methyl-, self-condensation products | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 28721-07-5 | 5H-Dibenz[b,f] azepine-5-carboxamide, 10,11-dihydro-10-oxo- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 288094-77-9 | 1-Propene, 2-methyl-, homopolymer, hydrogenated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 28829-38-1 | Poly[imino[(1S)-1-(2-carboxyethyl)-2-oxo-1,2-ethanediyl] sodium salt (1:1)] | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 28855-27-8 | Benzenemethanaminium, ar-dodecyl-ar,N,N,N-tetramethyl-, chloride | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 28874-51-3 | L-Proline, 5-oxo-, sodium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 288839-50-9 | 1-Octadecanaminium, N,N-dimethyl-N-octyl-, methyl sulfate (1:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 29059-24-3 | Tetradecanoic acid, monoester with 1,2-propanediol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 29116-98-1 | Sorbitan, di-(9Z)-9-octadecenoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 29193-02-0 | L-Proline, 5-oxo-, manganese salt (1:?) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 2919-66-6 | Pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-methyl-16-methylene- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 293-51-6 | Cyclotetrasiloxane | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 29354-98-1 | Hexadecanol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 2937-54-4 | Ethanesulfonothioic acid, 2-amino- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 29383-26-4 | Octadecanoic acid, hydroxyl-, 2-ethylhexyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 2944-65-2 | Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, iron(2+) salt (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 29454-16-8 | Butanedioic acid, 2-sulfo-, sodium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 29457-07-6 | 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[(2R)-carboxy-3-thienylacetyl]amino]-3,3-dimethyl-7-oxo-, disodium salt, (2S,5R,6R)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 29894-35-7 | 9-Octadecenoic acid, 12-hydroxy-, (9Z,12R)-, polymer with 1,2,3-propanetriol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 299184-75-1 | Oils, Argania spinosa | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 29923-31-7 | L-Glutamic acid, N-(1-oxododecyl)-, sodium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 299-39-8 | 7,14-Methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine, dodecahydro-, (7S,7aR,14S,14aS)-, sulfate (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 299-42-3 | Benzenemethanol, .alpha.-[(1S)-1-(methylamino)ethyl]-, (.alpha.R)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 3.1.1.73 | 4-hydroxy-3-methoxycinnamoyl-sugar hydrolase | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 3.2.1.6 | 3-(1→3;1→4)-.beta.-D-glucan 3(4)-glucanohydrolase | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 3.2.1.7 | 1.-beta.-D-fructan fructanohydrolase | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 3.2.1.133 | 1, 4-.alpha.-D glucan alpha-maltohydrolase | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 3.4.11 | Aminopeptidase | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 3.4.21 | Serine endopetidase | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 3.4.22.3 | Ficin | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 302-27-2 | Aconitane-3,8,13,14,15-pentol, 20-ethyl-1,6,16-trimethoxy-4-(methoxymethyl)-, 8-acetate 14-benzoate, (1.alpha.,3.alpha.,6.alpha.,14.alpha.,15.alpha.,16.beta.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 30233-64-8 | Docosanoic acid, monoester with 1,2,3-propanetriol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 302-96-5 | 1'H-Androstano[3,2-c]pyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 30364-51-3 | Glycine, N-methyl-N-(1-oxotetradecyl)-, sodium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 303-98-0 | 2,5-Cyclohexadiene-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaen-1-yl]-5,6-dimethoxy-3-methyl- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 304-55-2 | Butanedioic acid, 2,3-dimercapto-, (2R,3S)-rel- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 30484-77-6 | Piperazine, 1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenyl-2-propenyl]-, dihydrochloride | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 3055-93-4 | Ethanol, 2-[2-(dodecyloxy)ethoxy]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 3055-94-5 | Ethanol, 2-[2-[2-(dodecyloxy)ethoxy]ethoxy]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 3055-97-8 | 3,6,9,12,15,18,21-Heptaoxatritriacontan-1-ol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 3055-98-9 | 3,6,9,12,15,18,21,24-Octaoxahexatriacontan-1-ol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 3055-99-0 | 3,6,9,12,15,18,21,24,27-Nonaoxanonatriacontan-1-ol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 3056-17-5 | Thymidine, 2',3'-didehydro-3'-deoxy- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 305812-16-2 | Poly(oxy-1,2-ethanediyl), .alpha. , .alpha'. , .alpha".-1,2,3-propanetriyltris [.omega.-methoxy- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 30599-15-6 | 1,3-Propanediol, 2,2-bis(hydroxymethyl)-, polymer with oxirane | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 30652-11-0 | 4(1H)-Pyridinone, 3-hydroxy-1,2-dimethyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 30657-38-6 | L-Proline, 5-oxo-, compd. with L-lysine (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 306769-73-3 | 1-Dodecanaminium, N,N-dimethyl-N-[3-[(2-methyl-1-oxo-2-propenyl)amino]propyl]-, chloride, polymer with N-[3-(dimethylamino)propyl]-2-methyl-2-propenamide and 1-ethenyl-2-pyrrolidinone | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 3069-40-7 | Silane, trimethoxyoctyl- | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 306-94-5 | Naphthalene, 1,1,2,2,3,3,4,4,4a,5,5,6,6,7,7,8,8,8a-octadecafluorodecahydro- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 308061-47-4 | Alkanes, C12-16 | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 308063-77-6 | Caseins, reaction products with diethylenetriamine | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 308066-66-2 | Oligosaccharides, fructose-contg. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 308067-11-0 | Glycerides, C8-10 mono-, di- and tri-, ethoxylated | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 308067-58-5 | IMMUNE GLOBULIN G | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 308068-01-1 | Jojoba oil, isomerizes | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 308068-34-0 | Glycerides, C16-18 mono-, ethoxylated | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 308068-38-4 | Glycerides, mono-, acetates | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 308068-42-0 | Glycerides, mixed mono- and di-, esters with diacetyltartaric acid | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 308068-94-2 | Imidazolium compounds, 2-C12-14-alkyl-1-(carboxymethyl)-4,5-dihydro-1-(2-hydroxyethyl)-, inner salts | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 308068-97-5 | Onium compounds, isoquinolinium, C12-18-alkyl, bromides | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 308069-41-2 | Phospholipids, soya | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 308074-11-5 | Protein hydrolyzates, compds. with (Z)-N-[3-(dimethylamino)propyl]-9-octadecenamide | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 30909-51-4 | Decanoic acid, 2-[4-[3-[2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]-1-piperazinyl]ethyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 31229-74-0 | Hexadecanoic acid, diester with 5-hydroxy-6-methyl-3,4-pyridinedimethanol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 31230-04-3 | Silanediol, 1-methyl-1-phenyl-,homopolymer | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 31282-04-9 | D-Streptamine, O-6-amino-6-deoxy-L-glycero-D-galacto-heptopyranosylidene-(1→2-3)-O-.beta.-D-talopyranosyl-(1→5)-2-deoxy-N3-methyl- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 3130-87-8 | Asparagine | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 313258-61-6 | Fat and Glyceridic oils, wheat germ | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 31478-84-9 | Heptadecanoic acid, 16-methyl-, 1-methylethyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 31511-30-5 | 4H-1-Benzopyran-4-one, 3-[[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-, tris(2-hydroxyethyl) ether | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 31512-74-0 | Poly[oxy-1,2-ethanediyl(dimethyliminio)-1,2-ethanediyl(dimethyliminio)-1,2-ethanediyl chloride (1:2)] | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 316-42-7 | 2H-Benzo[a]quinolizine, 3-ethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-isoquinolinyl]methyl]-, hydrochloride (1:2), (2S,3R,11bS)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 3164-34-9 | Butanedioic acid, 2,3-dihydroxy- [R-(R*,R*)]-, calcium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 31677-93-7 | 1-Propanone, 1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-, hydrochloride (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 31692-79-2 | Poly[oxy(dimethylsilylene)], .alpha.-hydro-.omega.-hydroxy- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 317-34-0 | 1H-Purine-2,6-dione, 3,9-dihydro-1,3-dimethyl-, compd. with 1,2-ethanediamine (2:1) | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 31799-91-4 | Hyaluronic acid, potassium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 31846-06-7 | Cyclohexanol, 3-(1,1-dimethylethyl)-, 1-acetate | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 3184-65-4 | Phenol, 4-chloro-2-(phenylmethyl)-, sodium salt (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 31961-83-8 | Metaphosphate (P10O3010-) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 32028-95-8 | Poly(silylene) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 32093-35-9 | Imidazo[2,1-b]thiazole, 2,3,5,6-tetrahydro-6-phenyl-, (6S)-, phosphate (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 3211-76-5 | Butanoic acid, 2-amino-4-(methylseleno)-,(2S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 32128-65-7 | Poly(oxy-1,2-ethanediyl), .alpha.-(2-octyldodecyl)-.omega.-hydroxy- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 321735-39-1 | Siloxanes and Silicones, di-Me, 3-hydroxypropyl group- and 3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl group-terminated, polymers with iso-Bu methacrylate | Higher priority based on available information - Human health concern | Clarification required | TBD |
| 321735-42-6 | Siloxanes and Silicones, di-Me, 3-hydroxypropyl group- and 3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl group-terminated,polymers with iso-Bu methacrylate and 2,2,2-trifluoroethyl methacrylate | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 32221-81-1 | Glutamic acid, monosodium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 32310-26-2 | Androstene | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 32440-50-9 | 2-Pyrrolidinone, 1-ethenyl-, polymer with 1-hexadecene | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 3251-56-7 | Phenol, 2-methoxy-4-nitro- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 32780-64-6 | Benzamide, 2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]-, hydrochloride (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 32839-18-2 | Docosahexaenoic acid, (Z,Z,Z,Z,Z,Z)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 32839-30-8 | Eicosapentaenoic acid, (Z,Z,Z,Z,Z)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 329925-33-9 | Oxacyclopentadec-10-en-2-one, 13-methyl- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 33005-95-7 | 2-Thiopheneacetic acid, 5-benzoyl-.alpha.-methyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 3305-68-8 | 9-Octadecen-1-ol, phosphate (3:1), (9Z,9'Z,9"Z)- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 33069-62-4 | Benzenepropanoic acid, .beta.-(benzoylamino)-.alpha.-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (.alpha.R,.beta.S)- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 33089-61-1 | Methanimidamide, N'-(2,4-dimethylphenyl)-N-[[(2,4-dimethylphenyl)imino]methyl]-N-methyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 330-95-0 | Urea, N, N'-Bis(4-nitrophenyl) -, compd. with 4,6-dimethyl-2(1H)-pyrimidinone(1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 33124-69-5 | threo-2,3-Hexodiulosonic acid, .gamma.-lactone | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 33171-05-0 | 1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxyphenyl)-, (1E,6E)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| *22608-11-3/33171-16-3 | 1,6-Heptadiene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-, (1E,6E)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 331731-18-1 | Adalimumab | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 332348-12-6 | 1-25-Oncostrain M (human precursor) fusion protein with CTLA-A (antigen)(human) fusion protein with immuglobulin G1 (human heavy chain fragment), bimol.(146146')-disulfide | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 33239-19-9 | Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 3',6'-dihydroxy-4',5'-diiodo-, sodium salt (1:2) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 33286-22-5 | 1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-, hydrochloride (1:1), (2S,3S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 33386-08-2 | 8-Azaspiro[4.5]decane-7,9-dione, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 33564-30-6 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-, monosodium salt, (6R,7S)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 33735-91-0 | 6H-Purin-6-one, 2-amino-1,7-dihydro-, hydrochloride | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 337376-15-5 | Icodextrin | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 3374-30-9 | Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl(phenylmethyl)amino]phenyl](5-hydroxy-2,4-disulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-, inner salt, calcium salt (2:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 3385-03-3 | Pregna-1,4-diene-3,20-dione, 6-fluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (6.alpha.,11.beta.,16.alpha.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 3386-18-3 | 3,6,9,12,15,18,21,24-Octaoxahexacosane-1,26-diol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 338-98-7 | Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-9-fluoro-11,17-dihydroxy-, (11.beta.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 33907-46-9 | Octadecanoic acid, hydroxy-, 2-hydroxyethyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 33907-47-0 | Octadecanoic acid, hydroxy-, monoester with 1,2-propanediol | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 33940-98-6 | 9-Octadecenoic acid (9Z)-, monoester with triglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 33954-26-6 | Benzoic acid, 3-(acetylamino)-5-[[(2-hydroxyethyl)amino]carbonyl]-2,4,6-triiodo-, monosodium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 3397-16-8 | L-Glutamic acid, N-(1-oxooctadecyl)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 34031-32-8 | Gold, [1-(thio-.kappa.S)-.beta.-D-glucopyranose 2,3,4,6-tetraacetato](triethylphosphine)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 34183-22-7 | 1-Propanone, 1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-, hydrochloride | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 34364-24-4 | Benzoic acid, isooctadecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 34368-04-2 | 1,2-Benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 34381-68-5 | Butanamide, N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]-, hydrochloride (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 344 (INS) | Lecithin Citrate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 34406-66-1 | Dodecanoic acid, monoester with decaglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 34424-97-0 | Octadecanoic acid, diester with hexaglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 34452-51-2 | Acetic acid, 2-mercapto-, potassium salt (1:1) | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 34464-38-5 | Isodecane | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 34466-20-1 | Ribose | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 34513-50-3 | 1-Dodecanol, octyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 345648-01-3 | 1-Propanaminium N- (3-aminopropyl) -2,3-dihydroxy-N,N-dimethyl-,N-limnanthes alba seed-oil acyl derivs., chlorides | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 34580-13-7 | 10H-Benzo[4,5]cyclohepta[1,2-b]thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 34580-14-8 | 10H-Benzo[4,5]cyclohepta[1,2-b]thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-, (2E)-2-butenedioate (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 347174-92-9 | Macrocystis pyrifera extract | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 34769-44-3 | 1,3(2H,9bH)-Dibenzofurandione, 2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-, sodium salt (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 348120-87-6 | Hexanoic acid, 3,5,5-trimethyl-, hexadecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 348120-88-7 | Hexanoic acid, 3,5,5 -trimethyl-, octadecyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 34965-01-0 | Pyrrolidine, 1-[2-(dodecyloxy)ethyl]-, hydrochloride | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 34973-08-5 | Luteinizing hormone-releasing factor (swine), acetate (salt) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 350708-35-9 | Aspartic acid, compd. with .alpha.-methylbenzeneethanamine (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 350708-40-6 | D-Glucaric acid, compd. with (.alpha.S)-.alpha.-methylbenzeneethanamine(1:2) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 35121-78-9 | Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, (5Z,9.alpha.,11.alpha.,13E,15S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 35189-28-7 | 18,19-Dinorpregn-4-en-20-yn-3-one, 17-(acetyloxy)-13-ethyl-, 3-oxime, (17.alpha.)- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 3520-90-9 | 3,6,9,12,15,18,21-Heptaoxatricosan-1-ol, 23-(4-octylphenoxy)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 3521-62-8 | Erythromycin, 2'-propanoate, dodecyl sulfate (salt) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 3521-84-4 | D-Glucitol, 1-deoxy-1-(methylamino)-, 3,3'-[(1,6-dioxo-1,6-hexanediyl)diimino]bis[2,4,6-triiodobenzoate] (2:1) (salt) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 3522-50-7 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, iron(3+) salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 35230-14-9 | Propanoic acid, 2-hydroxy-, octadecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 35305-74-9 | L-Glutamine, N-acetyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 35474-99-8 | 5,8,11,14-Eicosatetraenoic acid, 2,3-dihydroxypropyl ester, (5Z,8Z,11Z,14Z)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 35554-44-0 | 1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-(2-propen-1-yloxy)ethyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 35602-69-8 | Cholest-5-en-3-ol (3.beta.)-, 3-octadecanoate | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 356065-50-4 | Fats and Glyceridic oils, Brazil nut | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 3564-09-8 | 2,7-Naphthalenedisulfonic acid, 3-hydroxy-4-[2-(2,4,5-trimethylphenyl)diazenyl]-, sodium salt (1:2) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 35700-23-3 | Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-15-methyl-, (5Z,9.alpha.,11.alpha.,13E,15S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 357-07-3 | Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-methyl-, hydrochloride, (5.alpha.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 357-08-4 | Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, hydrochloride, (5.alpha.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 35711-34-3 | 1H-Pyrrole-2-acetic acid, 1-methyl-5-(4-methylbenzoyl)-, sodium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 3578-72-1 | Docosanoic acid, calcium salt (2:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 35944-74-2 | 1H-Imidazole-5-carboxylic acid, 1-(1-phenylethyl)-, methyl ester, monohydrochloride | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 3599-32-4 | 1H-Benz[e]indolium, 2-[7-[1,3-dihydro-1,1-dimethyl-3-(4-sulfobutyl)-2H-benz[e]indol-2-ylidene]-1,3,5-heptatrien-1-yl]-1,1-dimethyl-3-(4-sulfobutyl)-, inner salt, sodium salt (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 36062-04-1 | 3,5-Heptanedione, 1,7-bis(4-hydroxy-3-methoxyphenyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 361459-38-3 | Glycerides, mixed decanoyl and octanoyl mono-, di- and tri-, ethoxylated | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 362-74-3 | Adenosine, N-(1-oxobutyl)-, cyclic 3',5'-(hydrogen phosphate) 2'-butanoate | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 36284-86-3 | Octadecanamide, N-(2-hydroxy-1,1-dimethylethyl)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 36393-20-1 | Zincate(2-), bis[L-aspartato(2-)-.kappa.N,.kappa.O1]-, dihydrogen, (T-4)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 364782-34-3 | 1-Naphthalenemethanamine, .alpha.-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-, hydrochloride, (1:1) (.apha.R) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 36521-89-8 | Sorbitan, dioctadecanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 36655-86-4 | D-Glucuronic acid, homopolymer | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 36703-88-5 | Inosine, compd. with 1-(dimethylamino)-2-propanol 4-(acetylamino)benzoate (1:3:3) | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 36791-04-5 | 1H-1,2,4-Triazole-3-carboxamide, 1-.beta.-D-ribofuranosyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 3687-18-1 | 1-Propanesulfonic acid, 3-amino- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 368869-33-4 | Fatty acids, C18-unsatd., dimers, hydrogenated, diesters with triglycerol triisostearate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 3697-42-5 | 2,4,11,13-Tetraazatetradecanediimidamide, N,N"-bis(4-chlorophenyl)-3,12-diimino-, hydrochloride (1:2) | Higher priority based on available information - Environmental concern | Assessed in Screening Assessment Report (SAR) | TBD |
| 37025-55-1 | 1-Carbaoxytocin, 1-butanoic acid-2-(O-methyl-L-tyrosine)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 37203-87-5 | Formaldehyde, mixt. with methylphenol | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 3721-26-4 | Cyclopropanamine, 2-phenyl-, (1R,2S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 37220-90-9 | Silicic acid, lithium magnesium salt | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 37222-66-5 | Potassium peroxymonosulfate sulfate (K5(HSO5)2(HSO4)(SO4)) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 37259-53-3 | Lyase, hyaluronate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 37266-93-6 | .alpha.-D-Glucopyranoside, .beta.-D-fructofuranosyl, dodecanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 37270-89-6 | Heparin, calcium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 372-75-8 | L-Ornithine, N5-(aminocarbonyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 37286-92-3 | Benzenesulfonic acid, ethenyl-, homopolymer, calcium salt | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 37288-34-9 | Hyaluronoglucuronidase | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 37288-39-4 | Glucosidase, sucrose .alpha.- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 37309-58-3 | Decene, homopolymer | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 37316-87-3 | Blood-coagulation factor Ixa | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 37318-79-9 | Sorbitan, (9Z)-9-octadecenoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 37321-09-8 | D-Streptamine, O-4-amino-4-deoxy-.alpha.-D-glucopyranosyl-(1→8)-O-(8R)-2-amino-2,3,7-trideoxy-7-(methylamino)-D-glycero-.alpha.-D-allo-octodialdo-1,5:8,4-dipyranosyl-(1→4)-2-deoxy- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 37326-33-3 | Hyaluronoglucosaminidase | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 37349-34-1 | 1,2,3-Propanetriol, homopolymer, monooctadecanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 37361-00-5 | .beta.-D-Glucan, (1→6)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 3737-09-5 | 2-Pyridineacetamide, .alpha.-[2-[bis(1-methylethyl)amino]ethyl]-.alpha.-phenyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 3778-73-2 | 2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 3792-50-5 | L-Aspartic acid, sodium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 3801-06-7 | Pregna-1,4-diene-3,20-dione, 17-(acetyloxy)-9-fluoro-11-hydroxy-6-methyl-, (6.alpha.,11.beta.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 38079-62-8 | L-Glutamic acid, N-(1-oxooxtadecyl)-, sodium salt (1:2) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 381718-28-1 | Fats and Glyceridic oils, Rubus idaeus | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 38194-50-2 | 1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-, (1Z)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 382-67-2 | Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-, (11.beta.,16.alpha.)- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 383419-34-9 | Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, ether with methyl D-glucopyranoside (4:1), benzoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 3847-29-8 | Erythromycin, 4-O-.beta.-D-galactopyranosyl-D-gluconate (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 38480-64-7 | 1-Dodecanesulfonic acid, ion(1-) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 38517-23-6 | L-Glutamic acid, N-(1-oxooctadecyl)-, sodium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 38517-37-2 | L-Glutamic acid, N-(1-oxotetradecyl)-, sodium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 38577-97-8 | Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 3',6'-dihydroxy-4',5'-diiodo- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 38621-51-1 | Octadecanoic acid, 12-hydroxy-, monoester with 1,2-propanediol | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 38754-83-5 | Glutamic acid, N-(1-oxotetradecyl)-, monosodium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 38866-20-5 | Morpholinium, 4-[3-[(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthracenyl)amino]propyl]-4-methyl-, methyl sulfate (1:1) | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 38886-21-4 | Phenol, 2-methoxynitro- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 38916-34-6 | Somatostatin (sheep) | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 38975-03-0 | 3,6,9,12,15-Pentaoxaheptacosanoic acid, sodium salt | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 39012-86-7 | 1,3(2H,9bH)-Dibenzofurandione, 2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-, sodium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 3902-71-4 | 7H-Furo[3,2-g][1]benzopyran-7-one, 2,5,9-trimethyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 39034-24-7 | 3,6,9,12-Tetraoxahexacosan-1-ol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 3910-88-1 | 2-Butanone, 4-(octahydro-5,5,8a-trimethylspiro[naphthalene-2(1H),2'-oxiran]-1-yl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 39175-72-9 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, ester with 1,2,3-propanetriol monooctadecanoate (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 391900-47-3 | Leontopodium alpinum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 39300-95-3 | .alpha.-D-Glucopyranoside, .beta.-D-fructofuranosyl, hexadecanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 39322-04-8 | Chromium potassium oxide | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 39346-84-4 | Starch, dihydrogen phosphate, 2-hydroxypropyl ether | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 3936-02-5 | Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-[(3- sulfobenzoyl)oxy]-, sodium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 39404-33-6 | Dextrates | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 39409-82-0 | Carbonic acid, magnesium salt (1:1), mixt. with magnesium hydroxide (Mg(OH)2), hydrate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 39456-59-2 | Phosphoric acid, mixt. with sodium fluoride (NaF) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 3976-75-8 | 3,4-Thiophenediol, tetrahydro-, (3R,4S)-rel- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 39831-55-5 | D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1→6)-O-[6-amino-6-deoxy-.alpha.-D-glucopyranosyl-(1→4)]-N1-[(2S)-4-amino-2-hydroxy-1-oxybutyl]-2-deoxy-, sulfate (1:2) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 4.1.1.5 | (S)-2-hydroxy-2-methyl-3-oxobutanoate carboxy-lyase | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 40031-31-0 | 2-Butanone, 1,3,4-trihydroxy- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 40160-92-7 | Poly(oxy-1,2-ethanediyl), .alpha.-(3-pentadecylphenyl)-.omega.-hydroxy- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 40188-41-8 | Octanenitrile, 3,7-dimethyl- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 40391-99-9 | Phosphonic acid, P,P'-(3-amino-1-hydroxypropylidene) bis- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 40445-72-5 | Cholest-5-en-3-ol (3.beta.)-, 12-hydroxyoctadecanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 404-86-4 | 6-Nonenamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methyl-, (6E)- | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 40665-92-7 | 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E,3S)-4-(3-chlorophenoxy)-3-hydroxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-, (5Z)-rel- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 4070-80-8 | 2-Butenedioic acid (2E)-, monooctadecyl ester, sodium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 40738-57-6 | 2-Propenoic acid, ethenylidene ester, homopolymer | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 40754-59-4 | Butanedioic acid, 2-sulfo-, 4-[2-[2-[2-(dodecyloxy)ethoxy]ethoxy]ethyl] ester, sodium salt (1:2) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 40958-31-4 | Somatostatin (sheep reduced) | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 41080-66-4 | Poly(oxy-1,2-ethanediyl), .alpha.,.alpha.',.alpha."-1,2,3-propanetriyltris[.omega.-[(1-oxooctadecyl)oxy]- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 41389-11-1 | Phenol, 3-methyl-2-(2-propenyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 41389-12-2 | Phenol, 5-methyl-2-(2-propenyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 41395-89-5 | Isononanoic acid, isodecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 41575-94-4 | Platinum, diammine[1,1-cyclobutanedi(carboxylato-.kappa.O)(2-)]-, (SP-4-2)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 41621-49-2 | 2(1H)-Pyridinone, 6-cyclohexyl-1-hydroxy-4-methyl-, compd. with 2-aminoethanol (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 41669-40-3 | Tetradecanoic acid, compd. with 2,2',2"-nitrilotris[ethanol] (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 41672-81-5 | L-Proline, 1-(1-oxohexadecyl)-4-[(1-oxohexadecyl)oxy]-, (4R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 41760-23-0 | L-Cystine, N,N'-bis(1-oxooctyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 41859-67-0 | Propanoic acid, 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 41927-88-2 | Sodium iodide (Na123I) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 42116-76-7 | Carbamothioic acid, N-[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]-, O-methyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 42131-25-9 | Isononanoic acid, isononyl ester | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 42175-36-0 | Propanoic acid, 2-hydroxy-, (9Z)-9-octadecenyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 42231-41-4 | Octanoic acid, tridecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 42232-29-1 | Hexadecanoic acid, dodecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 42408-82-2 | Morphinan-3,14-diol, 17-(cyclobutylmethyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 42461-84-7 | D-Glucitol, 1-deoxy-1-(methylamino)-, 2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylate (1:1) | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 42553-65-1 | .beta.-D-Glucopyranose, 6-O-.beta.-D-glucopyranosyl-, 1,1'-[(2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethyl-2,4,6,8,10,12,14-hexadecaheptaenedioate] | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 426262-08-0 | Protein hydrolyzates, sour orange (Citrus aurantium dulcis), reaction products with ascorbic acid | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 427-51-0 | 3'H-Cyclopropa[1,2]pregna-1,4,6-triene-3,20-dione, 17-(acetyloxy)-6-chloro-1,2-dihydro-, (1.beta.,2.beta.)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 42766-91-6 | Poly (oxy-1, 2-ethanediyl), .alpha.-[(3b, 5a)-cholestan-3-yl]-.omega.-hydroxy- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 42822-86-6 | 2-hydroxy-.alpha.,.alpha.,4-trimethylcyclohexanemethanol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 4291-63-8 | Adenosine, 2-chloro-2'-deoxy- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 42924-53-8 | 2-Butanone, 4-(6-methoxy-2-naphthalenyl)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 4316-73-8 | Glycine, N-methyl-, sodium salt (1:1) | Higher priority based on available information - Human health concern | Clarification required | TBD |
| 4386-03-2 | Butanoic acid, 4-[(2-carboxyethyl)amino] | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 43200-80-2 | 1-Piperazinecarboxylic acid, 4-methyl-, 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 43218-56-0 | Acetamide, 2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 43229-80-7 | Formamide, N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, rel-, (2E)-2-butenedioate (2:1) (salt) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 4342-03-4 | 1H-Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazen-1-yl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 4372-02-5 | Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 4',5'-dibromo-3',6'-dihydroxy-, sodium salt (1:2) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 437-38-7 | Propanamide, N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 4403-12-7 | Ethanol, 2-[2-[2-(tridecyloxy)ethoxy]ethoxy]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 4419-92-5 | Benzoic acid, 2-hydroxy-, compd. with N-ethylethanamine (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 442 (INS) | Ammonium salt of phosphorylated glyceride | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 4450-94-6 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, ammonium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 4478-97-1 | 3,6,9,12,15-Pentaoxahentriacontan-1-ol | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 448944-47-6 | L-Tryptophanamide, N-acetyl-L-norleucyl-L-alanyl-L-histidyl-D-phenylalanyl-L-arginyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 4492-73-3 | 1H-Thieno[3,4-d]imidazole-4-pentanoic acid, hexahydro-2-oxo-, (3aS,4S,6aR)-, compd. with N-(2,5-dioxo-4-imidazolidinyl)urea (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 44987-75-9 | 2,4-Hexadienoic acid, 1-methylethyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 45267-19-4 | Tetradecanamide, N-[3-(dimethylamino)propyl]- | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 4536-30-5 | Ethanol, 2-(dodecyloxy)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 4560-68-3 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-,1,2,3-trihexadecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 4583-26-0 | 1-Oxaspiro[4, 5]decan-2-one, 8-(1-methylethyl)-, cis- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 458-88-8 | Piperidine, 2-propyl-, (2S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 4618-23-9 | Benzoic acid, 2,3,4,5-tetrachloro-6-(2,4,5,7-tetrabromo-6-hydroxy-3-oxo-3H-xanthen-9-yl)-, disodium salt | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 464-92-6 | Urs-12-en-28-oic acid, 2,3,23-trihydroxy-, (2.alpha.,3.beta.,4.alpha.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 4697-14-7 | 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[2-carboxy-2-(3-thienyl)acetyl]amino]-3,3-dimethyl-7-oxo-, sodium salt(1:2), (2S,5R,6R)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 4706-78-9 | Sulfuric acid, monododecyl ester, potassium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 472-11-7 | Spirost-5-ene-1,3-diol, (1.beta.,3.beta.,25R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 472b (INS) | Lactylated Mono- and Diglycerides | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 473 (INS) | Sucrose esters of fatty acids | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 474-62-4 | Ergost-5-en-3-ol, (3.beta.,24R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 475 (INS) | Polyglycerol Esters of Fatty Acids | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 477 (INS) | Propylene Glycol Mono Fatty Acid Esters | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 477 (INS) | Propylene Glycol Monoesters and Diesters of fat-forming fatty acids | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 477-32-7 | Butanoic acid, 2-methyl-, (9R,10R)-10-(acetyloxy)-9,10-dihydro-8,8-dimethyl-2-oxo-2H,8H-benzo[1,2-b:3,4-b']dipyran-9-yl ester, (2R) - | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 47931-85-1 | Calcitonin (salmon) | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 480995-77-5 | 2-Propenoic acid, 2-methyl-,polymer with butyl 2-propenoate, hexadecyleicosyl 2-methyl-2-propenoate and methyl 2-methyl-2-propenoate | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 481-06-1 | Naphtho[1,2-b]furan-2,8(3H,4H)-dione, 3a,5,5a,9b-tetrahydro-3,5a,9-trimethyl-, (3S,3aS,5aS,9bS)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 4827-59-2 | Olean-12-en-29-oic acid, 11-oxo-3-[(1-oxooctadecyl)oxy]-, (3.beta.,20.beta.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 483-18-1 | 2H-Benzo[a]quinolizine, 3-ethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-isoquinolinyl]methyl]-, (2S,3R,11bS)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 484-33-3 | 1,3-Propanedione, 1-(4-methoxy-5-benzofuranyl)-3-phenyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 4861-19-2 | Urea, phosphate (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 487-26-3 | 4H-1-Benzopyran-4-one, 2,3-dihydro-2-phenyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 488-43-7 | 1-amino-1-deoxy-D-glucitol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 490-83-5 | L-threo-2,3-Hexodiulosonic acid, .gamma.-lactone | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 491-58-7 | 9(10H)-Anthracenone, 1,8-dihydroxy-3-methyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 4934-42-3 | .alpha.-D-Glucopyranuronic acid, monosodium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 49553-76-6 | 9-Octadecenoic acid (9Z)-, monoester with oxybis[propanediol] | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 49562-28-9 | Propanoic acid, 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-, 1-methylethyl ester | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 4956-37-0 | Estra-1,3,5(10)-triene-3,17-diol (17.beta.)-, 17-heptanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 495-69-2 | Glycine, N-benzoyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 49625-21-0 | Butanoic acid, 4-[[4-[[[(4-methoxy-2-nitrophenyl)amino]carbonyl]amino]benzoyl]amino]-2-oxo- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 49697-38-3 | Androsta-1,4-dien-3-one, 11-hydroxy-16,17-dimethyl-17-(1-oxopropyl)-, (11.beta.,16.alpha.,17.beta.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 497227-50-6 | Digoxin Immune Fab (Ovine) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 497-30-3 | 1H-Imidazole-4-ethanaminium, .alpha.-carboxy-2,3-dihydro-N,N,N-trimethyl-2-thioxo-, inner salt, (.alpha.S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 49745-95-1 | 1,2-Benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 497-76-7 | .beta.-D-Glucopyranoside, 4-hydroxyphenyl | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 4991-65-5 | 1,3-Benzoxathiol-2-one, 6-hydroxy- | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 5.3.1.9 | D-glucose-6-phosphate aldose-ketose-isomerase | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 500-38-9 | 1,2-Benzenediol, 4,4'-(2,3-dimethyl-1,4-butanediyl)bis- | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 500-92-5 | Imidodicarbonimidic diamide, N-(4-chlorophenyl)-N'-(1-methylethyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 501-30-4 | 4H-Pyran-4-one, 5-hydroxy-2-(hydroxymethyl)- | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 50-47-5 | 5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N-methyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 50545-60-3 | Phenol, methyl-, tetrabromo deriv. | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 505-73-7 | Acetic acid, 2,2'-dithiobis- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 506-03-6 | 1,2-Propanediol, 3-(hexadecyloxy)-, (2S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 50610-28-1 | Ethanol, 2-[(4-amino-2-chloro-5-nitrophenyl)amino]- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 50622-20-3 | L-Glutamic acid, N-(1-oxododecyl)-, sodium salt (1:2) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 50638-95-4 | Benzene, [2-[(3-methyl-2-buten-1-yl)oxy]ethyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 50643-20-4 | Poly (oxy-1,2-ethanediyl), .alpha.-hexadecyl-.omega.-hydroxy-,phosphate, | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 50679-08-8 | 1-Piperidinebutanol, .alpha.-[4-(1,1-dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 507454-10-6 | formaldehyde cross-linked hyaluronan | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 50800-85-6 | Indium chloride (111InCl3) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 508-02-1 | Olean-12-en-28-oic acid, 3-hydroxy-, (3.beta.)- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 50813-16-6 | Metaphosphoric acid, sodium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 50982-74-6 | Ethanol, 2-(4-amino-3-nitrophenoxy)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 50994-40-6 | 1,4-Benzenediamine, sulfate (1:?) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 51022-69-6 | Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-16,17-[cyclopentylidenebis(oxy)]-9-fluoro-11-hydroxy-, (11.beta.,16.alpha.)- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 51023-21-3 | 1H-Imidazolol, ethyldihydro[(9Z)-9-octadecen-1-yl]- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 51033-30-8 | Decanoic acid, monoester with triglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 51115-67-4 | Butanamide, N,2,3-trimethyl-2-(1-methylethyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 51-15-0 | Pyridinium, 2-[(hydroxyimino)methyl]-1-methyl-, chloride | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 51158-08-8 | Poly (oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-,ether with 1,2,3- propanetriol monooctadecanoate (2:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 5117-19-1 | 3,6,9,12,15,18,21-heptaoxatricosane-1,23-diol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 51192-09-7 | Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, ether with 1,2,3-propanetriol mono-(9Z)-9-octadecenoate (2:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 5119-24-4 | Galactopyranuronic acid, compd. with allantoin (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 512-42-5 | Sulfuric acid, monomethyl ester, sodium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 51260-59-4 | Hexadecanol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 513-10-0 | Ethanaminium, 2-[(diethoxyphosphinyl)thio]-N,N,N-trimethyl-, iodide | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 51311-89-8 | Antimony iodide | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 51322-75-9 | 2,1,3-Benzothiadiazol-4-amine, 5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 51333-22-3 | Pregna-1,4-diene-3,20-dione, 16,17-[butylidenebis(oxy)]-11,21-dihydroxy-, (11.beta.,16.alpha.)- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 51365-71-0 | 1,2-Benzenedicarboxamide, N,N'-dioctadecyl- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 51395-96-1 | Mannan | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 51-40-1 | 1,2-Benzenediol, 4-[(1R)-2-amino-1-hydroxyethyl]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt) | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 514-36-3 | Pregn-4-ene-3,20-dione, 21-(acetyloxy)-9-fluoro-11,17-dihydroxy-, (11.beta.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 51513-58-7 | 6,10-Dodecadienal, 3,7,11-trimethyl-,(6E)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 51-55-8 | Benzeneacetic acid, .alpha.-(hydroxymethyl)- (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 5168-89-8 | 3,6,9,12,15,18-Hexaoxaoctacosan-1-ol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 51742-87-1 | 4-Quinolinemethanol, .alpha.-(2R)-2-piperidinyl-2,8-bis(trifluoromethyl)-, (.alpha.S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 5175-83-7 | Phenol, 2,4,6-tribromo-, bismuth(3+) salt (3:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 51781-21-6 | 2(1H)-Quinolinone, 5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride (1:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 517-88-4 | 1,4-Naphthalenedione, 5,8-dihydroxy-2-[(1S)-1-hydroxy-4-methyl-3-penten-1-yl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 51810-70-9 | Zinc phosphide | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 518-28-5 | Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-, (5R,5aR,8aR,9R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 518-40-1 | Benzoic acid, 2-(6-hydroxy-4,5-diiodo-3-oxo-3H-xanthen-9-yl)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 51852-65-4 | Poly(oxy-1,2-ethanediyl), .alpha.-[2-hydroxy-3-[(1-oxooctadecyl)oxy]propyl]-.omega.-hydroxy- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 51898-34-1 | 3-Pyridinecarboxylic acid, (2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-yl ester, rel- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 51938-44-4 | Sorbitan, octadecanoate (2:3) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 51952-41-1 | Luteinizing hormone-releasing factor (swine), hydrochloride (1:?) | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 52-01-7 | Pregn-4-ene-21-carboxylic acid, 7-(acetylthio)-17-hydroxy-3-oxo-, .gamma.-lactone, (7.alpha.,17.alpha.)- | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 520-18-3 | 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 520-26-3 | 4H-1-Benzopyran-4-one,7-[[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-,(S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 52108-64-2 | Chitin, 6-(carboxymethyl) ether | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 52128-35-5 | 2,4-Quinazolinediamine, 5-methyl-6-[[(3,4,5-trimethoxyphenyl)amino]methyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 521-78-8 | 5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N,N,.beta.-trimethyl-, (2Z)-2-butenedioate (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 52205-73-9 | Estra-1,3,5(10)-triene-3,17-diol (17.beta.)-, 3-[N,N-bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate), sodium salt (1:2) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 52232-67-4 | L-Phenylalanine, L-seryl-L-valyl-L-seryl-L-a-glutamyl-L-isoleucyl-L-glutaminyl-L-leucyl-L-methionyl-L-histidyl-L-asparaginyl-L-leucylglycyl-L-lysyl-L-histidyl-L-leucyl-L-asparaginyl-L-seryl-L-methionyl-L-a-glutamyl-L-arginyl-L-valyl-L-a-glutamyl-L-tryptophyl-L-leucyl-L-arginyl-L-lysyl-L-lysyl-L-leucyl-L-glutaminyl-L-a-aspartyl-L-valyl-L-histidyl-L-asparaginyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 522-40-7 | Phenol, 4,4'-[(1E)-1,2-diethyl-1,2-ethenediyl]bis-, 1,1'-bis(dihydrogen phosphate) | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 52-24-4 | Aziridine, 1,1',1"-phosphinothioylidynetris- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 522-48-5 | 1H-Imidazole, 4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-, hydrochloride (1:1) | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 522-51-0 | Quinolinium, 1,1'-(1,10-decanediyl)bis[4-amino-2-methyl-, dichloride | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 52263-83-9 | 9H-Carbazole-2-acetic acid, 6-chloro-.alpha.-methyl-, (.alpha.R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 52304-36-6 | .beta.-Alanine, N-acetyl-N-butyl-, ethyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 52315-75-0 | L-Lysine, N6-(1-oxododecyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 52467-63-7 | 1-Hexadecanaminium, N,N-dihexadecyl-N-methyl-, chloride (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 52468-60-7 | Piperazine, 1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenyl-2-propenyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 52557-98-9 | Bicyclo[2.2.1]heptane-2-carboxylic acid, 3,3-dimethyl- | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 52558-73-3 | Glycine, N-methyl-N-(1-oxotetradecyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 525-82-6 | 4H-1-Benzopyran-4-one, 2-phenyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 52609-21-9 | Poly(oxy-1,2-ethanediyl), .alpha.,.alpha.'-[(2S)-1,5-dioxo-2-[(1-oxododecyl)amino]-1,5-pentanediyl]bis[.omega.-(octadecyloxy)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 52645-53-1 | Cyclopropanecarboxylic acid, 3-(2,2-dichloroethenyl)-2,2-dimethyl-, (3-phenoxyphenyl)methyl ester | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 52725-64-1 | Tetradecanamide, N,N-bis(2-hydroxyethyl)-, mixt. with N,N-bis(2-hydroxyethyl)dodecanamide | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 5274-65-7 | Ethanol, 2-[2-[(9Z)-9-octadecenyloxy]ethoxy]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 52793-97-2 | Benzenaminium, N,N,N-trimethyl-4-[(4,7,7-trimethyl-3-oxobicyclo[2.2.1]hept-2-ylidene)methyl]-, methyl sulphate (1:1) | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 52845-07-5 | Isoeicosane | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 53026-67-8 | Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, ether with methyl D-glucopyranoside (4:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 530-43-8 | Hexadecanoic acid, (2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl ester | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 5306-85-4 | D-Glucitol, 1,4:3,6-dianhydro-2,5-di-O-methyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 53082-57-8 | 2-Butenoic acid, 2-methyl-, propyl ester, (2Z)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 53123-88-9 | Rapamycin | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 53-16-7 | Estra-1,3,5(10)-trien-17-one, 3-hydroxy- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 53171-04-3 | 1-Propanaminium, 2-hydroxy-N,N,N-trimethyl-3-[(1-oxododecyl)oxy]-, chloride | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 532-11-6 | 3H-1,2-Dithiole-3-thione, 5-(4-methoxyphenyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 53-21-4 | 8-Azabicyclo[3.2.1]octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, hydrochloride (1:1), (1R,2R,3S,5S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 53230-10-7 | 4-Quinolinemethanol, .alpha.-(2R)-2-piperidinyl-2,8-bis(trifluoromethyl)-, (.alpha.S)-rel- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 53238-80-5 | .beta.-d-Glucan, (1→3), (1→6) - | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 5323-95-5 | 9-Octadecenoic acid, 12-hydroxy-, sodium salt (1:1), (9Z,12R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 53240-01-0 | D-Glucose, homopolymer, decyl ether | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 532-40-1 | Thiazolium, 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-4-methyl-5-[2-(phosphonooxy)ethyl]-, chloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 53251-94-8 | Morpholinium, 4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]-, bromide | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 533-50-6 | 2-Butanone, 1,3,4-trihydroxy-, (3S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 533910-00-8 | Decanedioc acid, mixed esters with isostearic acid and 2,2'-[oxybis(methylene)]bis[2-ethyl-1,3-propanediol] | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 533928-79-9 | Hexanoic acid,2-ethyl-,triester with 1,2,3,4-butanetetrol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 5340-95-4 | D-Glucopyranose, 6-O-.alpha.-D-galactopyranosyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 53-43-0 | Androst-5-en-17-one, 3-hydroxy-, (3.beta.)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 5343-92-0 | 1,2-Pentanediol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 5353-26-4 | 3,6,9,12-Tetraoxatriacont-21-en-1-ol, (Z)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| *81859-24-7/53568-66-4 | Cellulose, 2-hydroxyethyl 2-[2-hydroxy-3-(trimethylammonio)propoxy]ethyl 2-hydroxy-3-(trimethylammonio)propyl ether, chloride | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 53609-72-6 | Poly[oxy(methyl-1,2-ethanediyl)], .alpha.,.alpha.'-1,4- butanediylbis[.omega.-hydroxy- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 536993-92-7 | Spirulina maxima, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 53716-49-7 | 9H-Carbazole-2-acetic acid, 6-chloro-.alpha.-methyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 53772-83-1 | 1-Piperazineethanol, 4-[(3Z)-3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 538-02-3 | Cyclopentaneethanamine, N,.alpha.-dimethyl-, hydrochloride | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 53850-34-3 | Proteins, thaumatins | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 53882-12-5 | Acetic acid, 2,2'-[(2-chloro-5-cyano-1,3-phenylene)diimino]bis[2-oxo- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 53885-35-1 | Thieno[3,2-c]pyridine, 5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydro-, hydrochloride (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 54-35-3 | 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]- (2S,5R,6R)-, compd. with 2-(diethylamino)ethyl 4-aminobenzoate (1:1) | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 54024-22-5 | 18,19-Dinorpregn-4-en-20-yn-17-ol, 13-ethyl-11-methylene-, (17.alpha.)- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 541-15-1 | 1-Butanaminium, 2,4-dihydroxy-N,N,N-trimethyl-4-oxo-, inner salt, (2R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 541-35-5 | Butanamide | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 54182-58-0 | Aluminum, hexadeca-.mu.-hydroxytetracosahydroxy[.mu.8-[[1,3,4,6-tetra-O-sulfo-.beta.-D-fructofuranosyl .alpha.-D-glucopyranoside tetrakis(sulfato-.kappa.O')](8-)]]hexadeca- | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 5422-34-4 | Propanamide, 2-hydroxy-N-(2-hydroxyethyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 54301-26-7 | Glycine, N-(1-oxo-10-undecenyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 54392-28-8 | Sorbitan, triisooctadecanoate, poly(oxy-1,2-ethanediyl) derivs. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 54422-45-6 | 9-Octadecenamide, N-[2-hydroxy-1-(hydroxymethyl)heptadecyl]-, (9Z)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 544-62-7 | 1,2-Propanediol, 3-(octadecyloxy)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 54482-09-6 | Hexadecanamide, 2-hydroxy-N-[2-hydroxy-1-(hydroxymethyl) heptadecyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 54527-84-3 | 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-methyl 5-[2-[methyl(phenylmethyl)amino]ethyl] ester, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 54549-25-6 | D-Glucopyranoside, decyl | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 54549-26-7 | D-Glucopyranoside, tetradecyl | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 54549-27-8 | D-Glucopyranoside, hexadecyl | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| *54578-91-5/ 54018-18-7 | 2-Butenedioic acid (2Z)-, polymer with methoxyethene, butyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 54590-52-2 | Benzenesulfonic acid, 4-dodecyl-, compd. with 1-amino-2-propanol (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 546-46-3 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, zinc salt (2:3) | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 54684-78-5 | Octadecanoic acid, 12-[(1-oxooctadecyl)oxy]-, octadecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 54-71-7 | 2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, hydrochloride (1:1), (3S,4R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 548-73-2 | 2H-Benzimidazol-2-one, 1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 54910-89-3 | Benzenepropanamine, N-methyl-.gamma.-[4-(trifluoromethyl)phenoxy]- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 54965-21-8 | Carbamic acid, N-[6-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 54965-24-1 | Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 549-66-6 | Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-, monopentanoate (salt) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 55-03-8 | L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, sodium salt (1:1) | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 55028-72-3 | 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-, sodium salt (1:1), (5Z)-rel- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 55079-83-9 | 2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (2E,4E,6E,8E)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 551-11-1 | Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9.alpha.,11.alpha.,13E,15S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 55134-13-9 | Salinomycin, 4-methyl-, (4S)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 55172-29-7 | Thallium chloride (201TlCl) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 552-12-5 | D-Galactopyranuronic acid | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 55268-74-1 | 4H-Pyrazino[2,1-a]isoquinolin-4-one, 2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 552-94-3 | Benzoic acid, 2-hydroxy-, 2-carboxyphenyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 55297-96-6 | Acetic acid, [[2-(diethylamino)ethyl]thio]-, 6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-yl ester, [3aS-(3a.alpha.,4.beta.,5.alpha.,6.alpha.,8.beta.,9.alpha.,9a.beta.,10S*)]-, (E)-2-butenedioate (1:1) (salt) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 55306-04-2 | Olean-12-en-28-oic acid, 2,3,19,23-tetrahydroxy-, .beta.-D-glucopyranosyl ester, (2.alpha.,3.beta.,4.beta.,19.alpha.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 553-54-8 | Benzoic acid, lithium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 5543-57-7 | 2H-1-Benzopyran-2-one, 4-hydroxy-3-[(1S)-3-oxo-1-phenylbutyl]- | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 554-57-4 | Acetamide, N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 55-48-1 | Benzeneacetic acid, .alpha.-(hydroxymethyl)- (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, sulfate (2:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 555-44-2 | Hexadecanoic acid, 1,1',1"-(1,2,3-propanetriyl) ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 555-45-3 | Tetradecanoic acid, 1,1',1"-(1,2,3-propanetriyl) ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 55584-26-4 | 2,4-Hexadienoic acid, 1-methylethyl ester, (2E,4E)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 556-38-7 | Pentanoic acid, zinc salt (2:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 557-61-9 | 1-Octacosanol | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 5579-66-8 | 3,6,9,12,15,18,21,24,27-Nonaoxanonacosane-1,29-diol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 55837-20-2 | 4(3H)-Quinazolinone, 7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-, rel- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 55840-13-6 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, ester with 1,2,3-propanetriol monooctadecanoate | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 55852-15-8 | Propanoic acid, 2-hydroxy-, compd. with N-[3-(dimethylamino)propyl]-16-methylheptadecanamide (1:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 55852-84-1 | Bacitracin, methylenebis[2-hydroxybenzoate] (salt) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 5588-33-0 | 10H-Phenothiazine, 10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylsulfinyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 55901-20-7 | Proline, 5-oxo-, compd. with 2,2',2"-nitrilotris[ethanol] (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 55940-73-3 | Benzoic acid, 2-hydroxy-, oxybis(methyl-2,1-ethanediyl) ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 56038-13-2 | .alpha.-D-Galactopyranoside, 1,6-dichloro-1,6-dideoxy-.beta.-D-fructofuranosyl 4-chloro-4-deoxy- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 56090-54-1 | Triglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 5611-51-8 | Pregna-1,4-diene-3,20-dione, 21-(3,3-dimethyl-1-oxobutoxy)-9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (11.beta.,16.alpha.)- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 56124-62-0 | Pentanoic acid, 2-[(2S,4S)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-.alpha.-L-lyxo-hexopyranosyl]oxy]-2-naphthacenyl]-2-oxoethyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 56180-94-0 | D-Glucose, O-4,6-dideoxy-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-.alpha.-D-glucopyranosyl-(1→4)-O-.alpha.-D-glucopyranosyl-(1→4)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 56211-40-6 | 3-Pyridinesulfonamide, N-[[(1-methylethyl)amino]carbonyl]-4-[(3-methylphenyl)amino]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 56235-92-8 | Butanedioic acid, hydroxy-, bis(2-ethylhexyl) ester | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 56272-24-3 | Histidine, hydrochloride | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 56275-01-5 | Silicic acid, trimethylsilyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 56296-78-7 | Benzenepropanamine, N-methyl-.gamma.-[4-(trifluoromethyl)phenoxy]-, hydrochloride (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 56343-01-2 | Benzoic acid, 2-hydroxy-5-sulfo-, sodium salt (1:2) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 563-72-4 | Ethanedioic acid, calcium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 56390-09-1 | 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 56519-72-3 | Decanoic acid, 1,3-propanediyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 56554-41-7 | 9,12,15-Octadecatrienoic acid, 2,3-dihydroxypropyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 56639-51-1 | Aluminum, hydroxybis(tetradecanoato-.kappa.O)- | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 56767-76-1 | [1,1'-Biphenyl]-4-acetic acid, 2-fluoro-.alpha.-methyl-, sodium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 56827-95-3 | 1-Hexadecanol, phosphate (3:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 5697-02-9 | 1-Naphthalenol, 2-methyl-, 1-acetate | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 56992-68-8 | Poly(oxy-1,2-ethanediyl), .alpha.-benzoyl-.omega.-(dodecyloxy)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 57022-38-5 | Propanamide, 3-amino-N-[2-(1H-imidazol-5-yl)ethyl]-, hydrochloride (1:2) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 5703-94-6 | 3,6,9,12-Tetraoxadocosan-1-ol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 57041-67-5 | Ethane, 2-(difluoromethoxy)-1,1,1,2-tetrafluoro- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 57072-40-9 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, chromium(3+) salt (1:?) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 5714-73-8 | Glycine, N-benzoyl-, compd. with 1,3,5,7-tetraazatricyclo[3.3.1.13,7]decane (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 57248-88-1 | Phosphonic acid, P,P'-(3-amino-1-hydroxypropylidene)bis-, sodium salt (1:2) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 5725-96-2 | Methanamine, N-hydroxy-N-methyl- | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 57271-36-0 | Benzene, ethenyl-, polymer with butene and ethene | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 57-42-1 | 4-Piperidinecarboxylic acid, 1-methyl-4-phenyl-, ethyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 5743-17-9 | 1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-, monobenzoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 57452-98-9 | 4H-Pyrazino[2,1-a]isoquinolin-4-one, 2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-, (11bR)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 57524-53-5 | Ethanol, 2-[(4-methoxy-2-nitrophenyl)amino]- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 57524-89-7 | Pregn-4-ene-3,20-dione, 11,21-dihydroxy-17-[(1-oxopentyl)oxy]-, (11.beta.)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 57568-20-4 | Propanoic acid, 2-hydroxy-, 2-octyldodecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 57569-76-3 | Poly(oxy-1,2-ethanediyl), .alpha.,.alpha.',.alpha."-1,2,3-propanetriyltris[.omega.-(acetyloxy)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 57606-04-9 | 2(3H)-Furanone, 4-ethyldihydro-3-hydroxy-4-methyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 57-63-6 | 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17.alpha.)- | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 576-37-4 | Glucuronic acid | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 576-55-6 | Phenol, 2,3,4,5-tetrabromo-6-methyl- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 57762-37-5 | 4-Thiazolidinecarboxylic acid, compd. with L-lysine (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 57773-65-6 | 1-9-Luteinizing hormone-releasing factor (swine), 6-D-tryptophan-9-(N-ethyl-L-prolinamide)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 57808-66-9 | 2H-Benzimidazol-2-one, 5-chloro-1-[1-[3-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl]-4-piperidinyl]-1,3-dihydro- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 57817-89-7 | Kaur-16-en-18-oic acid, 13-[(2-O-.beta.-D-glucopyranosyl-.beta.-D-glucopyranosyl)oxy]-, .beta.-D-glucopyranosyl ester, (4.alpha.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 57-83-0 | Pregn-4-ene-3,20-dione | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 57834-33-0 | Benzoic acid,4-[[(methylphenylamino)methylene]amino]-,ethyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 57834-50-1 | Benzoic acid, 4-[[[[4-(ethoxycarbony)phenyl]amino]methylene]amino]-,ethyl ester | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 57-85-2 | Androst-4-en-3-one, 17-(1-oxopropoxy)-, (17.beta.)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 57852-57-0 | 5,12-Naphthacenedione, 9-acetyl-7-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, hydrochloride (1:1), (7S,9S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 5786-21-0 | 5H-Dibenzo[b,e][1,4]diazepine, 8-chloro-11-(4-methyl-1-piperazinyl)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 57934-97-1 | 2-Cyclohexene-1-carboxylic acid, 2-ethyl-6,6-dimethyl-,ethyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 57963-76-5 | 4a(2H)-Naphthalenol, octahydro-4,4,8a-trimethyl-,trans- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 57963-77-6 | cis-1,1,10-Trimethyl-9-decahydronaphthol | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 57982-77-1 | 1-9-Luteinizing hormone-releasing factor (swine), 6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 58001-44-8 | 4-Oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, (2R,3Z,5R)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 58-05-9 | L-Glutamic acid, N-[4-[[(2-amino-5-formyl-3,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 5819-47-6 | 5-Pyrrolidinecarboxylic acid, 2-oxo-, magnesium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 58-28-6 | 5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N-methyl-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 58306-30-2 | Carbamic acid, N,N'-[[2-[(2-methoxyacetyl)amino]-4-(phenylthio)phenyl]carbonimidoyl]bis-, C,C'-dimethyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 5836-69-1 | Phosphinic amide, P,P-dibutyl-N,N-dipropyl- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 58-46-8 | 2H-Benzo[a]quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-, (3R,11bR)-rel- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 58543-16-1 | Kaur-16-en-18-oic acid, 13-[(O-.beta.-glucopyranosyl-(1→2)-O-[.beta.-D-glucopyranosyl-(1→3)]-.beta.-D-glucopyranosyl)oxy]-,.beta.-D-glucopyranosyl ester, (4.alpha.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 58579-51-4 | Imidazo[2,1-b]quinazolin-2(3H)-one, 6,7-dichloro-1,5-dihydro-,hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 5858-61-7 | 2,7-Naphthalenedisulfonic acid, 3-[[4-(acetylamino)phenyl]azo]-4-hydroxy-, disodium salt | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 585-86-4 | D-Glucitol, 4-O-.beta.-D-galactopyranosyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 5863-51-4 | Benzenemethanaminium, N-[4-[(2-chlorophenyl)[4-[ethyl[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylene]-3-methyl-2,5-cyclohexadien-1-ylidene]-N-ethyl-3-sulfo-, inner salt, sodium salt (1:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 58748-27-9 | Fatty acids, C8-10, propylene esters | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 58786-99-5 | Morphinan-3,14-diol, 17-(cyclobutylmethyl)-, (2S,3S)-2,3-dihydroxybutanedioate (1:1) (salt) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 58846-77-8 | .beta.-D-Glucopyranoside, decyl | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 58855-36-0 | Ethanol, 2,2'-iminobis-, compd. with .alpha.-sulfo-.omega.-(dodecyloxy)poly(oxy-1,2-ethanediyl) (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 589-68-4 | Tetradecanoic acid, 2,3-dihydroxypropyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 59-05-2 | L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 5905-52-2 | Propanoic acid, 2-hydroxy-, iron(2+) salt (2:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 59056-93-8 | Ethanone, 1-[(2R,3S)-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2-naphthalenyl]-, rel- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 59070-56-3 | Poly(oxy-1,2-ethanediyl), .alpha.,.alpha'.,.alpha."-1,2,3-propanetriyltris[.omega.-hydroxy-, monododecanoate | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 59219-71-5 | Hexanoic acid, 3,5,5-trimethyl-, 3,5,5-trimethylhexyl ester | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 59231-35-5 | Hexanoic acid, 3,5,5-trimethyl-, isodecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 59272-74-1 | Spiro[7H-benzo[de]quinoline-7,1'-cyclohexane]-4',6-diol, 1,2,3,8,9,9a-hexahydro-5-methoxy-1-methyl-, (1'.alpha.,4'.beta.,9aR)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 5936-28-7 | 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-[(5R)-5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl]-, hydrochloride, (3S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 59-42-7 | Benzenemethanol, 3-hydroxy-.alpha.-[(methylamino)methyl]-, (.alpha.R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 594-45-6 | Ethanesulfonic acid | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 59-46-1 | Benzoic acid, 4-amino-, 2-(diethylamino)ethyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 59467-70-8 | 4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 5949-16-6 | Cinchonan-9-ol, (9S)-, sulfate (2:1) (salt) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 5949-44-0 | Androst-4-en-3-one, 17-[(1-oxoundecyl)oxy]-, (17.beta.)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 59-52-9 | 1-Propanol, 2,3-dimercapto- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 59587-08-5 | 1,3-Dioxolo[4,5-g]quinoline-7-carboxylic acid, 5-ethyl-5,8-dihydro-8-oxo-, sodium salt (1:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 59599-53-0 | Benzoic acid, 2-hydroxy-, 2-(2-hydroxy-1-methylethoxy)-1-methylethyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 59599-58-5 | Benzenesulfonic acid, 4-tridecyl-, compd. with 2,2',2"-nitrilotris[ethanol] (1:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 59599-61-0 | Octenoic acid, (5-hydroxy-6-methyl-3,4-pyridinediyl)bis(methylene) ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 596-51-0 | Pyrrolidinium, 3-[(2-cyclopentyl-2-hydroxy-2-phenylacetyl)oxy]-1,1-dimethyl-, bromide (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 5967-73-7 | 3-Heptanone, 6-(dimethylamino)-4,4-diphenyl-, hydrochloride, (6R)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 59708-52-0 | 4-Piperidinecarboxylic acid, 4-[(1-oxopropyl)phenylamino]-1-(2-phenylethyl)-, methyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 59729-32-7 | 5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-, hydrobromide (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 59729-33-8 | 5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 59792-81-3 | Aluminum, tris(5-oxo-L-prolinato-.kappa.N1,.kappa.O2)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 59804-37-4 | 2H-Thieno[2,3-e]-1,2-thiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 59820-63-2 | 2-[3-(methylamino)-4-nitrophenoxy]ethanol | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 5985-99-9 | Piperidine, 2-propyl-, (2R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 5987-82-6 | Benzoic acid, 4-amino-3-butoxy-, 2-(diethylamino)ethyl ester, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 59-92-7 | L-Tyrosine, 3-hydroxy- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 59970-10-4 | 3,6,9,12-Tetraoxatriacontan-1-ol | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 60031-93-8 | Cyclohexanemethanol, 4-ethenyl-a,a,4-trimethyl-3-(1-methylethenyl)-,1-acetate,(1R,3S,4S)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 60063-90-3 | Ammonium Carrageenan | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 60106-89-0 | 2-Propanol, 1-[(1-methylethyl)amino]-3-(2-propylphenoxy)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 60-13-9 | Benzeneethanamine, .alpha.-methyl-, sulfate (2:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 60142-96-3 | Cyclohexaneacetic acid, 1-(aminomethyl)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 60166-93-0 | 1,3-Benzenedicarboxamide, N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxy-1-oxopropyl]amino]-2,4,6-triiodo- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 60270-33-9 | Docosanamide, N-[3-(dimethylamino)propyl]- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 6027-43-6 | 1-Propanone, 3-(3,4-dihydroxyphenyl)-1-(3-.beta.-D-glucopyranosyl-2,4,6- trihydroxyphenyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 60-31-1 | Ethanaminium, 2-(acetyloxy)-N,N,N-trimethyl-, chloride (1:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 603-50-9 | Phenol, 4,4'-(2-pyridinylmethylene) bis-, 1,1'-diacetate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 603-85-0 | Phenol, 2-amino-3-nitro- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 60323-79-7 | Starch, polymer with 2-propenoic acid, graft, sodium salt | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 60-41-3 | Strychnidin-10-one, sulfate (2:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 604-68-2 | .alpha.-D-Glucopyranose, 1,2,3,4,6-pentaacetate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 6054-98-4 | Benzoic acid, 3,3'-(1,2-diazenediyl)bis[6-hydroxy-, sodium salt (1:2) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 606-06-4 | 2,5-Cyclohexadiene-1,4-dione, 2-[(2E)-3,7-dimethyl-2,6-octadienyl]-5,6-dimethoxy-3-methyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 60650-88-6 | Sericin A | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 60684-33-5 | 2,5-Cyclohexadiene-1,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaen-1-yl)-5,6-dimethoxy-3-methyl- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 60752-63-8 | L-Methionine, N-(2-thienylcarbonyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 60778-99-6 | Sulfuric acid, aluminum magnesium salt (1:?:?) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 60908-77-2 | Isohexadecane | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 60-92-4 | Adenosine, cyclic 3',5'-(hydrogen phosphate) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 611-75-6 | Benzenemethanamine, 2-amino-3,5-dibromo-N-cyclohexyl-N-methyl-, monohydrochloride | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 61177-45-5 | 4-Oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, potassium salt (1:1), (2R,3Z,5R)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 613-03-6 | 1,2,4-Benzenetriol, 1,2,4-triacetate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 61364-37-2 | Pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, (14bR)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 6145-69-3 | 1,2-Propanediol, 3-(hexadecyloxy)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 61477-96-1 | 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[(2R)-2-[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 6159-41-7 | 10-Undecenoic acid, potassium salt (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 616204-22-9 | L-Argininamide, N-acetyl-L-.alpha.-glutamyl-L-.alpha.-glutamyl-L-methionyl-L-glutaminyl-L-arginyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 61661-06-1 | 1,2-Benzenediol, 4-[2-[[(1S)-3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 61692-77-1 | 2-Butenoic acid, 2-methyl-, 2-methylbutyl ester, (2Z)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 61693-08-1 | Heptadecane, 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16-hexadecamethyl- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 61702-44-1 | 1,4-Benzenediamine, 2-chloro-, sulfate (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 617-05-0 | Benzoic acid, 4-hydroxy-3-methoxy-, ethyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 61718-82-9 | 1-Pentanone, 5-methoxy-1-[4-(trifluoromethyl)phenyl]-, O-(2-aminoethyl)oxime, (1E)-, (2Z)-2-butenedioate (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 61757-59-3 | Poly(oxy-1,2-ethanediyl),.alpha.-(carboxymethyl)-.omega.-(tridecyloxy)-,sodium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 61788-55-4 | Flavonoids, lemon oil | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 61789-08-0 | Glycerides, soya mono-, hydrogenated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 61789-25-1 | Corn oil, ethoxylated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 61789-88-6 | Fatty acids, olive-oil, sodium salts | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 61789-89-7 | Fatty acids, palm kernel-oil, sodium salts | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 61790-62-3 | Fatty acids, coco, reaction products with N1,N1-dimethyl-1,3-propanediamine | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 61790-79-2 | Fatty acids, palm-oil, sodium salts | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 6182-11-2 | Octadecanoic acid, 1,1'-(1-methyl-1,2-ethanediyl) ester | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 61849-14-7 | Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, monosodium salt, (5Z,9.alpha.,11.alpha.,13E,15S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 61869-08-7 | Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, (3S,4R)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 61886-59-7 | Benzenesulfonic acid, tridecyl-, compd. with 2,2',2"-nitrilotris[ethanol] (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 620-64-4 | Eicosanoic acid, 1,2,3-propanetriyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 620-67-7 | Heptanoic acid, 1,1',1"-(1,2,3-propanetriyl) ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 62125-22-8 | Isooctadecanoic acid, 1,1'-[2,2-bis[[(1-oxoisooctadecyl)oxy]methyl]-1,3-propanediyl] ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 62152-14-1 | 1-Propanesulfonic acid, 2-methyl-2-[(1-oxo-2-propen-1-yl)amino]-, ammonium salt (1:1), homopolymer | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 6217-54-5 | 4,7,10,13,16,19-Docosahexaenoic acid, (4Z,7Z,10Z,13Z,16Z,19Z)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 6219-67-6 | 1,3-Benzenediamine, 4-methoxy-, sulfate (1:?) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 6219-69-8 | 1,3-Benzenediamine, 4-ethoxy-, sulfate | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 62288-83-9 | Vasopressin, 1-(3-mercaptopropanoic acid)-8-D-arginine-, monoacetate(salt) | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 62406-73-9 | 6,10-Dioxaspiro[4,5]decane,8,8-dimethyl-7-(-1-methylethyl)- | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 62-52-2 | Magnesium, [aspartato(2-)]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 6261-30-9 | Cyclopentanol, 2-cyclopentylidene- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 62625-14-3 | Phenol, 2-amino-6-chloro-4-nitro-, hydrochloride (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 6273-99-0 | Mercury, [.mu.-[orthoborato(2-)-.kappa.O:.kappa.O']]diphenyldi- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 6297-03-6 | Octadecane, 1,1'-oxybis | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 629-82-3 | Octane, 1,1'-oxybis- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 6304-31-0 | Pyridine, 2-butyl-4-methyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 63074-08-8 | Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 63084-98-0 | Phenol, 4-amino-, sulfate (2:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 63089-86-1 | Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, ether with D-glucitol (6:1), tetra-(9Z)-9-octadecenoate | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 630-93-3 | 2,4-Imidazolidinedione, 5,5-diphenyl-, sodium salt (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 631-89-0 | Retinol, 15-[(9Z,12Z)-9,12-octadecadienoate] | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 635-38-1 | Hexadecanoic acid, [3-hydroxy-2-methyl-5-[[(1-oxohexadecyl)oxy]methyl]-4-pyridinyl]methyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 635-39-2 | 6H-Purin-6-one, 2-amino-1,9-dihydro-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 6358-53-8 | 2-Naphthalenol, 1-[2-(2,5-dimethoxyphenyl)diazenyl]- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 63590-64-7 | Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 63612-50-0 | 2,4-Imidazolidinedione, 5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 63659-18-7 | 2-Propanol, 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 63663-21-8 | Pentanediamide, N1,N5-dibutyl-2-[(1-oxododecyl)amino]-, (2S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 6371-76-2 | 2-Naphthalenecarboxylic acid, 3-hydroxy-4-(2-phenyldiazenyl)-, calcium salt (2:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 6371-96-6 | Butanamide, 2-[2-(4-methoxy-2-nitrophenyl)diazenyl]-N-(2-methylphenyl)-3-oxo- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 637-32-1 | Imidodicarbonimidic diamide, N-(4-chlorophenyl)-N'-(1-methylethyl)-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 638-94-8 | Pregna-1,4-diene-3,20-dione, 11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (11.beta.,16.alpha.)- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 63-89-8 | 3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxohexadecyl)oxy]-, inner salt, 4-oxide, (7R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 64019-93-8 | Propanoic acid, 2,2-dimethyl-, 4-[1-hydroxy-2-(methylamino)ethyl]-1,2-phenylene ester, hydrochloride | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 64024-15-3 | 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-, hydrochloride (1:1), (2R,6R,11R)-rel- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 64053-00-5 | Decanoic acid, 2-[4-[(3Z)-3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]-1-piperazinyl]ethyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 642072-46-6 | Ethanol, 2,2'-iminobis-,compd. with .alpha.-sulfo-.omega.-(tetradecyloxy) poly ( oxy-1,2-ethanediyl) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 64211-45-6 | Ethanone, 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)-, O-[(2,4-dichlorophenyl)methyl]oxime, (1Z)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 64221-86-9 | 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 6-[(1R)-1-hydroxyethyl]-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-, (5R,6S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 64228-81-5 | Isoquinolinium, 2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, dibenzenesulfonate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 64248-79-9 | Isooctadecanoic acid, sodium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 64294-91-3 | C.I. Pigment Yellow 43 | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 64366-24-1 | Carrageenan, potassium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 644-62-2 | Benzoic acid, 2-[(2,6-dichloro-3-methylphenyl)amino]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 645-05-6 | 1,3,5-Triazine-2,4,6-triamine, N2,N2,N4,N4,N6,N6-hexamethyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 64519-44-4 | L-Proline, 5-oxo-, (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 64519-82-0 | D-arabino-Hexitol, 6-O-.alpha.-D-glucopyranosyl-, (2.xi.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 64544-07-6 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-(2-furanyl)-2-(methoxyimino)acetyl]amino]-8-oxo-, 1-(acetyloxy)ethyl ester, (6R,7R)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 646996-25-0 | Glycine, N-(2-aminoethyl)-N-[2-(carboxymethoxy)ethyl]-, N-wheat germ-oil acyl derivs., disodium salts | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 64-73-3 | 2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-, monohydrochloride, (4S,4aS,5aS,6S,12aS)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 64855-91-0 | Proline, 5-oxo-, compd. with L-arginine (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 64924-67-0 | 4(3H)-Quinazolinone, 7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-, monohydrobromide, rel- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 6493-05-6 | 1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl-1-(5-oxohexyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 6505-30-2 | Benzenemethanaminium, N-[4-[[4-(diethylamino)phenyl][4-[ethyl[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylene]-3-methyl-2,5-cyclohexadien-1-ylidene]-N-ethyl-3-sulfo-, inner salt, sodium salt (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 65072-04-0 | Alkaloids, Veratrum | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 65-19-0 | Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, hydrochloride (1:1), (16.alpha.,17.alpha.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 65-22-5 | 4-Pyridinecarboxaldehyde, 3-hydroxy-5-(hydroxymethyl)-2-methyl-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 65235-31-6 | Phenol, 4-[(2-hydroxyethyl)amino]-3-nitro- | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 65271-80-9 | 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 65-28-1 | Phenol, 3-[[(4,5-dihydro-1H-imidazol-2-yl)methyl](4-methylphenyl)amino]-, methanesulfonate (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 6533-00-2 | 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17.alpha.)-(+-)- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 65389-08-4 | Indium-111In, tris(8-quinolinolato-.kappa.N1,.kappa.O8)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 65405-96-1 | Nickel, [.mu.-[carbonato(2-)-.kappa.O:.kappa.O']]dihydroxydi- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 65473-14-5 | 1-Naphthalenemethanamine, N-methyl-N-[(2E)-3-phenyl-2-propen-1-yl]-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 6548-12-5 | Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl[(3-sulfophenyl)methyl]amino]phenyl](2-sulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-3-sulfo-, inner salt, barium salt (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 6556-12-3 | D-Glucuronic acid | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 65710-07-8 | D-Streptamine, O-4-amino-4-deoxy-.alpha.-D-glucopyranosyl-(1→8)-O-(8R)-2-amino-2,3,7-trideoxy-7- (methylamino)-D-glycero-.alpha.-D-allo-octodialdo-1,5:8,4-dipyranosyl-(1→4)-2-deoxy-, sulphate (salt) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 65-71-4 | 2,4(1H,3H)-Pyrimidinedione, 5-methyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 65807-02-5 | 1-9-Luteinizing hormone-releasing factor (swine), 6-[O-(1,1-dimethylethyl)-D-serine]-, 2-(aminocarbonyl)hydrazide | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 65-82-7 | L-Methionine, N-acetyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 65896-16-4 | 1H-Imidazol-2-amine, N-(2-bromo-6-fluorophenyl)-4,5-dihydro- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 65899-73-2 | 1H-Imidazole, 1-[2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 6600-40-4 | L-Norvaline | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 660-27-5 | Acetic acid, 2,2-dichloro-, compd. with N-(1-methylethyl)-2-propanamine (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 66085-59-4 | 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-(2-methoxyethyl) 5-(1-methylethyl) ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 66095-81-6 | Ethanol, 2-[(2-methoxy-4-nitrophenyl)amino]- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 66104-22-1 | Ergoline, 8-[(methylthio)methyl]-6-propyl-, (8.beta.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 66104-23-2 | Ergoline, 8-[(methylthio)methyl]-6-propyl-, (8.beta.)-, monomethanesulfonate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 66108-95-0 | 1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 66161-62-4 | Glycine, N-(2-hydroxyethyl)-N-[2-[(1-oxododecyl)amino]ethyl]-, sodium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 66170-10-3 | L-Ascorbic acid, 2-(dihydrogen phosphate), sodium salt (1:3) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 66357-35-5 | 1,1-Ethenediamine, N'-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N-methyl-2-nitro- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 66357-59-3 | 1,1-Ethenediamine, N'-[2-[[[5-[(dimethylamino)methyl]-2 furanyl]methyl]thio]ethyl]-N-methyl-2-nitro-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 66376-36-1 | Phosphonic acid, P,P'-(4-amino-1-hydroxybutylidene)bis- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 66-40-0 | Ethanaminium, N,N,N-triethyl- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 6640-03-5 | 1-Tetradecanol, 1-(hydrogen phosphate) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 66469-15-6 | Isooctadecanoic acid, potassium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 66575-29-9 | 1H-Naphtho[2,1-b]pyran-1-one, 5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-, [3R-(3-.alpha.,4a-.beta.,5-.beta.,6-.beta.,6a-.alpha.,10-.alpha.,10a-.beta.,10b-.alpha.)]- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 66671-82-7 | 1,4-Benzenediamine, 2-methoxy-, sulfate (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 66711-21-5 | 1,4-Benzenediamine, 2,6-dichloro-N1-(4,5-dihydro-1H-imidazol-2-yl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 667-84-5 | Butamide, N-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 66794-58-9 | Sorbitan, monoisooctadecanoate, poly(oxy-1,2-ethanediyl) derivatives | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 66849-33-0 | 2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide, (2S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 66852-54-8 | Pregna-1,4-diene-3,20-dione, 21-chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (6.alpha.,11.beta.,16.beta.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 669066-11-9 | Celosia argentea cristata, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 67254-72-2 | Fatty acids, castor-oil, esters with polyglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 67254-73-3 | Glycerides, mixed mono- and di- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 67392-87-4 | Spiro[17H-dicyclopropa[6,7:15,16]cyclopenta[a]phenanthrene-17,2'(5'H)-furan]-3,5'(2H)-dione, 1,3',4',6,7,8,9,10,11,12,13,14,15,16,20,21-hexadecahydro-10,13-dimethyl-, (2'S,6R,7R,8R,9S,10R,13S,14S,15S,16S)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 676-46-0 | Butanedioic acid, 2-hydroxy-, sodium salt (1:2) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 67762-83-8 | Siloxanes and Silicones, di-Me, Me stearyl | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 67783-98-6 | Formaldehyde, polymer with 4,4'-(1-methylethylidene)bis[phenol] and 2-methylphenol | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 67784-87-6 | Glycerides, palm-oil mono- and di-, hydrogenated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 67784-88-7 | Glycerides, palm-oil mono- and di-, hydrogenated, ethoxylated | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 67801-20-1 | 4-Penten-2-ol,3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 67846-16-6 | 1-Propanaminium, N-ethyl-N,N-dimethyl-3-[(1-oxooctadecyl)amino]-, ethyl sulfate (1:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 67874-65-1 | Propanoic acid, 3-mercapto-, 2,3-dihydroxypropyl ester | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| *67914-69-6/ 85058-43-1 | 1-Piperazinecarboxylic acid, 4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-, ethyl ester, rel- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 67915-31-5 | Piperazine, 1-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-(1-methylethyl)-, rel- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 67938-21-0 | Isooctadecanoic acid, diester with oxybis[propanediol] | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 679809-58-6 | Enoxaparin sodium | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 68003-13-4 | Boric acid (H3BO3), compd. with 1-amino-2-propanol (1:1) | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| *68004-11-5/ 26855-44-7 | Octadecanoic acid, monoester with tetraglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 68015-98-5 | 1,3-Benzenediamine, 4-ethoxy-, sulfate (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 68-05-3 | Ethanaminium, N,N,N-triethyl-, iodide (1:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 68127-22-0 | D-Proline, 5-oxo-, (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 68130-12-1 | Boric acid, 2-aminoethyl ester | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 68130-24-5 | Decanoic acid, ester with 2,2'-[oxybis(methylene)]bis[2-(hydroxymethyl)-1,3-propanediol] octanoate pentanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 68130-52-9 | Decanoic acid, mixed esters with hexanoic acid, octanoic acid and trimethylolpropane | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 68155-26-0 | Amides, vegetable-oil, N,N-bis(hydroxyethyl) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 68187-29-1 | L-Glutamic acid, N-coco acyl derivs., compds. with triethanolamine (1:1) | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 68187-30-4 | L-Glutamic acid, N-coco acyl derivatives, disodium salts | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 68187-32-6 | L-Glutamic acid, N-coco acyl derivs., monosodium salts | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 68239-79-2 | Phenol, 3-(ethylamino)-4-methyl-, sulfate (2:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 68239-83-8 | Nitro-1,4-benzenediamine sulfate (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 68239-84-9 | Phenol, 3-(diethylamino)-, sulfate (2:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 68333-16-4 | Lactobacillus acidophilus | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 68373-14-8 | 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-, 4,4-dioxide, (2S,5R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 68391-32-2 | 2-Naphthalenaminium, 8-[2-(4-amino-3-nitrophenyl)diazenyl]-7-hydroxy-N,N,N-trimethyl-, chloride (1:1) | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 68401-82-1 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-, sodium salt (1:1), (6R,7R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 68413-33-2 | Quaternary ammonium compounds, bis(2-hydroxy-C>10-alkyl)dimethyl, chlorides | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 68424-38-4 | Fatty acids, C16-18, sodium salts | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 68440-49-3 | Peanut Oil, ethoxylated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 68459-67-6 | Castor oil, ester with glycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 68475-42-3 | Imidazo[2,1-b]quinazolin-2(3H)-one, 6,7-dichloro-1,5-dihydro- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 68475-50-3 | Aluminum, tris[5-amino-4-hydroxy-3-(phenylazo)-2,7-naphthalenedisulfonato(2-)]di- | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 68476-25-5 | Feldspar-group minerals | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| *68479-64-1/ 79702-63-9 | Butanedioic acid, 2-sulfo-, mono[2-[[(9Z)-1-oxo-9-octadecen-1-yl]amino]ethyl] ester, sodium salt (1:2) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 68506-86-5 | 5-Hexenoic acid, 4-amino- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 68552-95-4 | Fatty acids, vegetable-oil, ethoxylated | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| *68553-03-7/ 66105-29-1 | Glycerides, coco mono-, ethoxylated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 68554-53-0 | Siloxanes and Silicones, di-Me, (octadecyloxy)-terminated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 685-73-4 | D-Galacturonic acid | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 68580-63-2 | Octacosanol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 68606-18-8 | Glycerides, mixed coco, decanoyl and octanoyl | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 68606-81-5 | Currant, Ribes nigrum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 68607-24-9 | Quaternary ammonium compounds, C20-22-alkyltrimethyl, chlorides | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 90506-41-5 | Phosphoric acid, mono C12-14 alkyl esters, potassium salts | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 68650-43-1 | Chicory, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 68693-11-8 | Acetamide, 2-[(diphenylmethyl)sulfinyl]- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 68783-34-6 | Coconut oil, potassium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 68797-65-9 | 1-Propanaminium, N-ethyl-N,N-dimethyl-3-[(1-oxodocosyl)amino]-, ethyl sulfate (1:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 688013-96-9 | L-Tyrosine, N-[(2S)-3-carboxy-2-hydroxy-1-oxopropyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 68813-55-8 | 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, compd. with 3-[(1E)-2-(1,4,5,6-tetrahydro-1-methyl-2-pyrimidinyl)ethenyl]phenol (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 68814-13-1 | 1-Hexadecanol, phosphate | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 68844-77-9 | 1H-Benzimidazol-2-amine, 1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 68877-55-4 | Propanoic acid, 3-[2-(2-heptyl-4,5-dihydro-1.eta.-imidazol-1-yl)ethoxy]-, sodium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 68880-55-7 | Spiramycin, hexanedioate (1:1) (salt) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 68889-49-6 | 9-Octadecenoic acid (9Z)-, 1,2,3-propanetriyl ester, polymer with .alpha.-hydro-.omega.-hydroxypoly(oxy-1,2-ethanediyl) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 68890-92-6 | Poly(oxy-1,2-ethanediyl), .alpha.-(3-carboxy-1-oxosulfopropyl)-.omega.-hydroxy-, ethers with lanolin alcs., disodium salts | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 68908-98-5 | Poly(oxy-1,2-ethanediyl), .alpha.-(C12-13-alkyl)-.omega.-carboxymethoxy-, sodium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 68910-56-5 | Quaternary ammonium compounds, di-C12-15-alkyldimethyl, chlorides | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 68915-25-3 | Keratins, lauroyl | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 68919-21-1 | Keratins, octanoyl | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 68920-03-6 | Glycerides, C16-18 and C18-unsatd., deodorizer distillates | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 68929-04-4 | 1H-Imidazolium, 1-[2-(2-carboxyethoxy)ethyl]-1-(2-carboxyethyl)-4,5-dihydro-2-undecyl-, hydroxide, sodium salt (1:1:2) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 6893-02-3 | L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 68935-40-0 | 1H-Indene-2-propanoic acid, 2,3-dihydro-1-oxo-5,6-bis(phenylmethoxy)-2-propyl- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 68936-89-0 | 1,2,3-Propanetriol, homopolymer, (9Z,12R)-12-hydroxy-9-octadecenoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 68938-15-8 | Fatty acids, coco, hydrogenated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 68938-32-9 | Fatty acids, wheat germ-oil | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 68951-62-2 | Octadecanoic acid, reaction products with 2-amino-2-methyl-1-propanol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 68953-11-7 | Amides, mink-oil, N-[3-(dimethylamino)propyl] | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 68953-55-9 | Fats and Glyceridic oils, vegetable, esters with polyglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 68953-59-3 | Ethanaminium, 2-amino-N-(2-aminoethyl)-N-(2-hydroxyethyl)-N-methyl-, N,N'-bis(hydrogenated tallow acyl) derivs., Me sulfates (salts) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 68953-68-4 | Aluminum, chloro propylene glycol complexes | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 68956-08-1 | Fatty acids, C6-12, triesters with trimethylolpropane | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 6899-04-3 | Glutamine | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 68990-51-2 | Fatty acids, vegetable oil, esters with sterols mixed with vegetable-oil glycerides | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 68990-74-9 | Dandelion, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 69049-74-7 | 4H-Pyrano[3,2-g]quinoline-2,8-dicarboxylic acid, 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-, sodium salt (1:2) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 69071-70-1 | Fats and Glyceridic oils, apricot kernel, ethoxylated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 6916-74-1 | Docosanoic acid, 2,3-dihydroxypropyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 69247-83-2 | Hexanoic acid, 2-ethyl-, isooctadecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 6949-98-0 | Hexadecanoic acid, 9,10,16-trihydroxy- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 69-52-3 | 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-, sodium salt (1:1), (2S,5R,6R)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 69537-38-8 | 1-Propanaminium, 2-hydroxy-N,N,N-trimethyl-3-[(1-oxodocosyl)oxy]-, chloride (1:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 6966-09-2 | Cyclohexanone, 2-(1-piperidinylmethyl)-, hydrochloride (1:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 69712-56-7 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, (6R,7S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 70-00-8 | Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 70084-87-6 | Glutens, enzyme-modified | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 70131-69-0 | Silsesquioxanes, Ph | Higher priority based on available information - Human health concern | Commercial activity identified | To be assessed |
| 701-54-2 | Cyclohexanecarboxylic acid, 4-(aminomethyl)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 70214-77-6 | 2-Nonanol,6,8-dimethyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 70359-46-5 | 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 70609-66-4 | Ethanesulfonic acid, 2-[(1-oxododecyl)amino]-, sodium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 706808-37-9 | [29-tyrosine,104-glutamic acid] CTLA-4 (antigen) (human extracellular domain-containing fragment) fusion protein with immunoglobulin G1(human monoclonal Fc domain-containing fragment), bimol. (120120')-disulfide | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 70729-68-9 | Heptanoic acid, 1,1'-[oxybis(2,1-ethanediyloxy-2,1-ethanediyl)] ester | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 70729-87-2 | Isooctadecanoic acid, compd. with N,N-dimethyl-1-dodecanamine (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 7085-55-4 | 4H-1-Benzopyran-4-one, 2-[3,4-bis(2-hydroxyethoxy)phenyl]-3-[[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-5-hydroxy-7-(2-hydroxyethoxy)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 70913-86-9 | Alkanes C18-70 | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 70914-02-2 | Glycerides, C14-18 and C16-18-unsatd. mono- and di-, ethoxylated | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 7091-57-8 | 8-Quinolinol, benzoate (salt) | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 70969-43-6 | Fatty acids, palm kernel-oil, potassium salts | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 70983-91-4 | Glutens, corn, hydrolyzed, sodium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 71032-90-1 | 1,2-Propanediol, 3-[3-hydroxy-2-(9-octadecen-1-yloxy)propoxy]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 71060-72-5 | Quaternary ammonium compounds, tri-C14-18-alkylmethyl, chlorides | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 71109-09-6 | 1-Naphthaleneacetic acid, 4-cyclohexyl-.alpha.-methyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 71125-38-7 | 2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 71138-97-1 | Cellulose, 2-hydroxypropyl methyl ether, acetate hydrogen butanedioate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 71185-87-0 | Octadecanoic acid, triester with hexaglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 71195-58-9 | Propanamide, N-[1-[2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidinyl]-N-phenyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 71277-79-7 | .alpha.-D-Glucopyranosiduronic acid, (3.beta.,20.beta.)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-.beta.-D-glucopyranuronosyl-, sodium salt (1:2) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 71320-77-9 | Benzamide, 4-chloro-N-[2-(4-morpholinyl)ethyl]- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 71329-50-5 | Guar gum, 2-hydroxypropyl 2-hydroxy-3-(trimethylammonio)propyl ether, chloride | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 71368-20-2 | L-Glutamic acid, N-(1-oxotetradecyl)-, sodium salt (1:?) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 71463-34-8 | 1H-Imidazolium, 1-(carboxymethyl)-4,5-dihydro-1-(2-hydroxyethyl)-2-undecyl-, hydrogen sulfate (salt), monosodium salt | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 7147-34-4 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,2,3-tris(2-ethylhexyl)ester | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 71486-22-1 | Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-15-[(2R,6R,8S)-4-ethyl-1,3,6,7,8,9-hexahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2.beta.,3.beta.,4.beta.,5.alpha.,12R,19.alpha.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 71566-49-9 | Isononaoic acid,2-ethylhexyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 71735-79-0 | 13-Oxabicyclo[10.1.0]trideca-4,8-diene, trimethyl- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 71-78-3 | 2-Piperidinemethanol, .alpha.,.alpha.-diphenyl-, hydrochloride | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 71812-38-9 | Sorbitan, isooctadecanoate (2:3) | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 71-81-8 | Benzenepropanaminium, .gamma.-(aminocarbonyl)-N-methyl-N,N-bis(1-methylethyl)-.gamma.-phenyl-, iodide | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 71850-81-2 | 1-Propanaminium, N-(carboxymethyl)-3-[[(9Z,12R)-12-hydroxy-1-oxo-9-octadecen-1-yl]amino]-N,N-dimethyl-, inner salt | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 7187-62-4 | Quinolinium, 6-(dimethylamino)-2-[2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl]-1-methyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 71957-08-9 | Cobalt, bis(D-gluconato-.kappa.O1,.kappa.O2)-,(T-4)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 719-59-5 | Methanone, (2-amino-5-chlorophenyl)phenyl- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 71976-00-6 | 3,6,9,12,15,18,21,24,27,30-Decaoxaoctatetracont-39-en-1-ol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 7211-53-2 | Docosanoic acid, potassium salt (1:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 721-50-6 | Propanamide, N-(2-methylphenyl)-2-(propylamino)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 72175-39-4 | Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, ether with methyl D-glucopyranoside, octadecanoate (8:2:3) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 72230-86-5 | Terpenes and Terpenoids, cedarwood-oil, Texan, hydroxy, acetates | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 72255-09-5 | Poly[oxy(methyl-1,2-ethanediyl)],.alpha.-hydro-.omega.-hydroxy-,ether with butanediol (2:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 7230-93-5 | Dodecanoic acid, aluminum salt (3:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 7232-21-5 | Benzamide, 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 72480-62-7 | Oils, ginseng | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 72484-69-6 | Oxirane, methyl-, polymer with oxirane, mono(2-decyltetradecyl) ether | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 72509-76-3 | 3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3-ethyl 5-methyl ester | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 72559-06-9 | Spiro[9,4-(epoxypentadeca[1,11,13]trienimino)-2H-furo[2',3':7,8]naphth[1,2-d]imidazole-2,4'-piperidine]-5,10,26(3H,9H)-trione, 16-(acetyloxy)-6,18,20-trihydroxy-14-methoxy-7,9,15,17,19,21,25-heptamethyl-1'-(2-methylpropyl)-, (9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 72576-78-4 | Octanoic acid, isooctadecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 72576-80-8 | Hexadecanoic acid, isooctadecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 72576-81-9 | Tetradecanoic acid, isooctadecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 72956-09-3 | 2-Propanol, 1-(9H-carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 72957-37-0 | N2-(N-glycyl-L-histidyl)-L-lysine monoacetate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| *72968-47-9/ 84012-31-7 | Passionflower, Passiflora incarnate, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 73020-09-4 | Oat gum | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 73231-34-2 | Acetamide, 2,2-dichloro-N-[(1S,2R)-1-(fluoromethyl)-2-hydroxy-2-[4-(methylsulfonyl)phenyl]ethyl]- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 73296-86-3 | Isooctadecanoic acid, ester with oxybis[propanediol] | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| *73296-98-7/ 84082-59-7 | Mate, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 73-31-4 | Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]- | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 73334-07-3 | 1,3-Benzenedicarboxamide, N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-N1-methyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 73384-59-5 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-, (6R,7R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 73590-58-6 | 1H-Benzimidazole, 6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 7360-38-5 | Hexanoic acid, 2-ethyl-, 1,1',1"-(1,2,3-propanetriyl) ester | Higher priority based on available information - Human health concern | Commercial activity identified | To be assessed |
| 7361-61-7 | 4H-1,3-Thiazin-2-amine, N-(2,6-dimethylphenyl)-5,6-dihydro- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 73771-04-7 | Pregna-1,4-diene-3,20-dione, 17-[(ethoxycarbonyl)oxy]-11-hydroxy-21-(1-oxopropoxy)-, (11.beta.)- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 73772-45-9 | 1-Propanaminium, N-(carboxymethyl)-N,N-dimethyl-3-[(1-oxodecyl)amino]-, inner salt | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 73772-46-0 | 1-Propanaminium, N-(carboxymethyl)-N,N-dimethyl-3-[(1-oxooctyl)amino]-, inner salt | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 7400-08-0 | 2-Propenoic acid, 3-(4-hydroxpheyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 74103-07-4 | 1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 7413-34-5 | L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, sodium salt (1:2) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 7414-83-7 | Phosphonic acid, P,P'-(1-hydroxyethylidene)bis-, sodium salt (1:2) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 74191-85-8 | Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](2,3-dihydro-1,4-benzodioxin-2-yl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 742087-55-4 | Steroids, soya hydroxy, 12-hydroxyoctadecanoates | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 74315-67-6 | Amylopectin, 2-hydroxypropyl ether | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 7440-56-4 | Germanium | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 7446-27-7 | Phosphoric acid, lead(2+) salt (2:3) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 74464-83-8 | 2-Pyridineacetamide, .alpha.-[2-[bis(1-methylethyl)amino]ethyl]-.alpha.-phenyl-, (.alpha.R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 74504-65-7 | 1,2,3-Propanetriol, homopolymer, decanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 74563-64-7 | 1,2,3-Hexadecanetriol, 3,7,11,15-tetramethyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 74578-69-1 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-, sodium salt (1:2), (6R,7R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 7460-12-0 | Benzenemethanol, .alpha.-[(1S)-1-(methylamino)ethyl]-, (.alpha.S)-, sulfate (2:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 74610-55-2 | Tylosin, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 74811-65-7 | Croscarmellose sodium | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 748142-30-5 | Octadecanoic acid, 12-hydroxy-, homopolymer, ester with 1,1'-[oxybis[2,2-bis(hydroxymethyl)-3,1-propanediyl]] didocosanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 7492-32-2 | Benzenepropanaminium, .gamma.-(aminocarbonyl)-N-methyl-N,N-bis(1-methylethyl)-.gamma.-phenyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 7492-68-4 | Carbonic acid, copper salt | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 75018-70-1 | Ethanesulfonic acid, 2-[[[[(3.alpha.,5.beta.,7.alpha.,12.alpha.,20S)-3,7,12-trihydroxy-20-methylpregnan-21-yl]seleno-75Se]acetyl]amino]- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 75248-76-9 | 2-Butenoic acid, polymer with ethenyl acetate and ethenyl 4-(1,1-dimethylethyl)benzoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 752-56-7 | Riboflavin, 2',3',4',5'-tetrabutanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 75330-75-5 | Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (2S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 7541-59-5 | 1,2,3,4-Butanetetrol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 7542-37-2 | D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1→3)-O-.beta.-D-ribofuranosyl-(1→5)-O-[2-amino-2-deoxy-.alpha.-D-glucopyranosyl-(1→4)]-2-deoxy- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 7554-65-6 | 1H-Pyrazole, 4-methyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 75607-67-9 | 9H-Purin-6-amine, 2-fluoro-9-(5-O-phosphono-.beta.-D-arabinofuranosyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 756819-45-1 | Siloxanes and Silicones, di-Me, mono[3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl] group-terminated, polymers with Bu methacrylate, 2-ethylhexyl acrylate and Me methacrylate | Higher priority based on available information - Human health concern | A Notice or Order has been published indicating that the Significant New Activity (SNAc) provisions of the Canadian Environmental Protection Act, 1999 apply to this substance | Removed from R-ICL |
| 75706-12-6 | 4-Isoxazolecarboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 75760-37-1 | 2-Propenoic acid, 2-methyl-, polymer with ethyl 2-propenoate and .alpha.-(2-methyl-1-oxo-2-propenyl)-.omega.-(octadecyloxy)poly(oxy-1,2-ethanediyl) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 75911-79-4 | Bicyclo[3.2.1]octan-8-ol, 1,5-dimethyl-, 8-acetate | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 76009-37-5 | 9-Octadecenoic acid (9Z)-, diester with hexaglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 762-26-5 | 4,8-Decadienal, 5,9-dimethyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 76-25-5 | Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (11.beta.,16.alpha.)- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 76-38-0 | Ethane, 2,2-dichloro-1,1-difluoro-1-methoxy- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 76414-35-2 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,2,3-trioctyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 76420-72-9 | L-Proline, N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 76-42-6 | Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5.alpha.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 7651-99-2 | Phosphonic acid, P,P',P",P"-[1,2-ethanediylbis[nitrilobis(methylene)]]tetrakis-, sodium salt (1:5) | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 76547-98-3 | L-Proline, N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 76584-70-8 | Pentanoic acid, 2-propyl-, sodium salt (2:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 7659-95-2 | 2,6-Pyridinedicarboxylic acid, 4-[2-[(2S)-2-carboxy-5-(.beta.-D-glucopyranosyloxy)-2,3-dihydro-6-hydroxy-1H-indol-1-yl]ethenyl]-2,3-dihydro-, (2S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 7675-83-4 | L-Aspartic acid, compd. with L-arginine (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 7681-78-9 | Cyclohexanaminium, 4,4'-methylenebis[N,N,N-trimethyl-, diiodide | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 7681-93-8 | 6,11,28-Trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid, 22-[(3-amino-3,6-dideoxy-b-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-, (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 76932-56-4 | Luteinizing hormone-releasing factor (swine), 6-[3-(2-naphthalenyl)-D-alanine]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 76963-41-2 | 1,1-Ethenediamine, N'-[2-[[[2-[(dimethylamino)methyl]-4-thiazolyl]methyl]thio]ethyl]-N-methyl-2-nitro- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 7704-67-8 | Erythromycin, thiocyanate (salt) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 7704-71-4 | 2-Butenedioic acid (2E)-, magnesium salt (1:?) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 7704-72-5 | 2-Butenedioic acid (2E)-, potassium salt (1:?) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 7704-73-6 | 2-Butenedioic acid (2E)-, sodium salt (1:?) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 770691-21-9 | Gadolinium, [rel-10-[(2R,3S)-2-(hydroxy-κO)-3-hydroxy-1-(hydroxymethyl) propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)- .kappa.N1,.kappa.N4,.kappa.N7,.kappa.N10,.kappa.O1,.kappa.O4,.kappa.O7]-, (SA-8-1425362'5')- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 7718-51-6 | 2-Butenedioic acid (2E)-, calcium salt (1:?) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 7732-97-0 | Estra-1,3,5(10)-triene-3,17-diol (17.beta.)-, diheptanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 7757-81-5 | 2,4-Hexadienoic acid, sodium salt (1:1), (2E,4E)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 7757-87-1 | Phosphoric acid, magnesium salt (2:3) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 7757-96-2 | 2,5-Furandione, dihydro-3-(1-octenyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 7773-03-7 | Sulfurous acid, potassium salt (1:1) | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 7776-28-5 | myo-Inositol, hexakis(dihydrogen phosphate), calcium salt (1:6) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 7783-84-8 | Phosphinic acid, iron(3+) salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 77851-07-1 | 2-cyclohexene-1-carboxylic acid, 2,3,6,6-tetramethyl-, ethyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 78822-40-9 | L-threo-.alpha.-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-4-ethyl-2-piperidinyl]carbonyl]amino]-1-thio-, hydrochloride (1:1) | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 77883-43-3 | Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](2,3-dihydro-1,4-benzodioxin-2-yl)-, methanesulfonate (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 7789-46-0 | Iron bromide (FeBr2) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 7790-44-5 | Stibine, triiodo- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 77923-28-5 | Cyclododecane, (2-methoxyethoxy)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 77940-93-3 | 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 1-methylethyl ester, (4S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 78103-84-1 | 1-Naphthalenecarbonitrile, 1,2,3,4-tetrahydro-4,4-dimethyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 78110-38-0 | Propanoic acid, 2-[[(Z)-[1-(2-amino-4-thiazolyl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 78246-49-8 | Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride (1:1), (3S,4R)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 78336-31-9 | Poly(oxy-1,2-ethanediyl), .alpha.-(12-hydroxydodecyl)-.omega.-[(12-hydroxydodecyl)oxy]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 78415-72-2 | [3,4'-Bipyridine]-5-carbonitrile, 1,6-dihydro-2-methyl-6-oxo- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 78418-01-6 | 2-hydroxy-5-(1-oxooctyl)-benzoic acid | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 78509-74-7 | 1-(hexadecyloxy)octadecan-2-ol) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 78616-98-5 | Dodecanoic acid, 2-aminoethyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 78628-80-5 | 1-Naphthalenemethanamine, N-[(2E)-6,6-dimethyl-2-hepten-4-yn-1-yl]-N-methyl-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 78755-81-4 | 4H-Imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid, 8-fluoro-5,6-dihydro-5-methyl-6-oxo-, ethyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 78809-92-4 | Chitosan, N-(3-carboxy-1-oxopropyl) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 79120-33-5 | Litharge (PbO) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 79-17-4 | Hydrazinecarboximidamide | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 79350-37-1 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-, (6R,7R)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 79416-55-0 | Docosanoic acid, 1,1'-(1,2-ethanediyl) ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 79449-98-2 | 4-Piperidinecarboxylic acid, 1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-, (3R,4S)-rel- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 79458-68-7 | Lysine, compd. with S-(carboxymethyl)-L-cysteine (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 79516-68-0 | 4-Piperidinecarboxylic acid, 1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-, (3S,4R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 79547-78-7 | 4-Piperidinecarboxylic acid, 1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-, hydrochloride (1:1), (3S,4R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 79548-73-5 | L-threo-.alpha.-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-4-ethyl-2-piperidinyl]carbonyl]amino]-1-thio- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 79559-97-0 | 1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, hydrochloride (1:1), (1S,4S)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 79617-96-2 | 1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, (1S,4S)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 79665-93-3 | 9-Octadecenoic acid (9Z)-, monoester with decaglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 797-63-7 | 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17.alpha.)- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 79777-30-3 | Octadecanoic acid, monoester with decaglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 79794-75-5 | 1-Piperidinecarboxylic acid, 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-, ethyl ester | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 79811-24-8 | L-Glutamic acid, N-(1-oxooctadecyl)-, sodium salt (1:?) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 79902-63-9 | Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 8000-26-8 | Oils, pine needle | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 8001-27-2 | Hirudin | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 8005-33-2 | C.I. Natural Black 1 | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 8007-48-5 | Oils, sweet bay | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 8007-56-5 | Aqua regia | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 8013-00-1 | Terpinene | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 80154-34-3 | Benzaldehyde, 4-(.beta.-D-allopyranosyloxy)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 8015-61-0 | Aloin | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 8016-24-8 | Oils, hemp seed | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 8016-55-5 | Rhubarb, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 8026-99-1 | Oils, lime, sweet | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 8027-43-8 | Oils, birch bud | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 8027-93-8 | Carbonic acid, dipotassium salt, sulfurized | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 8028-45-3 | Glycerides, oxidized | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 80370-57-6 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-[[(2-furanylcarbonyl)thio]methyl]-8-oxo-, (6R,7R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 80435-42-3 | Iron alloy, base, Fe 63-74,Cr 12.0-15.0,Ni 12.0-15.0,W 1.50-3.00,Mn 0-1.00,Si 0.30-0.80,C 0.35-0.50,Mo 0.20-0.50,P 0-0.045,S 0-0.030 (UNS S66009) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 80455-45-4 | Cellulose, hexadecyl 2-hydroxyethyl ether | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 80474-14-2 | Androsta-1,4-diene-17-carbothioic acid, 6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)-, S-(fluoromethyl) ester, (6.alpha.,11.beta.,16.alpha.,17.alpha.)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 8049-47-6 | Pancreatin | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 8049-84-1 | C.I. Natural Green 3 | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 8049-97-6 | Melanins | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 8050-05-3 | Milk Preparations, Yogurt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 8050-30-4 | Wood rosin, ester with 1,2,3-propanetriol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 8054-39-5 | Onion, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 8057-54-3 | Thymus gland, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 8057-61-2 | Kidney, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 808-48-0 | Pregn-4-ene-3,20-dione, 21-(2,2-dimethyl-1-oxopropoxy)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 80892-32-6 | 2-Propenoic acid, 2-methyl-, polymer with diethylbenzene (pharmaceutical grade) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 81025-04-9 | D-Glucitol, 4-O-.beta.-D-galactopyranosyl-, hydrate (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 81103-11-9 | Erythromycin, 6-O-methyl- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 81131-70-6 | 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-.beta.,.delta.,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-, sodium salt (1:1), (.beta.R,.delta.R,1S,2S,6S,8S,8aR)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 81403-80-7 | 2-Furancarboxamide, N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 81409-90-7 | Ergoline-8-carboxamide, N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-, (8.beta.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 81752-33-2 | Isooctadecanoic acid, monoester with oxybis[propanediol] | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 81782-89-0 | 6,8-Nonadien-3-one, 2,4,4,7-tetramethyl | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 81783-01-9 | 6,8-Nonadien-3-one,2,4,4,7-tetramethyl-,oxime | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 81818-54-4 | 1,4-Naphthalenedione, 2-methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 81897-25-8 | Isooctadecanoic acid, 2-ethylhexyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 81907-73-5 | 3-Cyclopentene-1-acetic acid, 2,2,3-trimethyl-, ethyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 82009-34-5 | 2-Heptenoic acid, 7-[[(2R)-2-amino-2-carboxyethyl]thio]-2-[[[(1S)-2,2-dimethylcyclopropyl]carbonyl]amino]-, (2Z)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 820212-37-1 | Siloxanes and Silicones,di-Me, hexacosyl Me | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 82030-87-3 | Somatotropin (human), N-L-methionyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 82048-29-1 | 1-Piperidinyloxy, 4-[(3-carboxy-1-oxopropyl)amino]-2,2,6,6-tetramethyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 820-66-6 | 1-Octadecanaminium, N-(carboxymethyl)-N,N-dimethyl-, inner salt | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 82097-50-5 | Benzenesulfonamide, 2-(2-chloroethoxy)-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 82204-94-2 | L-Glutamic acid, N-(1-oxododecyl)-, 1,5-bis(2-octyldodecyl) ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 82248-59-7 | Benzenepropanamine, N-methyl-.gamma.(2-methylphenoxy)-, hydrochloride (1:1), (.gamma.R)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 82249-33-0 | Hexanedioic acid, 3-(2,3-dihydroxypropyloxy)-2-hydroxypropyl diester, esters from reaction with a mixture of octanoic, decanoic, isooctadecanoic, octadecanoic and 12-hydroxyoctadecanoic acids | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 82410-32-0 | 6H-Purin-6-one, 2-amino-1,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 82419-36-1 | 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 82586-55-8 | 3-Isoquinolinecarboxylic acid, 2-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-, hydrochloride (1:1), (3S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 82640-04-8 | Methanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-, hydrochloride (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 827306-88-7 | L-Lysinamide, N2-acetyl-L-lysylglycyl-L-histidyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 82752-99-6 | 3H-1,2,4-Triazol-3-one, 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-, monohydrochloride | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 827596-80-5 | Octadecanoic acid, 12-hydroxy-, polymer with oxirane, triblock | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 82980-39-0 | Glycerides, wheat germ-oil | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 83016-76-6 | 2-Propanol, 1-amino-, compd. with .alfa.-sulfo-.omega.-(dodecyloxy) poly (oxy-1, 2-ethanediyl) (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 83120-95-0 | 2-Propenoic acid, 2-methyl-, dodecyl ester, polymer with 1-ethenyl-2-pyrrolidinone and 2-propenoic acid | Higher priority based on available information - Human health concern | Commercial activity identified | To be assessed |
| 83150-76-9 | L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 832-01-9 | 2-Propenoic acid, 3-(4-methoxyphenyl)-, methyl ester | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 83271-10-7 | Dextrin, hexadecanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 83-43-2 | Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-6-methyl-, (6.alpha.,11.beta.)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 83-46-5 | stigmast-5-en-3-ol, (3-.beta.)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 83-48-7 | Stigmasta-5,22-dien-3-ol, (3.beta.,22E)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 83512-85-0 | Chitosan, N-(carboxymethyl) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 83615-24-1 | Cholest-5-en-3-ol (3.beta.)-, 3-isooctadecanoate | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 83-67-0 | 1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 83684-11-1 | Phosphonic acid, mono(3-methyloxiranyl) ester, (2R-cis)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 83-73-8 | 8-Quinolinol, 5,7-diiodo- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 83763-47-7 | Ethanol, 2-[(3-amino-4-methoxyphenyl)amino]- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 83763-48-8 | Ethanol, 2-[(3-amino-4-methoxyphenyl)amino]-, sulfate (1:1) | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 83826-43-1 | Tetradecanoic acid, octyldodecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 83881-52-1 | Acetic acid, 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, hydrochloride (1:2) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 83898-65-1 | 2H-Benzimidazol-2-one, 5-chloro-1-[1-[3-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl]-4-piperidinyl]-1,3-dihydro-, (2Z)-2-butenedioate (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 83905-01-5 | 1-Oxa-6-azacyclopentadecan-15-one, 13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-.beta.-D-xylo-hexopyranosyl]oxy]-, (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 83919-23-7 | Pregna-1,4-diene-3,20-dione, 9,21-dichloro-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16-methyl-, (11.beta.,16.alpha.)- | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 84012-19-1 | Eggplant, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84012-22-6 | Hieracium pilosella, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84012-36-2 | Polygonum bistorta, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84012-38-4 | Ruscus aculeatus, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84-02-6 | 10H-Phenothiazine, 2-chloro-10-[3-(4-methyl-1-piperazinyl)propyl]-, (2Z)-2-butenedioate (1:2) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 84041-77-0 | Ethanol, 2,2'-[(2-nitro-1,4-phenylene)diimino]bis- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 84057-84-1 | 1,2,4-Triazine-3,5-diamine, 6-(2,3-dichlorophenyl)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 84069-44-3 | Chitosan, 2-hydroxypropyl ether | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 84082-55-3 | Lupine, L. albus, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84082-60-0 | Matricaria recutita, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84082-61-1 | Melissa officinalis extract | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84082-63-3 | Menyanthes trifoliata, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84082-68-8 | Myristica fragrans, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84366-81-4 | Riboflavin 5'-(trihydrogen diphosphate), P'→5'-ester with adenosine, disodium salt | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 84449-90-1 | Methanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 84563-62-2 | Chitosan, hexanedioate (salt) | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 84603-54-3 | Calluna vulgaris, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84603-61-2 | Hawthorn, Crataegus oxyacantha, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84603-73-6 | Laurus nobilis, ext | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84604-04-6 | Polygonum aviculare, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84604-07-9 | Prunus serotina, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84604-12-6 | Rose, Rosa centifolia, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84604-13-7 | Rose, Rosa gallica, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84604-15-9 | Sabal serrulatum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84604-16-0 | Saccharomyces cerevisiae, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84604-17-1 | Saffron, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84604-20-6 | Silybum marianum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84605-10-7 | 13-Docosenoic acid, isooctadecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 84605-12-9 | 13-Docosenoic acid, 13-docosenyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 84608-82-2 | 2-hydroxy-3-(oleoyloxy) propyl 5-oxo-L-prolinate | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 84625-28-5 | Ash (Fraxinus), F. excelsior, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84625-36-5 | Euphrasia officinalis, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84625-39-8 | Fennel ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84625-42-3 | Galium aparine, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| *84625-48-9/ 84929-75-9 | Rhamnus frangula, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84625-61-6 | 3H-1,2,4-Triazol-3-one, 4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 84642-57-9 | Cyclopentanone, 2-[(3,3,5-trimethylcyclohexyl)acetyl]- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 84643-53-8 | 1-Hexadecanaminium, 2-hydroxy-N-(2-hydroxyethyl)-N,N-dimethyl-, chloride (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 84649-82-1 | Aloe ferox, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84649-87-6 | Arctium majus, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84649-90-1 | Asparagus, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84649-91-2 | Avens, Geum urbanum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84649-93-4 | Barosma Betulina, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84649-96-7 | Boldo, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84649-98-9 | Cinnamomum zeylanicum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84649-99-0 | Cocoa, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84650-07-7 | Galega officinalis, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84650-11-3 | Geranium robertianum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84650-12-4 | Ginseng, Panax pseudoginseng, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84650-13-5 | Guaiacum officinale, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84650-18-0 | Nepeta hederacea, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84650-41-9 | Pterocarpus santalinus, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84650-55-5 | Rhamnus purshiana, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84681-71-0 | Rape oil, hydrogenated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84695-94-3 | Alchemilla vulgaris, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84695-96-5 | Ammi visnaga, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84696-01-5 | Cola Nitida, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84696-12-8 | Eleutherococcus senticosus, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84696-13-9 | Fucus vesiculosus, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84696-20-8 | Horehound, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84696-27-5 | Nymphaea alba, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84696-40-2 | Pepper (Piper), P. methysticum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84696-50-4 | Solanum dulcamara, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| *84696-51-5/ 90064-01-0 | Spearmint, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84750-06-1 | Octadecanoic acid, monoester with 1,2,3-propanetriol, mixt. with .alpha.-(1-oxooctadecyl)-.omega.-hydroxypoly(oxy-1,2-ethanediyl) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 84753-08-2 | 1, 3-bis (2-ethylhexyl) cyclohexane | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 84775-42-8 | Anise, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84775-50-8 | Coriander, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84775-51-9 | Cumin, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84775-54-2 | Cypripedium calceolus pubescens, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84775-57-5 | Filipendula ulmaria, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84775-63-3 | Indigofera tinctoria, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84775-71-3 | Ocimum basilicum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84775-83-7 | Sage, Salvia sclarea, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84775-94-0 | Radish, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84775-95-1 | Rhatany, Krameria triandra, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84775-96-2 | Roselle, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84776-25-0 | Cetraria islandica, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84776-26-1 | Cimicifuga racemosa, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84776-30-7 | Combretum micranthum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84776-64-7 | Jasmine, Jasminum grandiflorum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 847-84-7 | 3-Hexanone, 6-(dimethylamino)-4,4-diphenyl-, hydrochloride | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 84787-64-4 | Anacyclus pyrethrum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84787-66-6 | Condurango, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84787-71-3 | Sanguisorba officinalis, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84837-08-1 | Aloe, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84878-33-1 | Isononanoic acid, hexadecyl ester | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 84878-34-2 | Isononanoic acid, octadecyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 84878-61-5 | 2H-Pyran-2-acetic acid, 6-[(1R)-1-[(2S,5R,7S,8R,9S)-2-[(2S,2'R,3'S,5R,5'R)-3'-[(2,6-dideoxy-3,4-di-O-methyl-.beta.-L-arabino-hexopyranosyl)oxy]octahydro-2-methyl-5'-[(2S,3S,5R,6S)-tetrahydro-6-hydroxy-3,5,6-trimethyl-2H-pyran-2-yl][2,2'-bifuran]-5-yl]-9-hydroxy-2,8-dimethyl-1,6-dioxaspiro[4.5]dec-7-yl]ethyl]tetrahydro-2-hydroxy-4,5-dimethoxy-3-methyl-, ammonium salt (1:1), (2R,3S,4S,5R,6S)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 84929-28-2 | Guarana, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84929-30-6 | Lawsonia inermis alba, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84929-34-0 | Myrica cerifera, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84929-35-1 | Nepeta cataria, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84929-42-0 | Pine, Pinus maritima, ext | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84929-46-4 | Ptychopetalum olacoides, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84929-54-4 | Viburnum prunifolium, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84929-57-7 | Allspice, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84929-68-0 | Morinda citrifolia, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84929-76-0 | Rubus idaeus, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84929-78-2 | Strawberry, Fragaria vesca, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84961-45-5 | Ceratonia siliqua, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84961-57-9 | Pomegranate, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84961-62-6 | Tamarind, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84961-64-8 | Tanacetum vulgare, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 84988-87-4 | Glycerides, Vegetable Oil | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85005-44-3 | Glycerides, lanolin | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85066-57-5 | Poly(oxy-1,2-ethanediyl), .alpha.-(1-oxooctadecyl)-.omega.-(octadecyloxy)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 85085-21-8 | Astragalus gummifer, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85085-23-0 | Beeswax, saponified | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85085-31-0 | Eriodictyon glutinosum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85085-34-3 | Fir, Abies balsamea, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85085-46-7 | Lycium barbarum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85085-48-9 | Melaleuca alternifolia, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85085-51-4 | Nelumbo nucifera, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85085-54-7 | Cyperus rotundus, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85116-63-8 | Aloysia triphylla, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85116-74-1 | Cerebrosides | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85116-75-2 | Hemlock (poison), ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85117-06-2 | Goldenrod, Solidago virgaurea, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85117-13-1 | Quince, Cydonia oblonga, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85186-76-1 | Fatty acids, C14-18 and C18-unsatd., branched and linear, 2-ethylhexyl esters | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85187-05-9 | Senna, Cassia angustifolia, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85-19-8 | Methanone, (5-chloro-2-hydroxyphenyl)phenyl- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 85251-63-4 | Apple, Malus sylvestris,ext | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85251-64-5 | Barley, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85251-65-6 | Beech, Fagus sylvatica, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85252-25-1 | Benzoic acid, 2-hydroxy-, isodecyl ester | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 85264-33-1 | 1H-Pyrazole-1-methanol, 3,5-dimethyl- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 85305-88-0 | Ceramide, 1-O-.beta.-D-galactopyranosyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 85392-03-6 | 5-Decenoic acid | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 85392-04-7 | 6-Decenoic acid | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 85392-05-8 | 5-Decenoic acid, 1-butyl-5-carboxypentyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 85392-06-9 | 6-Decenoic acid, 1-butyl-5-carboxypentyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 853947-59-8 | Decanoic acid, reaction products with 1,3-butanediol and octanoic acid | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 85441-61-8 | 3-Isoquinolinecarboxylic acid, 2-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-, (3S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 85480-28-0 | Hexanedioic acid, isodecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 85480-47-3 | Acorus calamus, ext., hydrogenated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 855310-95-1 | Octadecanoic acid, 12-hydroxy-homopolymer, ester with 2,2-(oxybis(methylene))bis(2-(hydroxymethyl)-1,3-propanedriol)(3:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 85536-07-8 | Glycerides, C8-10 mono- and di- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85536-23-8 | Amides, rape-oil, N-(hydroxyethyl), ethoxylated | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 85563-48-0 | 1-Hexadecanaminium, N-(2-hydroxyethyl)-N,N-dimethyl-, phosphate (1:1) (salt) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 85586-07-8 | Sulfuric acid, mono-C12-14-alkyl esters, sodium salts | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 85586-30-7 | Glycerides, rape-oil mono- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85594-37-2 | Grape, ext | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85-61-0 | Coenzyme A | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85622-93-1 | Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| *85650-52-8/ 61337-67-5 | Pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 85-70-1 | 1,2-Benzenedicarboxylic acid, 1-(2-butoxy-2-oxoethyl) 2-butyl ester | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 85711-58-6 | Lecithins, hydrolyzed | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85711-76-8 | Dodecanoic acid, hydrogenated castor-oil alkyl esters | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 85721-05-7 | 1-Piperazineethanol, 4-[(3Z)-3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]-, acetate (ester) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 85721-33-1 | 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 85765-48-6 | Ethanol, 2-[4-[(2-aminoethyl)amino]-3-nitrophenoxy]- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 85895-78-9 | Propanoic acid, 2-hydroxy-, potassium salt (1:1), (2S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 85940-31-4 | Caraway, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85940-33-6 | Carlina acaulis, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 85940-38-1 | Ephedra sinica, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 86050-77-3 | D-Glucitol, 1-deoxy-1-(methylamino)-, [N,N-bis[2-[bis[(carboxy-.kappa.O)methyl]amino-.kappa.N]ethyl]glycinato(5-)-.kappa.N,.kappa.O]gadolinate(2-) (2:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 861407-54-7 | Octanoic acid, 5,7,7-trimethyl-2-(1,3,3-trimethylbutyl)-,2-[[3-hydroxy-2,2-bis[[[5,7,7-trimethyl-1-oxo-2-(1,3,3-trimethylbutyl)octyl]oxy]methyl]propoxy]methyl]-2-[[[5,7,7-trimethyl-1-oxo-2-(1,3,3-trimethylbutyl)octyl]oxy]methyl]-1,3-propanediyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 86347-15-1 | 1H-Imidazole, 5-[1-(2,3-dimethylphenyl)ethyl]-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 86362-36-9 | 3-Pyridinecarboxylic acid, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 86386-73-4 | 1H-1,2,4-Triazole-1-ethanol, .alpha.-(2,4-difluorophenyl)-.alpha.-(1H-1,2,4-triazol-1-ylmethyl)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 86419-69-4 | 1,2-Ethanediamine, N1-(5-methoxy-2-nitrophenyl)-, hydrochloride (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 86481-08-5 | Poly(oxy-1,2-ethanediyl), .alpha., .alpha'.-(1-methyl-1,2-ethanediyl)bis[.omega.-[[(9Z)-1-oxo-9-octadecenyl]oxy]- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 86541-74-4 | 1H-1-Benzazepine-1-acetic acid, 3-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-, hydrochloride (1:1), (3S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 865-44-1 | Iodine chloride (ICl3) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 86601-87-8 | 13-Docosenoic acid, tetracosyl ester, (13Z)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 866-82-0 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, copper(2+) salt (1:2) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 867301-59-5 | Pikea robusta, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 86-75-9 | 8-Quinolinol, 8-benzoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 868047-49-8 | Castor oil, hydrogenated, Isostearate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 86827-92-1 | 3,4-Thiophenediol, tetrahydro- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 86846-21-1 | Poly(oxy-1,2-ethanediyl),.alpha.,.alpha'.,.alpha."-1,2,3-propanetriyltris[.omega.-[(1-oxoisooctadecyl)oxy]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 869-06-7 | Butanedioic acid,2 hydroxy-,magnesium salt (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 869734-19-0 | acids, Cannabis sativa seed-oil, esters with polyethylene glycol ether with glycerol (3:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 87-08-1 | 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-, (2S,5R,6R)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 87-18-3 | Benzoic acid, 2-hydroxy-, 4-(1,1-dimethylethyl)phenyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 872131-04-9 | Divinyl sulfone cross-linked hyaluronan | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 87226-41-3 | Pyrano[3,4-b]indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-, (1R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 87233-61-2 | 1H-Benzimidazole, 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 87333-19-5 | Cyclopenta[b]pyrrole-2-carboxylic acid, 1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydro-, (2S,3aS,6aS)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 87362-54-7 | Bicyclo[3.3.1]nonan-1-ol, 5-methyl-, 1-acetate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 87390-32-7 | Tetradecanoic acid, monoester with decaglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 875919-10-1 | Fatty acids, limnanthes alba seed-oil, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-nonadecafluoro-1-[[(2-octyldodecyl)oxy]methyl]undecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 87679-37-6 | 1H-Indole-2-carboxylic acid, 1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydro-, (2S,3aR,7aS)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 877677-19-5 | Rumex occidentalis, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 87771-40-2 | 1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)(2-hydroxyethyl)amino]-2,4,6-triiodo- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 87806-31-3 | Photofrin Porfimer sodium | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 87-99-0 | Xylitol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 88040-23-7 | Pyrrolidinium, 1-[[(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-, inner salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 88103-59-7 | 13-Docosenoic acid, 2-octyldodecyl ester, (13Z)- | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 88120-12-1 | Isooctadecanoic acid, compd. with 2,2',2"-nitrilotris[ethanol] (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 88150-42-9 | 3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 88416-50-6 | Phosphonic acid, (dichloromethylene)bis-, disodium salt, tetrahydrate | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 88598-53-2 | .alpha.-D-Glucopyranose, 2-deoxy-6-O-[2-deoxy-2-[[(3R)-1-oxo-3-[(1-oxododecyl)oxy]tetradecyl]amino]-3-O-[(3R)-1-oxo-3-[(1-oxotetradecyl)oxy]tetradecyl]-4-O-phosphono-.beta.-D-glucopyranosyl]-2-[[(3R)-3-hydroxy-1-oxotetradecyl]amino]-, 3-[(3R)-3-hydroxytetradecanoate] | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 88768-40-5 | 6H-Pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid, 9-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]octahydro-10-oxo-, (1S,9S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 88845-49-2 | Furcellaran, calcium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 88889-14-9 | L-Proline, 4-cyclohexyl-1-[2-[(R)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]acetyl]-, sodium salt (1:1), (4S)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 89141-50-4 | Arsonodithious acid, [4-[(4,6-diamino-1,3,5-triazin-2-yl)amino]phenyl]-, bis(2-aminoethyl) ester, dihydrochloride | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 89365-50-4 | 1,3-Benzenedimethanol, 4-hydroxy-.alpha.1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 89786-04-9 | 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, (2S,3S,5R)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 89957-43-7 | Annatto tree, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 89957-45-9 | Anthyllis vulneraria, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 89957-58-4 | Artemisia abrotanum, ext | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 89957-81-3 | Avens, Geum rivale, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 89957-84-6 | Barberry, Berberis aristata, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 89957-89-1 | Beet, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 89957-90-4 | Beet, red, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 89957-98-2 | Boswellia carterii, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 89958-09-8 | Buckwheat, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 89958-13-4 | Cabbage, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 89958-29-2 | Carnation, Dianthus caryophyllus, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 89961-55-7 | Poly(oxy-1,2-ethanediyl),.alpha.-(3-carboxy-1-oxosulfopropyl)-.omega.-[(9Z)- 9-octadecen-1-yloxy]-,sodium salt (1:2) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 89997-35-3 | Celery, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 89997-53-5 | Cherry, sour, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 89997-65-9 | Chrysanthemum parthenium, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 89997-82-0 | Cola acuminata, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 89997-84-2 | Collinsonia canadensis, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 89997-98-8 | Crithmum maritimum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 89998-03-8 | Cucurbita pepo, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 9000-02-6 | Amber | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 9000-20-8 | Kino, eucalyptus | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 9000-21-9 | Furcellaran | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 9000-57-1 | Resins, sandarac | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 9000-58-2 | Resins, scammony | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 9001-01-8 | Kallikrein | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 9001-12-1 | Collagenase | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 9001-28-9 | Blood-coagulation factor IX | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 9001-63-2 | Lysozyme | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 9001-77-8 | Phosphatase, acid | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 9001-78-9 | Phosphatase, alkaline | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 9002-61-3 | Gonadotropin, chorionic | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 9002-64-6 | Parathormone | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 9002-70-4 | Gonadotropin, pregnant mare serum | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 90027-90-0 | Phoenix Dactylifera (Date) Fruit Extract | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90028-03-8 | Dill, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90028-20-9 | Echinacea purpurea, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90028-31-2 | Epilobium angustifolium, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90028-32-3 | Equisetum hyemale, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90028-68-5 | Evernia prunastri, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| *9002-96-4/ 30999-06-5 | Poly(oxy-1,2-ethanediyl), .alpha.-[4-[[(2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-yl]oxy]-1,4-dioxobutyl]-.omega.-hydroxy- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 90038-01-0 | 1H-Imidazole, 5-[(2,3-dimethylphenyl)methyl]-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 9003-97-8 | Polycarbophil calcium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 9004-30-2 | Cellulose, carboxymethyl 2-hydroxyethyl ether | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 90045-23-1 | Garcinia cambogia, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90045-46-8 | Guava, Psidium guajava pyrifera, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90045-52-6 | Hawthorn, Crataegus monogyna extract | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90045-73-1 | Hirudo medicinalis, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90045-89-9 | Iris germanica florentina, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90045-98-0 | Jojoba, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90045-99-1 | Jujube, Zizyphus jujuba, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90046-08-5 | Knautia arvensis, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90046-12-1 | Laminaria digitata, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 9004-59-5 | Cellulose, ethyl methyl ether |
Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 9004-84-6 | Poly(oxy-1,2-ethanediyl), .alpha.-sulfo-.omega.-(tridecyloxy)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 90063-39-1 | Ledum palustre, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90063-40-4 | Lentil, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90063-50-6 | Lilac, Syringa vulgaris, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90063-53-9 | Linden, Tilia americana, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90063-56-2 | Linden, Tilia vulgaris, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90063-58-4 | Lithospermum officinale, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90063-83-5 | Mandarin orange, tangerine, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90063-86-8 | Mango, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90063-92-6 | Melia azedarach, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90063-96-0 | Mentha aquatica, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90063-97-1 | Mentha arvensis, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90064-03-2 | Mercurialis perennis, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90064-11-2 | Mulberry, Morus nigra, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90064-35-0 | Nymphaea odorata, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 9006-52-4 | Tannins, albumin complexes | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 9008-02-0 | Hemoglobins | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90082-21-6 | Opuntia ficus-indica, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90082-36-3 | Panicum miliaceum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90082-41-0 | Pea, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90082-59-0 | Pepper (Piper), P. cubeba, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90082-75-0 | Pine, Pinus pinaster, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90082-77-2 | Pine, Pinus strobus, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90082-86-3 | Plantain, Plantago ovata, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90082-87-4 | Plum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90082-95-4 | Polygala senega latifolia, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 9008-30-4 | Lysophosphatidylcholines | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90083-08-2 | Potato, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 9009-32-9 | 1,2,3-Propanetriol, homopolymer, octadecanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 9009-65-8 | Protamines, sulfates | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 90105-89-8 | Prickly ash, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90105-92-3 | Prunella vulgaris, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90106-13-1 | Rauwolfia serpentina, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90106-16-4 | Reseda luteola, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90106-20-0 | Rhododendron chrysanthum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90106-33-5 | Rhus glabra, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90106-41-5 | Rumex crispus, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90106-48-2 | Rye, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 9010-66-6 | Zeins | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90106-66-4 | Scutellaria galericulata, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90106-68-6 | Sea buckthorn, Hippophae rhamnoides, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90131-20-7 | Sorbus domestica, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90131-25-2 | Spinach, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90131-34-3 | Stellaria media, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90131-43-4 | Tagetes erecta, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90131-48-9 | Terminalia chebula, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90131-49-0 | Terminalia sericea, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90131-55-8 | Teucrium scorodonia, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90131-58-1 | Thuya occidentalis, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90131-68-3 | Tribulus terrestris, ext | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90147-43-6 | Withania somnifera, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90147-49-2 | Yam, Dioscorea villosa, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90147-58-3 | Yucca filamentosa, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90170-45-9 | L-Alanine, N-coco acyl derivs., sodium salts | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 90170-86-8 | L-Aspartic acid, N-coco acyl derivs., sodium salts | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 9022-75-7 | Poly[oxy[hydroxymethyl)-1,2-ethanediyl]], .alpha.-dodecyl-.omega.-hydroxy- | Higher priority based on available information - Human health concern | Commercial activity identified | To be assessed |
| 9024-52-6 | Aldolase, fructose diphosphate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 9025-35-8 | Galactosidase, .alpha.- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90274-24-1 | Benzenemethanol, 4-hydroxy-a-[[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]methyl]-, hydrochloride (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 90283-04-8 | 1-Dodecanaminium, N-[2-(dodecyloxy)-2-oxoethyl]-N,N-dimethyl-, chloride | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 90320-32-4 | Alisma plantago, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90320-42-6 | Alpinia officinarum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90357-06-5 | Propanamide, N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 9036-66-2 | D-Galacto-L-arabinan | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 9036-88-8 | D-Mannan | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90387-74-9 | Glycine, N-coco acyl derivs., sodium salts | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 90-39-1 | 7,14-Methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine, dodecahydro-, (7S,7aR,14S,14aS)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 9039-53-6 | Kinase (enzyme-activating), uro- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 90411-66-8 | Hexanoic acid, 2-ethyl-, C12-15-alkyl esters | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 90411-68-0 | Hexanoic acid, 2-ethyl-, C16-18-alkyl esters | Higher priority based on available information - Human health concern | Commercial activity identified | To be assessed |
| 9041-22-9 | .beta.-D-Glucan | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 9042-08-4 | Rennets | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 9042-14-2 | Dextran, hydrogen sulfate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 9044-05-7 | Dextran, carboxymethyl ether | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 9045-23-2 | Lactoglobulins, .beta- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 9046-38-2 | D-Galacturonan | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 9048-49-1 | HUMAN ALBUMIN | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 9050-93-5 | .beta.-D-Glucan, (1→3)-, carboxymethyl ether, sodium salt | Higher priority based on available information - Human health concern | Clarification required | TBD |
| *9051-97-2/ 9050-90-2/ 9052-00-0/ 31667-87-5/ 199665-06-0 | .beta.-D-Glucan, (1→3)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90529-57-0 | 1-Propanaminium, 3-amino-N-ethyl-N,N-dimethyl-, N-soya acyl derivs., Et sulfates | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 9057-02-7 | Pullulan (A polysaccharide polymer consisting of .alpha.-1,4-; .alpha.-1,6-glucan units) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 90604-34-5 | Alcohols, C20-22 | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 90604-49-2 | Sweetsop, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90604-80-1 | Zirconium, chloro glycine hydroxy aluminum complexes | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 9061-82-9 | Carrageenan, sodium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 9062-73-1 | Sorbitan, dodecanoate, poly(oxy-1,2-ethanediyl) derivs. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 9065-63-8 | Oxirane, methyl-, polymer with oxirane, butyl ether | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 9074-78-6 | .alpha.-D-Glucan | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 9079-02-1 | Natto Gum | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90-81-3 | Benzenemethanol, .alpha.-[(1R)-1-(methylamino)ethyl]-, (.alpha.S)-rel- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 90817-34-8 | 2,3-Pyridinediamine, 6-methoxy-N2-methyl- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 90967-66-1 | Hexanoic acid, 3,5,5-trimethyl-, isooctadecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 90990-01-5 | Connective tissue, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 90990-05-9 | Fatty acids, avocado-oil, iso-Pr esters | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 90990-06-0 | Fatty acids, avocado-oil, isooctadecyl esters | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 90990-08-2 | Fatty acids, C8-18 | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91031-35-5 | Fatty acids, C16-18, esters with propylene glycol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 91031-45-7 | Fatty acids, C16-18, 1, 2-ethanediylbis (oxy-2, 1-ethanediyl) esters | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 91031-63-9 | Fatty acids, C16-18, magnesium salts | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91032-11-0 | Fatty acids, C12-20, reaction products with triethanolamine,di-Me sulfate-quaternized | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 91052-14-1 | Glycerides C16-18 and C-18 unsatd.mono-and di-,acetates | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 91052-16-3 | Glycerides, C16-18 and C18-unsatd. mono- and di-, citrates | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 91052-49-2 | Glycerides, C12-18 mono- and di- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91052-83-4 | Glycerides, sunflower-oil mono- and di-, 2,3-bis(acetyloxy)butanedioates | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91069-37-3 | 1-Oxaspiro[4.5]decan-2-one, 8-methyl-, cis- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 91069-38-4 | 1-Oxaspiro[4.5]decan-2-one, 8-methyl-, trans- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 91069-39-5 | 1-Oxaspiro[4,5]decan-2-one, 8-ethy-,cis- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 91069-40-8 | 1-Oxaspiro [4,5]decan-2-one,8-ethyl-,trans- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| *91078-95-4/ 8016-14-6 | Fats and Glyceridic oils, fish, hydrogenated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91079-91-3 | Protein hydrolyzates, fish | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 911484-90-7 | 1,3-Benzenedicarboxylic acid, 5-sulfo-, polymer with 1,3-benzenedicarboxylic acid, 1,4-cyclohexanedimethanol and 2,2'-oxybis[ethanol], sodium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 91161-71-6 | 1-Naphthalenemethanamine, N-[(2E)-6,6-dimethyl-2-hepten-4-yn-1-yl]-N-methyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 91374-20-8 | 2H-Indol-2-one, 4-[2-(dipropylamino)ethyl]-1,3-dihydro-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 91374-21-9 | 2H-Indol-2-one, 4-[2-(dipropylamino)ethyl]-1,3-dihydro- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 915223-67-5 | Siloxanes and Silicones, di-Me, Me 3,3,4,4,5,5,6,6,6-nonafluorohexyl, Me stearyl | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 91648-56-5 | Ethanol, 2-(2-ethoxyethoxy)-, 2"-[(C12-15-branched and linear alkyl)oxy] derivs., hydrogen sulfates, sodium salts | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 91-68-9 | Phenol, 3-(diethylamino)- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 91722-22-4 | Sugarcane, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91722-67-7 | Larrea divaricata, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91723-14-7 | Glycerides, sunflower-oil mono- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91744-23-9 | Glycerides, C16-18 and C18-unsatd. mono-, di- and tri-, citrates, potassium salts | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91744-28-4 | Glycerides, C12-18 di- and tri- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91744-32-0 | Glycerides, C8-10 mono-, di- and tri- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91744-36-4 | Glycerides, C16-18 mono-, di- and tri-, citrates | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91744-38-6 | Glycerides, C16-18 mono-, di- and tri-, hydrogenated, citrates, potassium salts | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91744-48-8 | Glycerides, lard mono-, di- and tri-, hydrogenated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91744-56-8 | Glycerides, mixed C8-10 and succinyl | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 91744-68-2 | Glycerides, palm-oil mono-, di- and tri-, hydrogenated, citrates | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91745-12-9 | Adansonia digitata, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91770-13-7 | Hierochloe odorata, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91770-19-3 | Loquat, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91770-22-8 | Maple, Acer saccharum, ext | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91770-69-3 | Spruce, Picea abies, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91771-33-4 | Bambusa vulgaris, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91771-60-7 | Cryptomeria japonica, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91824-88-3 | Isooctadecanoic acid, monoester with tetraglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 91845-22-6 | Helichrysum stoechas, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91845-35-1 | Ocimum sanctum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 91995-81-2 | Fatty acids, C10-20 and C16-18-unsatd., reaction products with triethanolamine,di-Me sulfate-quaternized | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 92045-76-6 | Paraffin waxes and Hydrocarbon waxes, microcryst., hydrotreated | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 92045-77-7 | Petrolatum (petroleum), hydrotreated | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 92128-82-0 | Laminaria,ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 92128-87-5 | Lecithins, hydrogenated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 92134-98-0 | 2,4-Imidazolidinedione, 5,5-diphenyl-3-[(phosphonooxy)methyl]-, disodium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 92-13-7 | 2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S,4R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 921608-21-1 | Castor oil, hydrogenated, 12-hydroxyoctadecanoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 92201-55-3 | Cedrus atlantica, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 92201-88-2 | Imidazolium compounds, 2-(C9-19 and C9-19-unsatd. alkyl)-1-[(C10-20 and C10-20-unsatd. amido)ethyl]-4,5-dihydro-1-Me, Me sulfates | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 92202-01-2 | Olive oil, reaction products with sorbitol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 922708-02-9 | Eicosanedioc Acid,1,20-bis(23-Dihydroxypropyl)ester,Tridocosanoate Monoisooctadecanoste | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 92276-53-4 | Propanesulfonic acid, amino- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 92339-11-2 | 1,3-Benzenedicarboxamide, 5,5'-[(2-hydroxy-1,3-propanediyl)bis(acetylimino)]bis[N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 92346-80-0 | Acanthopanax senticosus, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 92348-62-4 | Octanoic acid, hydroxy- | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 92456-63-8 | Actinidia chinensis, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 92456-72-9 | Cassava, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 92457-01-7 | Gardenia jasminoides, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 92457-12-0 | Jojoba, ext., hydrogenated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 92665-29-7 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-(1-propen-1-yl)-, (6R,7R)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 92731-30-1 | Mucopolysaccharides, heparinoids, duodenum, mucosa | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 92759-13-2 | Cinchonan-9-ol, 6'-methoxy-, pentanoate (ester), (8.alpha.,9R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| *92761-26-7/ 90457-82-2 | Bicyclo[2.2.1]heptane-1-methanesulfonic acid, 3,3'-(1,4-phenylenedimethylidyne)bis[7,7-dimethyl-2-oxo- | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 92880-86-9 | Furcellaran, potassium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 92880-87-0 | Furcellaran, sodium salt | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 92952-81-3 | Phenol, 4-[(3-hydroxypropyl)amino]-3-nitro- | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 93106-60-6 | 3-Quinolinecarboxylic acid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 93107-08-5 | 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, hydrochloride (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 93164-89-7 | Bacopa monnieri, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 93165-11-8 | Commiphora mukul, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 93166-05-3 | 1-Propanaminium, N-(2-aminoethyl)-N-(carboxymethyl)-2-hydroxy-N-(2-hydroxyethyl)-3-(phosphonooxy)-, N-C6-18 acyl derivs., inner salts, disodium salts | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 93221-48-8 | 2-Propanol, 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]-, (2S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 93379-54-5 | Benzeneacetamide, 4-[(2S)-2-hydroxy-3-[(1-methylethyl)amino]propoxy]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 93384-25-9 | Ledum groenlandicum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 93384-34-0 | Phospholipids, spinal cord | Higher priority based on available information - Human health concern | Identified for future survey | TBD |
| 93384-40-8 | Sage, salvia hispanica, ext | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 93385-03-6 | 3,6,9,12-Tetraoxaoctacosan-1-ol, 11-methyl-, acetate | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 93385-12-7 | Octadecanoic acid, 12-[(1-oxooctadecyl)oxy]-, isooctadecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 93385-13-8 | Ethanol, 2-[2-[2-[2-(isohexadecyloxy)propoxy]ethoxy]ethoxy]-, acetate | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 93385-14-9 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,2,3-triisohexadecyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 93413-44-6 | Cyclohexanol, 1-[(1S)-2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 93413-69-5 | Cyclohexanol, 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 93479-97-1 | 1H-Pyrrole-1-carboxamide, 3-ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(trans-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 93507-51-8 | 1-Propanaminium, 3-[(2-hydroxy-1-oxopropyl)amino]-N,N,N-trimethyl-, chloride (1:1) | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 93571-82-5 | Fatty acids, C6-24 and C16-18-unsatd., esters with sucrose | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 93572-53-3 | Fats and Glyceridic oils, menhaden, hydrogenated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 93573-19-4 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, tris(1-methyl-C11-17-alkyl) esters | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 936544-53-5 | L-Argininamide, N-(1-oxohexadecyl)-L-histidyl-D-phenylalanyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 93685-96-2 | Mimosa, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 93803-86-2 | Isooctadecanoic acid, octyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 93820-81-6 | Hexadecanoic acid, C16-18-alkyl esters | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 93820-97-4 | Octadecanoic acid, C16-18-alkyl esters | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 93841-25-9 | Benzeneethanol, 2,5-diamino-, sulfate (1:1) | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 93957-54-1 | 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, (3R,5S,6E)-rel- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 93957-55-2 | 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, sodium salt (1:1), (3R,5S,6E)-rel- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 93981-97-6 | Hexanoic acid, 2-ethyl-, 1-methyl-1,2-ethanediyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 94089-18-6 | Butanamide, 2,4-bis(acetyloxy)-N-[3-(acetyloxy)propyl]-3,3-dimethyl-, (2R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 94158-13-1 | Ethanol, 2,2'-[(4-amino-3-nitrophenyl)imino]bis-, monohydrochloride | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 94158-14-2 | Ethanol, 2-(1,3-benzodioxol-5-ylamino)-, hydrochloride (1:1) | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 94167-02-9 | Fucus serratus, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 94167-04-1 | Linden, Tilia tomentosa, ext | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 94167-05-2 | Mulberry, Morus alba, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 94201-19-1 | 1-Oxaspiro[4.5]decan-2-one, 8-methyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 94201-62-4 | Docosanoic acid, 2-hydroxy-1,3-propanediyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 94218-72-1 | Interleukin 2 (human clone pTIL2-21a protein moiety) | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 94237-18-0 | Butanedioic acid, 2,3-dihydroxy-, ditetradecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 94-24-6 | Benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 94247-26-4 | Tetradecyl isooctadecanoate | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 94247-28-6 | Docosanoic acid, isohexadecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 94277-32-4 | 1,2-Hexadecanediol, 1,1'-(hydrogen phosphate), monosodium salt | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 94279-95-5 | Prunus africana, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 94279-99-9 | Scutellaria baicalensis, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 94333-50-3 | 1-Cyclohexene-1-carboxylic acid, 2-ethyl-3,6,6-trimethyl-, ethyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 94333-51-4 | Cyclohexanecarboxylic acid, 6-ethylidene-2,2,5-trimethyl-, ethyl ester | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 94334-08-4 | Hedychium flavum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 94334-35-7 | Tuberose, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 94349-62-9 | Aloe barbasensis, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 94350-04-6 | Protein hydrolyzates, flaxseed | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 94350-05-7 | Protein hydrolyzates, rice bran | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 94350-06-8 | Protein hydrolyzates, wheat germ | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 94400-98-3 | Naphth[2,3-b]oxirene, 1a,2,3,4,5,6,7,7a-octahydro-1a,3,3,4,6,6-hexamethyl-, (1aR,4S,7aS)-rel- | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 94423-19-5 | Octadecanoic acid, diester with triglycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 94-43-9 | Mercury, (benzoato-O)phenyl- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 94465-74-4 | Fomes officinalis, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 94465-78-8 | Mytilus edulis, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 94465-79-9 | Ostrea edulis, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 94-51-9 | 1-Propanol, 3,3'-oxybis-, 1,1'-dibenzoate | Higher priority based on available information - Human health concern | Commercial activity identified | To be assessed |
| 94551-75-4 | Protein hydrolyzates, tuna | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 94749-08-3 | 2-Naphthalenecarboxylic acid, 1-hydroxy-, compd. with 4-hydroxy-.alpha.1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 94891-31-3 | Quaternary ammonium compounds, di-C16-18-alkyldimethyl, salts with hectorite | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 94891-33-5 | Benzenemethanaminium, N,N-dimethyl-N-octadecyl-, chloride, reaction products with hectorite | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 949109-75-5 | Sterols, phytosterols | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 94944-92-0 | Eggs, salmon, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 94945-01-4 | Gelidium cargilagineum, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 95009-14-6 | Agaricus bisporus, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 95058-81-4 | Cytidine, 2'-deoxy-2',2'-difluoro- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 95094-00-1 | 2-Propanol, 1-(9H-carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-, (2S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 95193-70-7 | Amines, N-(C8-18 and C18-unsatd. alkyl)trimethylenedi-, reaction products with 2-chloroethanol and sodium chloroacetate | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 95193-83-2 | 1H-Indene-1,3 (2H)-dione, 2-(2-quinolinyl)-, sulfonated, sodium salts | Higher priority based on available information - Environmental and human health concern | Clarification required | TBD |
| 95233-18-4 | 1,4-Naphthalenedione, 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxy- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 952500-62-8 | Ophiopogon japonicus, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 95370-65-3 | Proline, 5-oxo-, compd. with N2-coco acyl-L-arginine Et ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 95371-16-7 | Sulfonic acids, C14-16-1-alkene, sodium salts | Higher priority based on available information - Human health concern | No commercial activity identified | Removed from R-ICL |
| 95382-33-5 | Magnesium, bis[6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl-.kappa.O]-1H-benzimidazolato-.kappa.N3]-, (T-4)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 95576-89-9 | 1,2-Propanediol, 3-[(4-amino-2-chloro-5-nitrophenyl)amino]- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 95576-92-4 | 1,2-Propanediol, 3,3'-[(2-chloro-5-nitro-1,4-phenylene)diimino]bis- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 95-84-1 | Phenol, 2-amino-4-methyl- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 958873-87-5 | Ethanaminium, 2-Amino-N-(2-Aminoethyl)-N-[2-(2-Hydroxyethoxy)Ethyl]-N-Methyl-, N,N'-Di-Limnanthes Alba Seed-Oil Acyl Derivs., Me Sulfates(Salts) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 95912-87-1 | Fatty acids, C16-18, C12-18-alkyl esters | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 96036-03-2 | 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 3-[[(3S,5S)-5-[(dimethylamino)carbonyl]-3-pyrrolidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-, (4R,5S,6S)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 96055-45-7 | 2-Propenoic acid, 2-methyl-, polymer with diethenylbenzene, compd. with 3-[(2S)-1-methyl-2-pyrrolidinyl]pyridine | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 96081-39-9 | Alkyl(C16-18)polyethyleneglycol tetra decylene glycolether | Higher priority based on available information - Environmental and human health concern | Commercial activity identified | To be assessed |
| 96352-58-8 | .alpha.-D-Glucopyranoside, .beta.-D-fructofuranosyl O-.alpha.-D-galactopyranosyl-(1-6)-, (9Z)-9-octadecenoate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 96499-68-2 | Dodecanoic acid, monoester with oxybis[propanediol] | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 96507-89-0 | Bifidobacterium longum, lysate | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 96507-91-4 | Cardamom, Elettaria cardamomum miniscula, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 96684-40-1 | .beta.-Cyclodextrin, compd. with 4-hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide (5:2) | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 96690-56-1 | Walnut, Juglans nigra, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 96829-58-2 | L-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 96-83-3 | Benzenepropanoic acid, 3-amino-.alpha.-ethyl-2,4,6-triiodo- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 96840-56-1 | Phenol, 2-ethoxy-4-[(1-methylethoxy)methyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 96946-41-7 | Isoquinolinium, 2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,1'R,2R,2'R)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 96946-42-8 | Isoquinolinium, 2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-,1R,1'R,2R,2'R)-, benzenesulfonate (1:2) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 97-18-7 | Phenol, 2,2'-thiobis[4,6-dichloro- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 97240-79-4 | .beta.-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 97281-48-6 | Phosphatidylcholines, soya, hydrogenated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 97281-59-9 | Ulva lactuca, ext | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 97298-48-1 | 2-Butenedioic acid, 1, 4-bis (1-methylheptyl) ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 97338-28-8 | Octadecanoic acid, 12-[(1-oxooctadecyl) oxy]-, isohexadecyl ester | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 97358-80-0 | Isooctadecanoic acid, mono- and diesters with glycerol | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 97375-39-8 | Zirconium, 4,5-dihydro-5-oxo-1-(4-sulfophenyl)-4-[(4-sulfophenyl)azo]-1H-pyrazole-3-carboxylate complexes | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 97468-37-6 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[[2-(4-pyridinylthio)acetyl]amino]-, (6R,7R')-, compd. with N,N'- bis(phenylmethyl)-1,2-ethanediamine (2:1) | Higher priority based on available information - Environmental concern | Clarification required | TBD |
| 97488-92-1 | Glycerides, vegetable-oil mono- and di-, hydrogenated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 97615-94-6 | Fish, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 97722-02-6 | Glycerides, tall-oil mono-, di-, and tri- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 97766-44-4 | Swertia cordata, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 977-79-7 | Pregna-4,6-diene-3,20-dione, 6,17-dimethyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 97862-59-4 | 1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-C8-18 acyl derivs., inner salts | Higher priority based on available information - Environmental and human health concern | A Ministerial Condition has been imposed on this substance | Removed from R-ICL |
| 97862-76-5 | Foots oil (petroleum), carbon-treated | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 97862-89-0 | Paraffin waxes (petroleum), carbon-treated | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 97862-97-0 | Petrolatum (petroleum), carbon-treated | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 97867-33-9 | 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, compd. with 2-hydroxypropanoic acid (1:1) | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 97952-68-6 | Quaternary ammonium compounds, benzylbis(hydrogenated tallow alkyl)methyl, salts with montmorillonite | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 97952-72-2 | Salai, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 980-71-2 | 2-Pyridinepropanamine, .gamma.-(4-bromophenyl)-N,N-dimethyl-, (2Z)-2-butenedioate (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 98106-71-9 | Mandarin orange, Satsuma, ext. | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 98123-83-2 | Pyrazino[2,1-a][2]benzazepin-4(1H)-one, 2-(cyclohexylcarbonyl)-2,3,6,7,8,12b-hexahydro- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 98133-47-2 | Butanamide, 2,4-bis(acetyloxy)-N-[3-(acetyloxy)propyl]-3,3-dimethyl- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 98319-26-7 | 1H-Indeno[5,4-f]quinoline-7-carboxamide, N-(1,1-dimethylethyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)- | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 98530-12-2 | Interferon .alpha.2 (human leukocyte clone pM21 protein moiety reduced) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 98530-76-8 | Blood-coagulation factor XIVa (human protein moiety) | Lower priority in the context of the R-ICL - based on available information no concern was identified | No commercial activity identified | Removed from R-ICL |
| 98717-15-8 | 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-propyl-, hydrochloride (1:1), (2S)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 98-96-4 | 2-Pyrazinecarboxamide | Higher priority based on available information - Environmental concern | Commercial activity identified | To be assessed |
| 99011-02-6 | 1H-Imidazo[4,5-c]quinolin-4-amine, 1-(2-methylpropyl)- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 990-73-8 | Propanamide, N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 99-10-5 | Benzoic acid, 3,5-dihydroxy- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 99283-10-0 | Colony-stimulating factor 2 (human clone pHG25 protein moiety reduced) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 99294-93-6 | Imidazo[1,2-.alpha.]pyridine-3-acetamide, N,N,6-trimethyl-2-(4-methylphenyl)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 99300-78-4 | Cyclohexanol, 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 99343-90-5 | Furan, tetrahydro-2,4-dimethyl-4-phenyl-, (2R,4R)-rel- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 99343-91-6 | Furan, tetrahydro-2,4-dimethyl-4-phenyl-, (2R,4S)-rel- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 99439-28-8 | Quartz-beta (SiO2) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 99542-23-1 | 1-Propanaminium, N-ethyl-N,N-dimethyl-3-[[(9Z,12Z)-1-oxo-9,12-octadecadienyl]amino]-, ethyl sulfate | Higher priority based on available information - Environmental concern | No commercial activity identified | Removed from R-ICL |
| 99-57-0 | Phenol, 2-amino-4-nitro- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 99610-72-7 | Phenol, 2-[(2-hydroxyethyl)amino]-4,6-dinitro- | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| 99614-01-4 | 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-, hydrochloride (1:1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 99614-02-5 | 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]- | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| 99924-37-5 | Protein hydrolyzates, reticulin | Lower priority in the context of the R-ICL - based on available information no concern was identified | Identified for future survey | TBD |
| 99948-86-4 | 2-[(dihydroxymethylsilyl)oxy]propionic acid | Higher priority based on available information - Environmental and human health concern | No commercial activity identified | Removed from R-ICL |
| ATCC 55456 | Vibrio cholerae strain CVD 103-HgR Live Attenuated | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD |
| ATCC 76060 | ASPERGILLUS AWAMORI | Higher priority based on available information - Human health concern | Clarification required | TBD |
| ATCC 76061 | ASPERGILLUS AWAMORI | Higher priority based on available information - Human health concern | Clarification required | TBD |
| ATCC 76061K | ASPERGILLUS AWAMORI | Higher priority based on available information - Human health concern | Clarification required | TBD |
| HEPATITIS A VIRUS VACCINE INACTIVATED - HM - 175 | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD | |
| HEPATITIS B SURFACE ANTIGEN - RIT 4376 (RECOMBINANT) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD | |
| VARICELLA VIRUS - OKA STRAIN LIVE ATTENUATED | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD | |
| DIPHTHERIA TOXOID | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD | |
| TETANUS TOXOID | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD | |
| PERTUSSIS TOXOID | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD | |
| PERTUSSIS FILAMENTOUS HAEMAGGLUTININ | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD | |
| PERTUSSIS PERTACTIN | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD | |
| INACTIVATED POLIO VIRUS TYPE1 - MAHONEY STRAIN | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD | |
| INACTIVATED POLIO VIRUS TYPE2 - MEF - 1 STRAIN | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD | |
| INACTIVATED POLIO VIRUS TYPE3 - SAUKETT STRAIN | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD | |
| MEASLES VIRUS VACCINE LIVE ATTENUATED - SCHWARTZ STRAIN | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD | |
| MUMPS VIRUS VACCINE LIVE ATTENUATED - RIT4385 STRAIN | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD | |
| HAEMOPHILUS INFLUENZAE - TYPE B (HIB) CAPSULAR POLYSACCHARIDE | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD | |
| Purified, split, inactivated influenza virus strain A/Singapore/6/1986 (H1N1) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD | |
| Purified, split, inactivated influenza virus strain A/Wuhan/359/1995 (H3N2) | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD | |
| Purified, split, inactivated influenza virus strain B/Beijing/184/1993 | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD | |
| SALMONELLA TYPHI VI VACCINE CAPSULAR POLYSACCHARIDE - TY2 STRAIN | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD | |
| MEASLES VIRUS EDMONSTON STRAIN LIVE ATTENUATED | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD | |
| MUMPS VIRUS JERYL LYNN STRAIN LIVE ATTENUATED | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD | |
| RUBELLA VIRUS WISTAR RA 27/3 STRAIN LIVE ATTENUATED | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD | |
| VARICELLA VIRUS OKA/MERCK STRAIN LIVE ATTENUATED | Lower priority in the context of the R-ICL - based on available information no concern was identified | Clarification required | TBD | |
| 1.1.3.4/9001-37-0 | .beta.-D-glucose:oxygen 1-oxidoreductase | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1.11.1.6 | hydrogen-peroxide:hydrogen-peroxide oxidoreductase | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 100-21-0 | 1,4-Benzenedicarboxylic acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10024-97-2 | Nitrogen oxide (N2O) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10025-87-3 | Phosphoric trichloride | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10025-91-9 | Stibine, trichloro- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10034-85-2 | Hydriodic acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10034-99-8 | Sulfuric acid magnesium salt (1:1), heptahydrate | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10043-01-3 | Sulfuric acid, aluminum salt (3:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10043-11-5 | Boron Nitride (BN) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10043-22-8 | Ethanedioic acid, potassium salt (1:?) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10043-52-4 | Calcium chloride | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10043-84-2 | Phosphinic acid, manganese(2+) salt (2:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10049-04-4 | Chlorine oxide (ClO2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 100-51-6 | Benzenemethanol | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10058-23-8 | Peroxymonosulfuric acid, monopotassium salt | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10058-44-3 | Diphosphoric acid, iron(3+) salt (3:4) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10101-39-0 | Silicic acid (H2SiO3), calcium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10101-53-8 | Sulfuric acid, chromium(3+) salt (3:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10102-17-7 | Thiosulfuric acid (H2S2O3), disodium salt, pentahydrate | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10102-71-3 | Sulfuric acid, aluminum sodium salt (2:1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 101-20-2 | Urea, N-(4-chlorophenyl)-N'-(3,4-dichlorophenyl)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10124-31-9 | Phosphoric acid, ammonium salt (1:?) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10124-36-4 | Sulfuric acid, cadmium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10124-55-7 | Sulfuric acid, manganese salt | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10141-00-1 | Sulfuric acid, chromium(3+) potassium salt (2:1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 101-86-0 | Octanal, 2-(phenylmethylene)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10193-36-9 | Silicic acid (H4SiO4) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 102-71-6 | Ethanol, 2,2',2"-nitrilotris- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 102-76-1 | 1,2,3-Propanetriol, triacetate | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10279-63-7 | Sulfuric acid, chromium potassium salt (1:?:?) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 102972-64-5 | 2-Propenoic acid, 2-methyl-, 2-(dimethylamino)ethyl ester, polymer with 1-ethenylhexahydro-2H-azepin-2-one and 1-ethenyl-2-pyrrolidinone | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10326-41-7 | Propanoic acid, 2-hydroxy-, (2R)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10361-03-2 | Metaphosphoric acid (HPO3), sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10361-29-2 | Carbonic acid, ammonium salt (1:?) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10361-37-2 | Barium chloride (BaCl2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10361-65-6 | Phosphoric acid, ammonium salt (1:3) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 104037-85-6 | Benzoic acid, 2-[[3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl]amino]-, methyl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 104-29-0 | 1,2-Propanediol, 3-(4-chlorophenoxy)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 104986-28-9 | Hexanoic acid, 6-(acetyloxy)-, ethyl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1066-33-7 | Carbonic acid, ammonium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 106-89-8 | Oxirane, 2-(chloromethyl)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 106-97-8 | Butane | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 107-35-7 | Ethanesulfonic acid, 2-amino- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1077-28-7 | 1,2-Dithiolane-3-pentanoic acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 107-88-0 | 1,3-Butanediol | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 107-92-6 | Butanoic acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 108-24-7 | Acetic acid, 1,1'-anhydride | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 108-30-5 | 2,5-Furandione, dihydro- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 109-57-9 | Thiourea, N-2-propen-1-yl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 110-15-6 | Butanedioic acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 110-17-8 | 2-Butenedioic acid (2E)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 110-44-1 | 2,4-Hexadienoic acid, (2E,4E)-; 2,4-Hexadienoic acid, (E,E)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 110-54-3 | Hexane | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1107-26-2 | 8'-Apo-.beta.,.psi.-carotenal | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 11096-42-7 | Poly(oxy-1,2-ethanediyl), .alpha.-(nonylphenyl)-.omega.-hydroxy-, compd. with iodine | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 111019-03-5 | Poly[oxy(methyl-1,2-ethanediyl)], .alpha.-hexadecyl-.omega.-hydroxy-, phosphate | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 11103-57-4 | Vitamin A | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 11104-38-4 | Vitamin K1 | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 111-29-5 | 1,5-Pentanediol | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 11132-78-8 | Manganese chloride | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 11138-66-2 | Xanthan gum | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1115-63-5 | L-Aspartic acid, potassium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 111-76-2 | Ethanol, 2-butoxy- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 112-27-6 | Ethanol, 2,2'-[1,2-ethanediylbis(oxy)]bis- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1129-47-1 | Propanoic acid, 2-methyl-, cyclohexyl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 115-25-3 | Cyclobutane, octafluoro- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 116044-44-1 | Bicyclo[2.2.1]hept-5-ene-2-carboxylic acid, 3-(1-methylethyl)-, ethyl ester, (1R,2S,3S,4S)-rel- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 116126-82-0 | Bicyclo[2.2.1]hept-5-ene-2-carboxylic acid, 3-(1-methylethyl)-, ethyl ester, (1R,2R,3R,4S)-rel- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 117933-89-8 | 1,3-Dioxane, 2-(2,4-dimethyl-3-cyclohexen-1-yl)-5-methyl-5-(1-methylpropyl)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1184-64-1 | Carbonic acid, copper(2+) salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 118-56-9 | Benzoic acid, 2-hydroxy-, 3,3,5-trimethylcyclohexyl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 118-60-5 | Benzoic acid, 2-hydroxy-, 2-ethylhexyl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 12001-26-2 | Mica-group minerals | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 12002-43-6 | Gilsonite | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1203962-19-9 | 2-Propenoic acid, 2-methyl-, polymer with butyl 2-propenoate and methyl 2-methyl-2-propenoate, compd. with 2-amino-2-methyl-1-propanol | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 12041-76-8 | Benzenemethanol, dichloro- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 12069-69-1 | Copper, [.mu.-[carbonato(2-)-.kappa.O:.kappa.O']]dihydroxydi- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 12124-97-9 | Ammonium bromide ((NH4)Br) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 12125-02-9 | Ammonium chloride ((NH4)Cl) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 121251-67-0 | Spiro[bicyclo[4.1.0]heptane-2,5'-[1,3]dioxane], 2',2',3,7,7-pentamethyl-, (1R,3S,6S)-rel- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 121251-68-1 | Spiro[bicyclo[4.1.0]heptane-2,5'-[1,3]dioxane], 2',2',3,7,7-pentamethyl-, (1R,3R,6S)-rel- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 121-44-8 | Ethanamine, N,N-diethyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 12173-47-6 | Hectorite((Mg2.67LiO.33)Si4Na0.33[F0.5-1(OH)0-0.5]2O10) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 121-79-9 | Benzoic acid, 3,4,5-trihydroxy-, propyl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 12198-93-5 | Ozocerite | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 123-63-7 | 1,3,5-Trioxane, 2,4,6-trimethyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 123-77-3 | 1,2-Diazenedicarboxamide | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 124046-17-9 | Terpenes and Terpenoids, cypress, Cupressus funebris-oil, hydroxy, acetates | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 124-04-9 | Hexanedioic acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 124-38-9 | Carbon dioxide | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 12607-70-4 | Nickel carbonate hydroxide (Ni3(CO3)(OH)4) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 126-11-4 | 1,3-Propanediol, 2-(hydroxymethyl)-2-nitro- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 126-13-6 | .alpha.-D-Glucopyranoside, 6-O-acetyl-1,3,4-tris-O-(2-methyl-1-oxopropyl)-.beta.-D-fructofuranosyl, 6-acetate 2,3,4-tris(2-methylpropanoate) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 126-96-5 | Acetic acid, sodium salt (2:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 127-09-3 | Acetic acid, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 128-37-0 | Phenol, 2,6-bis(1,1-dimethylethyl)-4-methyl | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 129311-52-0 | Steroids, soya hydroxyl | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 129702-02-9 | 2-Propenoic acid, 2-methyl-, 2-methylpropyl ester, polymer with 2-propenoic acid and N-(1,1,3,3-tetramethylbutyl)-2-propenamide | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 130249-48-8 | Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-[(1-oxooctadecyl)oxy]-, ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| *1302-83-6/ 1317-97-1 | Lazurite | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1304-76-3 | Bismuth oxide (Bi2O3) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1304-85-4 | Bismuth hydroxide nitrate oxide (Bi5(OH)9(NO3)4O) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1305-62-0 | Calcium hydroxide | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1305-78-8 | Calcium Oxide | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1305-79-9 | Calcium peroxide | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1306-06-5 | Hydroxylapatite (Ca5(OH)(PO4)3) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1308-38-9 | Chromium oxide (Cr2O3) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 130-89-2 | Cinchonan-9-ol, 6'-methoxy-, hydrochloride (1:1), (8.alpha.,9R)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1309-37-1 | Iron oxide (Fe2O3) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1309-42-8 | Magnesium hydroxide (Mg(OH)2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1309-48-4 | Magnesium oxide (MgO) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1310-58-3 | Potassium hydroxide (K(OH)) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1310-73-2 | Sodium hydroxide (Na(OH)) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1312-76-1 | Silicic acid, potassium salt | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1313-13-9 | Manganese oxide (MnO2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1313-82-2 | Sodium sulfide (Na2S) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 131-53-3 | Methanone, (2-hydroxy-4-methoxyphenyl)(2-hydroxyphenyl)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1317-38-0 | Copper oxide (CuO) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1317-61-9 | Iron oxide (Fe3O4) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1319-46-6 | Lead, bis[carbonato(2-)]dihydroxytri- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1320-46-3 | 1,2,3-Propanetriol, mono(dihydrogen phosphate), manganese(2+) salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1327-39-5 | Silicic acid, aluminum calcium salt | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1327-43-1 | Silicic acid, aluminum magnesium salt | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1332-37-2 | Iron oxide | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1333-82-0 | Chromium oxide (CrO3) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1333-86-4 | Carbon black | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 133-42-6 | Gluconic acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1336-21-6 | Ammonium hydroxide ((NH4)(OH)) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1337-33-3 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, octadecyl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1338-41-6 | Sorbitan, monooctadecanoate | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 134-03-2 | L-Ascorbic acid, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 134-09-8 | Cyclohexanol, 5-methyl-2-(1-methylethyl)-, 1-(2-aminobenzoate) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 13410-01-0 | Selenic acid, sodium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1343-78-8 | Cochineal (dye) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1343-88-0 | Silicic acid, magnesium salt | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1343-98-2 | Silicic acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1344-00-9 | Silicic acid, aluminum sodium salt | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1344-95-2 | Silicic acid, calcium salt | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1345-25-1 | Iron oxide (FeO) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 13453-07-1 | Gold chloride (AuCl3) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 134-62-3 | Benzamide, N,N-diethyl-3-methyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 13463-67-7 | Titanium oxide (TiO2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 134-72-5 | Benzenemethanol, .alpha.-[(1S)-1-(methylamino)ethyl]-, (.alpha.R)-, sulfate (2:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 134-80-5 | 1-Propanone, 2-(diethylamino)-1-phenyl-, hydrochloride (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 135620-17-6 | Fatty acids, C18-36 | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 13601-19-9 | Ferrate(4-), hexakis(cyano-kC)-, sodium (1:4), (OC-6-11)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 136392-67-1 | 2,5-Furandione, polymer with 1,9-decadiene and methoxyethene | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 136-47-0 | Benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester, hydrochloride (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 136-77-6 | 1,3-Benzenediol, 4-hexyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 137-40-6 | Propanoic acid, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 137-66-6 | L-Ascorbic acid, 6-hexadecanoate | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1390-65-4 | Carmine | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 139-07-1 | Benzenemethanaminium, N-dodecyl-N,N-dimethyl-, chloride (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 139-33-3 | Glycine, N,N'-1,2-ethanediylbis[N-(carboxymethyl)-, sodium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1393-63-1 | C.I. Natural Orange 4 | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1400-62-0 | Orcein | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1401-55-4 | Tannins | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 140-64-7 | Ethanesulfonic acid, 2-hydroxy-, compd. with 4,4'-[1,5-pentanediylbis(oxy)]bis[benzenecarboximidamide] (2:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 141-78-6 | Acetic acid ethyl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 142-71-2 | Acetic acid, copper(2+) salt (2:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 144-33-2 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, sodium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 144-55-8 | Carbonic acid sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 14475-11-7 | Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, sodium salt (1:?) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 146-48-5 | Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, (16.alpha.,17.alpha.)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 147-24-0 | Ethanamine, 2-(diphenylmethoxy)-N,N-dimethyl-, hydrochloride (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 14807-96-6 | Talc (Mg3H2(SiO3)4) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 14808-60-7 | Quartz (SiO2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 148-24-3 | 8-Quinolinol | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 148-72-1 | 2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S,4R)-, nitrate (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 149-91-7 | Benzoic acid, 3,4,5-trihydroxy- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 15086-94-9 | Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 2',4',5',7'-tetrabromo-3',6'-dihydroxy- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 151-21-3 | Sulfuric acid monododecyl ester sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 151-50-8 | Potassium cyanide (K(CN)) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 15189-51-2 | Aurate(1-), tetrachloro-, sodium (1:1), (SP-4-1)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1592-23-0 | Octadecanoic acid, calcium salt (2:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 16177-21-2 | L-Glutamic acid, sodium salt (1:?) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 16291-96-6 | Charcoal | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1633-05-2 | Carbonic acid, strontium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 16423-68-0 | Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 3',6'-dihydroxy-2',4',5',7'-tetraiodo-, sodium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 16731-55-8 | Disulfurous acid, potassium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 16984-48-8 | Fluoride | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| *17354-14-2/ 12769-17-4 | 9,10-Anthracenedione, 1,4-bis(butylamino)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 17372-87-1 | Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 2',4',5',7'-tetrabromo-3',6'-dihydroxy-, sodium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 18472-87-2 | Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 2',4',5',7'-tetrabromo-4,5,6,7-tetrachloro-3',6'-dihydroxy-, sodium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1847-58-1 | Acetic acid, 2-sulfo-, dodecyl ester, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 19317-11-4 | 2,6,10-Dodecatrienal, 3,7,11-trimethyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1934-21-0 | 1H-Pyrazole-3-carboxylic acid, 4,5-dihydro-5-oxo-1-(4-sulfophenyl)-4-[2-(4-sulfophenyl)diazenyl]-, sodium salt (1:3) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 1948-33-0 | 1,4-Benzenediol, 2-(1,1-dimethylethyl)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 201363-52-2 | Amides, coco, N-(hydroxyethyl), propoxylated | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 20461-54-5 | Iodide | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 2078-54-8 | Phenol, 2,6-bis(1-methylethyl)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 2174-16-5 | Benzoic acid, 2-hydroxy-, compd. with 2,2',2"-nitrilotris[ethanol] (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 2216-51-5 | Cyclohexanol, 5-methyl-2-(1-methylethyl)-, (1R,2S,5R)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 22373-78-0 | Monensin, monosodium salt | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 22463-19-0 | Ethanone, 1-(3,3-dimethyl-1-cyclohexen-1-yl)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 22494-42-4 | [1,1'-Biphenyl]-3-carboxylic acid, 2',4'-difluoro-4-hydroxy- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 22644-09-3 | 4,7-Decadienal, (4Z,7Z)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 22839-47-0 | L-Phenylalanine, N-L-.alpha.-aspartyl-, 1-methyl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 23110-15-8 | 2,4,6,8-Decatetraenedioic acid, 1-[(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methyl-2-buten-1-yl)-2-oxiranyl]-1-oxaspiro[2.5]oct-6-yl] ester, (2E,4E,6E,8E)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 2338-05-8 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, iron salt (1:?) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 2353-45-9 | Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl[(3-sulfophenyl)methyl]amino]phenyl](4-hydroxy-2-sulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-3-sulfo-, inner salt, sodium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 23593-75-1 | 1H-Imidazole, 1-[(2-chlorophenyl)diphenylmethyl]- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 2445-72-9 | Propanoic acid, 2-methyl-, pentyl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 25013-16-5 | Phenol, (1,1-dimethylethyl)-4-methoxy- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 25155-18-4 | Benzenemethanaminium, N,N-dimethyl-N-[2-[2-[methyl-4-(1,1,3,3-tetramethylbutyl)phenoxy]ethoxy]ethyl]-, chloride | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 25322-68-3 | Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 25383-99-7 | Octadecanoic acid, 2-(1-carboxyethoxy)-1-methyl-2-oxoethyl ester, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 25395-31-7 | 1,2,3-Propanetriol, diacetate | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 2563-07-7 | Phenol, 2-ethoxy-4-methyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 25956-17-6 | 2-Naphthalenesulfonic acid, 6-hydroxy-5-[2-(2-methoxy-5-methyl-4-sulfophenyl)diazenyl]-, sodium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 26027-38-3 | Poly(oxy-1,2-ethanediyl), .alpha.-(4-nonylphenyl)-.omega.-hydroxy- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 26264-14-2 | Propanediol | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 26266-57-9 | Sorbitan, monohexadecanoate | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 26266-58-0 | Sorbitan, tri-(9Z)-9-octadecenoate | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 26446-35-5 | 1,2,3-Propanetriol, monoacetate | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 26658-19-5 | Sorbitan, trioctadecanoate | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| *26811-08-5/ 9065-13-8 | Formaldehyde, polymer with 5,5-dimethyl-2,4-imidazolidinedione | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 26912-64-1 | 4,7-Methano-1H-indene, 3a,4,5,6,7,7a-hexahydro-5(or 6)(2-propen-1-yloxy)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 27214-00-2 | 1,2,3-Propanetriol, mono(dihydrogen phosphate), calcium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 27215-38-9 | Dodecanoic acid, monoester with 1,2,3-propanetriol | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 2724-58-5 | Heptadecanoic acid, 16-methyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 27503-81-7 | 1H-Benzimidazole-6-sulfonic acid, 2-phenyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 2783-94-0 | 2-Naphthalenesulfonic acid, 6-hydroxy-5-[2-(4-sulfophenyl)diazenyl]-, sodium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 28300-74-5 | Antimonate(2-), bis[.mu.-[2,3-di(hydroxy-.kappa.O)butanedioato(4-)-.kappa.O1:.kappa.O4]]di-, potassium, hydrate (1:2:3), stereoisomer | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 29122-68-7 | Benzeneacetamide, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 2915-53-9 | 2-Butenedioic acid (2Z)-, 1,4-dioctyl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 298-14-6 | Carbonic acid, potassium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 299-28-5 | D-Gluconic acid, calcium salt (2:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 299-29-6 | Iron, bis(D-gluconato-kO1,kO2)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3.1.1.3/9001-62-1 | Lipase, triacylglycerol | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3.2.1.1 | 4-.alpha.-D-glucan glucanohydrolase | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3.2.1.15 | (1→4)-.alpha.-D-galacturonan glycanohydrolase | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3.2.1.23/9031-11-2 | Galactosidase, .beta.- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3.2.1.26/9001-57-4 | .beta.-D-fructofuranoside fructohydrolase | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3.2.1.3 | 4-.alpha.-D-glucan glucohydrolase | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3.2.1.4 | 4-(1,3;1,4)-.beta.-D-glucan 4-glucanohydrolase | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3.2.1.41 | pullulan 6-.alpha.-glucanohydrolase | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3.2.1.72 | 3-.beta.-D-xylan xylohydrolase | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3.4.21.4/9002-07-7 | Trypsin | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3.4.22.2 | Papain | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3.4.22.32/37189-34-7 | Stem Bromelain | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3.4.22.33/9001-00-7 | Fruit Bromelain | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3.4.23.1/9001-75-6 | Pepsin A | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3.4.23.4/9001-98-3 | Chymosin | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3.4.23.23 | Mucorpepsin | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3012-65-5 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, ammonium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 304-59-6 | Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, potassium sodium salt (1:1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 30473-39-3 | 1H-Imidazolium, 1-(carboxymethyl)-2-heptadecyl-4,5-dihydro-1-(2-hydroxyethyl)-, hydroxide, sodium salt (1:1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 30516-87-1 | Thymidine, 3'-azido-3'-deoxy- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 31416-78-1 | 2-Butenoic acid, cyclohexyl ester, (2E)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3164-29-2 | Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, ammonium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 32289-58-0 | Poly(iminocarbonimidoyliminocarbonimidoylimino-1,6-hexanediyl), hydrochloride (1:?) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3251-23-8 | Nitric acid, copper(2+) salt (2:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 32540-03-7 | Pentanal, 4-(4-methyl-3-cyclohexen-1-ylidene)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3344-18-1 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, magnesium salt (2:3) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 33673-62-0 | 2(3H)-Furanone, dihydro-4-methyl-5-pentyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 34552-83-5 | 1-Piperidinebutanamide, 4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-.alpha.,.alpha.-diphenyl-, hydrochloride (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3483-12-3 | 2,3-Butanediol, 1,4-dimercapto-, (2R,3R)-rel- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 35205-76-6 | 2-Nonenoic acid, 3-methyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 35205-77-7 | 3-Nonenoic acid, 3-methyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 35205-78-8 | Nonanoic acid, 3-methylene- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 35285-69-9 | Benzoic acid, 4-hydroxy-, propyl ester, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 352-93-2 | Ethane, 1,1'-thiobis- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3539-43-3 | 1-Hexadecanol, 1-(dihydrogen phosphate) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3567-66-6 | 2,7-Naphthalenedisulfonic acid, 5-amino-4-hydroxy-3-(2-phenyldiazenyl)-, sodium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 357-57-3 | Strychnidin-10-one, 2,3-dimethoxy- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3615-41-6 | L-Mannose, 6-deoxy- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 36291-32-4 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, monoester with 1,2,3-propanetriol | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 36861-47-9 | Bicyclo[2.2.1]heptan-2-one, 1,7,7-trimethyl-3-[(4-methylphenyl)methylene]- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 373-02-4 | Acetic acid, nickel(2+) salt (2:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 3844-45-9 | Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl[(3-sulfophenyl)methyl]amino]phenyl](2-sulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-3-sulfo-, hydroxide, inner salt, disodium salt | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 4040-50-0 | Tetradecanoic acid, aluminum salt | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 4065-45-6 | Benzenesulfonic acid, 5-benzoyl-4-hydroxy-2-methoxy- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 4075-81-4 | Propanoic acid, calcium salt (2:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 41340-25-4 | Pyrano[3,4-b]indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 41424-36-6 | Benzene, 1,3,5-tribromo-2-methoxy-4-methyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 42739-38-8 | Pentanoic acid, ammonium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| *43119-47-7/ 16676-75-8 | 3-Pyridinecarboxylic acid, (2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-yl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 4548-53-2 | 1-Naphthalenesulfonic acid, 3-[2-(2,4-dimethyl-5-sulfophenyl)diazenyl]-4-hydroxy-, sodium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 458-37-7 | 1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-, (1E,6E)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 4625-90-5 | 1-Oxaspiro[4.5]decan-2-one, 8-(1-methylethyl)-, trans- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 463-40-1 | 9,12,15-Octadecatrienoic acid, (9Z,12Z,15Z)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 471-34-1 | Carbonic acid calcium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 471-53-4 | Olean-12-en-29-oic acid, 3-hydroxy-11-oxo-, (3.beta.,20.beta.)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 479-61-8 | Magnesium, [3,7,11,15-tetramethyl-2-hexadecenyl 9-ethenyl-14-ethyl-21-(methoxycarbonyl)-4,8,13,18-tetramethyl-20-oxo-3-phorbinepropanoato(2-)-N23,N24,N25,N26]-, [SP-4-2-[3S-[3a(2E,7S*,11S*),4b,21b]]]- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 482-89-3 | 3H-Indol-3-one, 2-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,2-dihydro- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 483-63-6 | 2-Butenamide, N-ethyl-N-(2-methylphenyl)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 4892-02-8 | Benzoic acid, 2-mercapto-, methyl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 497-19-8 | Carbonic acid sodium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 49805-55-2 | Butanal, 2-methyl-, oxime, (E)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 49805-56-3 | Butanal, 2-methyl-, oxime, (1Z)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| *50-21-5/ 598-82-3 | Propanoic acid, 2-hydroxy- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 5026-62-0 | Benzoic acid, 4-hydroxy-, methyl ester, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 50-28-2 | Estra-1,3,5(10)-triene-3,17-diol (17.beta.)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 506-64-9 | Silver cyanide (Ag(CN)) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| *50-69-1/ 93781-19-2 | D-Ribose | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 50-70-4 | D-Glucitol | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 50-81-7 | L-Ascorbic acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 50-98-6 | Benzenemethanol, .alpha.-[(1S)-1-(methylamino)ethyl]-, hydrochloride (1:1), (.alpha.R)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 51022-70-9 | 1,3-Benzenedimethanol, .alpha.1-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-, sulfate (2:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 51274-00-1 | C.I. Pigment Yellow 42 | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 51-45-6 | 1H-Imidazole-5-ethanamine | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 514-78-3 | .beta,.beta.-Carotene-4,4'-dione | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| *515-98-0/ 52003-58-4 | Propanoic acid, 2-hydroxy-, ammonium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 51-63-8 | Benzeneethanamine, .alpha.-methyl-, (.alpha.S)-, sulfate (2:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 518-47-8 | Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 3',6'-dihydroxy-, sodium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 519-62-0 | Magnesium, [(2E,7R,11R)-3,7,11,15-tetramethyl-2-hexadecenyl (3S,4S,21R)-9-ethenyl-14-ethyl-13-formyl-21-(methoxycarbonyl)-4,8,18-trimethyl-20-oxo-3-phorbinepropanoato(2-)-.kappa.N23,.kappa.N24,.kappa.N25,.kappa.N26]-, (SP-4-2)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 52439-69-7 | .alpha.-D-Glucopyranoside, .beta.-D-fructofuranosyl, acetate octadecanoate | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 52557-97-8 | Bicyclo[2.2.1]heptane-2-carboxylic acid, 3,3-dimethyl-,methy ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 52-68-6 | Phosphonic acid, P-(2,2,2-trichloro-1-hydroxyethyl)-, dimethyl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 526-94-3 | Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 526-95-4 | D-Gluconic acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 527-07-1 | D-Gluconic acid, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 527-09-3 | Copper, bis(D-gluconato-.kappa.O1,.kappa.O2)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 52-89-1 | L-Cysteine, hydrochloride (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 529-35-1 | 1-Naphthalenol, 5,6,7,8-tetrahydro- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 531-75-9 | 2H-1-Benzopyran-2-one, 6-(.beta.-D-lucopyranosyloxy)-7-hydroxy | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 532-32-1 | Benzoic acid, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 53585-11-8 | Pentanal, 4-(4-methyl-3-cyclohexen-1-ylidene)-, (4E)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 53585-12-9 | Pentanal, 4-(4-methyl-3-cyclohexen-1-ylidene)-, (4Z)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 536-43-6 | 1-Propanone, 1-(4-butoxyphenyl)-3-(1-piperidinyl)-, hydrochloride (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 53694-17-0 | 2-Propen-1-aminium, N,N-dimethyl-N-2-propen-1-yl-, chloride (1:1), polymer with 2-propenoic acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 54-11-5 | Pyridine, 3-[(2S)-1-methyl-2-pyrrolidinyl]- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 546-93-0 | Carbonic acid, magnesium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 55066-48-3 | Benzenepentanol, .gamma.-methyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 55066-49-4 | Benzenepentanal, .beta.-methyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 55-56-1 | 2,4,11,13-Tetraazatetradecanediimidamide, N,N"-bis(4-chlorophenyl)-3,12-diimino- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 55589-62-3 | 1,2,3-Oxathiazin-4(3H)-one, 6-methyl-, 2,2-dioxide, potassium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 556-67-2 | Cyclotetrasiloxane, 2,2,4,4,6,6,8,8-octamethyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 557-04-0 | Octadecanoic acid, magnesium salt (2:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 557-34-6 | Acetic acid, zinc salt (2:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 5579-84-0 | 2-Pyridineethanamine, N-methyl-, hydrochloride (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 5595-79-9 | Phenol, 2-ethoxy-4-(methoxymethyl)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 56-23-5 | Methane, tetrachloro- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 56238-63-2 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-(2-furanyl)-2-(methoxyimino)acetyl]amino]-8-oxo-, sodium salt (1:1), (6R,7R)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 56265-46-4 | 2-Propenoic acid, 3-(4-methoxyphenyl)-,compd.with 2,2'-iminobis[ethanol] (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 56-34-8 | Ethanaminium, N,N,N-triethyl-, chloride (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 563-63-3 | Acetic acid, silver(1+) salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 56-40-6 | Glycine | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 56-45-1 | L-Serine | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 5655-61-8 | Bicyclo[2.2.1]heptan-2-ol, 1,7,7-trimethyl-, 2-acetate, (1S,2R,4S)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 56-81-5 | 1,2,3-Propanetriol | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 56-85-9 | L-Glutamine | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 56-86-0 | L-Glutamic acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 56-92-8 | 1H-Imidazole-5-ethanamine, hydrochloride (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 57074-34-7 | Ethanethioic acid, S-[1-methyl-1-[(1R,4R)-4-methyl-2-oxyocyclohexyl]ethyl] ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 57-10-3 | Hexadecanoic acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 57-11-4 | Octadecanoic acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 57129-12-1 | Ethanethioic acid, S-[1-methyl-1-[(1R,4S)-4-methyl-2-oxyocyclohexyl]ethyl] ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 5743-27-1 | L-Ascorbic acid, calcium salt (2:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 57455-37-5 | C.I. Pigment Blue 29 | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 57-55-6 | 1,2-Propanediol | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 57635-48-0 | Poly(oxy-1,2-ethanediyl), .alpha.-(carboxymethyl)-.omega.-[(9Z)-9-octadecen-1-yloxy]- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 577-11-7 | Butanedioic acid, 2-sulfo-, 1,4-bis(2-ethylhexyl) ester, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 5775-74-6 | Butanal, 3-methyl-, oxime, (1E) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 5780-40-5 | Butanal, 3-methyl-, oxime, (1Z)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 578-36-9 | Benzoic acid, 2-hydroxy-, potassium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 57-88-5 | Cholest-5-en-3-ol (3.beta.)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 5793-94-2 | Octadecanoic acid, 2-(1-carboxyethoxy)-1-methyl-2-oxoethyl ester, calcium salt (2:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 58-08-2 | 1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 582-25-2 | Benzoic acid, potassium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 583-52-8 | Ethanedioic acid, potassium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 584-08-7 | Carbonic acid, potassium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 584-79-2 | Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propen-1-yl)-, 2-methyl-4-oxo-3-(2-propen-1-yl)-2-cyclopenten-1-yl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 5858-81-1 | 2-Naphthalenecarboxylic acid, 3-hydroxy-4-[2-(4-methyl-2-sulfophenyl)diazenyl]-, sodium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 585-88-6 | D-Glucitol, 4-O-.alpha.-D-glucopyranosyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 58-61-7 | Adenosine | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 58778-82-8 | 2-Propenoic acid, 2-methyl-, methyl ester, polymer with 2-propenoic acid and N-(1,1,3,3-tetramethylbutyl)-2-propenamide | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 590-00-1 | 2,4-Hexadienoic acid, potassium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 59-23-4 | D-Galactose | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 593-29-3 | Octadecanoic acid, potassium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 59-33-6 | 1,2-Ethanediamine, N1-[(4-methoxyphenyl)methyl]-N2,N2-dimethyl-N1-2-pyridinyl-, (2Z)-2-butenedioate (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 5949-29-1 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, monohydrate | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 598-62-9 | Carbonic acid, manganese(2+) salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 59-98-3 | 1H-Imidazole, 4,5-dihydro-2-(phenylmethyl)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 60-01-5 | Butanoic acid, 1,2,3-propanetriyl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 61-33-6 | 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]- (2S,5R,6R)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 616-91-1 | L-Cysteine, N-acetyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 61-73-4 | Phenothiazin-5-ium, 3,7-bis(dimethylamino)-, chloride (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 61-75-6 | Benzenemethanaminium, 2-bromo-N-ethyl-N,N-dimethyl-, 4-methylbenzenesulfonate (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 61788-95-2 | Amines, (hydrogenated tallow alkyl)dimethyl | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 61789-91-1 | Waxes and Waxy substances, jojoba | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 61789-99-9 | Lard | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| *61790-81-6/ 8051-82-9 | Lanolin, ethoxylated | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 61791-42-2 | Ethanesulfonic acid, 2-(methylamino)-, N-coco acyl derivs., sodium salts | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 61-90-5 | L-Leucine | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 6197-30-4 | 2-Propenoic acid, 2-cyano-3,3-diphenyl-, 2-ethylhexyl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 62-33-9 | Calciate(2-), [[N,N'-1,2-ethanediylbis[N-[(carboxy-.kappa.O)methyl]glycinato-.kappa.N,.kappa.O]](4-)]-, sodium (1:2), (OC-6-21)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 62-51-1 | 1-Propanaminium, 2-(acetyloxy)-N,N,N-trimethyl-, chloride (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 62-53-3 | Benzenamine | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 62-54-4 | Acetic acid, calcium salt (2:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 62887-80-3 | Anemone | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 63148-62-9 | Siloxanes and Silicones, di-Me | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 631-61-8 | Acetic acid, ammonium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 63231-60-7 | Paraffin waxes and Hydrocarbon waxes, microcryst. | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 63231-63-0 | Ribonucleic acids | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 632-99-5 | Benzenamine, 4-[(4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl]-2-methyl-, hydrochloride (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 63394-02-5 | Rubber, silicone (Polydimethylsiloxane rubber) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 63-42-3 | D-glucose. 4-.ortho.-.beta.-D-galactopyranosyl | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 6381-77-7 | D-erythro-Hex-2-enonic acid, .gamma.-lactone, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 6381-92-6 | Glycine, N,N'-1,2-ethanediylbis[N-(carboxymethyl)-, sodium salt, hydrate (1:2:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 638-23-3 | L-Cysteine, S-(carboxymethyl)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 638-38-0 | Acetic acid, manganese(2+) salt (2:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 64-17-5 | Ethanol | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 64-18-6 | Formic acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 64-19-7 | Acetic acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 64365-11-3 | Charcoal, activated | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 643-79-8 | 1,2-Benzenedicarboxaldehyde | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 645-35-2 | L-Histidine, hydrochloride (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 64742-51-4 | Paraffin waxes (petroleum), hydrotreated | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 64742-60-5 | Hydrocarbon waxes (petroleum), hydrotreated microcryst. | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 6484-52-2 | Nitric acid ammonium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 65-85-0 | Benzoic Acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 65997-17-3 | Glass, oxide, chemicals | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 67-20-9 | 2,4-Imidazolidinedione, 1-[[(5-nitro-2-furanyl)methylene]amino]- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 67-56-1 | Methanol | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 67-63-0 | 2-Propanol | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 67-64-1 | 2-Propanone | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 67762-27-0 | Alcohols, C16-18 | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| *67846-47-3/ 173924-00-0 | Poly(oxy-1,2-ethanediyl), .alpha.,.alpha'.-(dimethylsilylene)bis[.omega.- methoxy- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 68-04-2 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, sodium salt (1:3) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 68333-82-4 | Amides, coco, N-(2-hydroxypropyl) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 6834-92-0 | Silicic acid (H2SO3), sodium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 68391-30-0 | 2-Naphthalenaminium, 7-hydroxy-8-[2-(2-methoxyphenyl)diazenyl]-N,N,N-trimethyl-, chloride (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 68391-31-1 | Benzenaminium, 3-[2-(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)diazenyl]-N,N,N-trimethyl-, chloride (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 68424-04-4 | Polydextrose | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 68425-17-2 | Syrups, hydrolyzed starch, hydrogenated | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 68440-15-3 | Fatty acids, palm oil | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 68515-73-1 | D-Glucopyranose, oligomeric, decyl octyl glycosides | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 68525-86-0 | Corn, flour | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 68611-44-9 | Silane, dichlorodimethyl-, reaction products with silica | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 68647-73-4 | Oils, tea-tree | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 68648-89-5 | Benzene, ethenyl-, polymer with 2-methyl-1,3-butadiene, hydrogenated | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 68876-77-7 | Saccharomyces cerevisiae | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 68908-68-9 | Fatty acids, C12-20, ethoxylated | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 68915-31-1 | Polyphosphoric acids, sodium salts | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 68917-78-2 | Resins, oleo-, paprika | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 68958-64-5 | Poly(oxy-1,2-ethanediyl), .alpha.,.alpha.',.alpha."-1,2,3-propanetriyltris[.omega.-[[(9Z)-1-oxo-9-octadecen-1-yl]oxy]- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 68990-63-6 | Fats and Glyceridic oils, shark-liver | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 68990-67-0 | Quillaja saponaria, ext. | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| *6915-15-7/ 617-48-1 | Butanedioic acid, 2-hydroxy- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 69-22-7 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, mixture with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 69300-15-8 | Decanenitrile,2-methyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| *69430-36-0/ 65997-21-9 | Keratins, hydrolyzates | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 69-57-8 | 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]- (2S,5R,6R)-, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 69655-05-6 | Inosine, 2',3'-dideoxy- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 69-65-8 | D-Mannitol | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 6969-49-9 | Benzoic acid, 2-hydroxy-, octyl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 70161-44-3 | Glycine, N-(hydroxymethyl)-, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 70-18-8 | Glycine, L-.gamma.-glutamyl-L-cysteinyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7028-48-0 | Benzeneacetaldehyde, oxime | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 70356-09-1 | 1,3-Propanedione, 1-[4-(1,1-dimethylethyl)phenyl]-3-(4-methoxyphenyl)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7069-42-3 | Retinol, 15-propanoate | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 71010-52-1 | Gellan gum | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 71298-42-5 | 3-Cyclohexene-1-carboxylic acid, 4-(1-methylethyl)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 71-43-2 | Benzene | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 71-52-3 | Carbonate, hydrogen | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 71902-01-7 | Sorbitan, isooctadecanoate | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 72-17-3 | Propanoic acid, 2-hydroxy-, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 72183-75-6 | Cyclohexanol, 1-methyl-2-(1-methylpropyl)-, 1-acetate | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7235-40-7 | .beta.,.beta.-Carotene | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7320-34-5 | Diphosphoric acid, potassium salt (1:4) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 73-24-5 | 9H-Purin-6-amine | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 73-78-9 | Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-, hydrochloride (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7429-90-5 | Aluminum | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7439-93-2 | Lithium | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7440-06-4 | Platinum | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7440-22-4 | Silver | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7440-36-0 | Antimony | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7440-38-2 | Arsenic | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7440-44-0 | Carbon | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7440-57-5 | Gold | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7440-69-9 | Bismuth | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7446-18-6 | Sulfuric acid, thallium(1+) salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7446-19-7 | Sulfuric acid, zinc salt (1:1), monohydrate | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7446-20-0 | Sulfuric acid, zinc salt (1:1), heptahydrate | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7447-40-7 | Potassium chloride (KCl) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7447-41-8 | Lithium chloride (LiCl) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7481-89-2 | Cytidine, 2',3'-dideoxy- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 74-90-8 | Hydrocyanic acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7492-55-9 | 2,4-Hexadienoic acid, calcium salt (2:1), (2E,4E)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7492-66-2 | 2,6-Octadiene, 1,1-diethoxy-3,7-dimethyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 74-98-6 | Propane | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 75-07-0 | Acetaldehyde | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 75-09-2 | Methane, dichloro- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 75-15-0 | Carbon disulfide | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 75-21-8 | Oxirane | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 75-28-5 | Propane, 2-methyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 75345-27-6 | Poly[(dimethyliminio)-2-butene-1,4-diyl chloride], .alpha.-[4-[tris(2-hydroxyethyl)ammonio]-2-butenyl]-.omega.-[tris(2-hydroxyethyl)ammonio]-, dichloride | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7549-43-1 | Cinchonan-9-ol, 6'-methoxy-, hydrochloride (1:?), (8.alpha.,9R)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 75-56-9 | Oxirane, methyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7558-79-4 | Phosphoric acid, sodium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7558-80-7 | Phosphoric acid, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7601-54-9 | Phosphoric acid, sodium salt (1:3) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 76095-16-4 | L-Proline, N-[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl-, (2Z)-2-butenedioate (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 76-15-3 | Ethane, 1-chloro-1,1,2,2,2-pentafluoro- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7631-86-9 | Silica | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7631-90-5 | Sulfurous acid, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7631-99-4 | Nitric acid sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7632-00-0 | Nitrous acid, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7646-79-9 | Cobalt chloride (CoCl2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7647-01-0 | Hydrochloric Acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 76-49-3 | Bicyclo[2.2.1]heptan-2-ol, 1,7,7-trimethyl-, 2-acetate, (1R,2S,4R)-rel- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7664-38-2 | Phosphoric Acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7664-93-9 | Sulfuric acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7681-38-1 | Sulfuric acid, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7681-52-9 | Hypochlorous acid, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7681-57-4 | Disulfurous acid, sodium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7693-13-2 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, calcium salt (1:?) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7695-91-2 | 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-, 6-acetate | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7697-37-2 | Nitric acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7699-41-4 | Silicic acid (H2SiO3) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7720-78-7 | Sulfuric acid, iron(2+) salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7722-64-7 | Permanganic acid (HMnO4), potassium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7722-76-1 | Phosphoric acid, ammonium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7722-84-1 | Hydrogen peroxide | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7722-88-5 | Diphosphoric acid, sodium salt (1:4) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7726-95-6 | Bromine | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7727-21-1 | Peroxydisulfuric acid ([(HO)S(O)2]2O2), potassium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7727-37-9 | Nitrogen | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7727-54-0 | Peroxydisulfuric acid ([(HO)S(O)2]2O2), ammonium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7757-79-1 | Nitric acid potassium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7757-82-6 | Sulfuric acid sodium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7757-83-7 | Sulfurous acid, sodium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7757-86-0 | Phosphoric acid, magnesium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7757-93-9 | Phosphoric acid, calcium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7758-02-3 | Potassium bromide (KBr) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7758-05-6 | Iodic acid (HIO3), potassium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7758-09-0 | Nitrous acid, potassium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7758-11-4 | Phosphoric acid, potassium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7758-16-9 | Diphosphoric acid, sodium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7758-19-2 | Chlorous acid, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7758-23-8 | Phosphoric acid, calcium salt (2:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7758-29-4 | Triphosphoric acid, sodium salt (1:5) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7758-87-4 | Phosphoric acid, calcium salt (2:3) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7772-99-8 | Tin chloride (SnCl2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7775-14-6 | Dithionous acid, sodium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7778-18-9 | Sulfuric acid, calcium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7778-74-7 | Perchloric acid, potassium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7778-77-0 | Phosphoric acid, potassium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7778-80-5 | Sulfuric acid potassium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7782-41-4 | Fluorine | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7782-50-5 | Chlorine | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7782-99-2 | Sulfurous acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7783-20-2 | Sulfuric acid ammonium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7783-28-0 | Phosphoric acid, ammonium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7783-86-0 | Iron iodide (FeI2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7783-90-6 | Silver chloride (AgCl) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7784-09-0 | Phosphoric acid, silver(1+) salt (1:3) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7784-25-0 | Sulfuric acid, aluminum ammonium salt (2:1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7784-26-1 | Sulfuric acid, aluminum ammonium salt, hydrate (2:1:1:12) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7784-28-3 | Sulfuric acid, aluminum sodium salt (2:1:1), dodecahydrate | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7785-84-4 | Metaphosphoric acid (H3P3O9), sodium salt (1:3) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7785-87-7 | Sulfuric acid, manganese(2+) salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7785-88-8 | Phosphoric acid, aluminum sodium salt (1:?:?) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7786-30-3 | Magnesium chloride (MgCl2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7786-81-4 | Sulfuric acid, nickel(2+) salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7789-00-6 | Chromic acid (H2CrO4), potassium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7789-23-3 | Potassium fluoride (KF) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7789-42-6 | Cadmium bromide (CdBr2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7789-77-7 | Phosphoric acid, calcium salt (1:1), dihydrate | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7789-79-9 | Phosphinic acid, calcium salt (2:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7789-80-2 | Iodic acid (HIO3), calcium salt (2:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 77-92-9 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 77-93-0 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,2,3-triethyl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7803-55-6 | Vanadate (VO31-), ammonium (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 78-93-3 | 2-Butanone | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 79-09-4 | Propanoic acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 79-21-0 | Ethaneperoxoic acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 79-33-4 | Propanoic acid, 2-hydroxy-, (2S)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 79-43-6 | Acetic acid, 2,2-dichloro- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 79-46-9 | 2-Nitropropane | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 79-83-4 | .beta.-Alanine, N-[(2R)-2,4-dihydroxy-3,3-dimethyl-1-oxobutyl]- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8000-28-0 | Oils, lavender | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| *8000-34-8/ 8015-97-2 | Oils, clove | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| *8001-21-6/ 84776-03-4 | Oils, Sunflower | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| *8001-25-0/ 8060-29-5 | Olive oil | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8001-26-1 | Linseed oil | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8001-31-8 | Coconut oil | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8001-61-4 | Balsams, copaiba | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8001-75-0 | Ceresin | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8001-79-4 | Castor oil | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8002-23-1 | Spermaceti | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8002-43-5 | Lecithins | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8002-74-2 | Paraffin waxes and Hydrocarbon waxes | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8003-34-7 | Pyrethrins and Pyrethroids | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8006-44-8 | Candelilla wax | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8006-54-0 | Lanolin | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8006-75-5 | Oils, dill | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8006-80-2 | Oils, sassafras | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8006-87-9 | Oils, sandalwood | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8008-52-4 | Oils, coriander | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8008-56-8 | Oils, lemon | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8009-03-8 | Petrolatum | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8012-89-3 | Beeswax | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8012-95-1 | Paraffin oil | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8015-86-9 | Carnauba wax | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8015-92-7 | Oils, chamomile | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8016-94-2 | Oils, vegetable, brominated | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8023-74-3 | Oils, mink | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8028-89-5 | Caramel (color) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8029-68-3 | Ichthammol | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8029-76-3 | Lecithins, hydroxylated | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8042-47-5 | White mineral oil (petroleum) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8047-15-2 | Saponins | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8050-07-5 | Frankincense | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 8050-81-5 | Simethicone | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 81-07-2 | 1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 81161-17-3 | Benzenepropanoic acid, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-, methyl ester, hydrochloride (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 814-80-2 | Propanoic acid, 2-hydroxy-, calcium salt (2:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 81782-77-6 | 3-Decen-5-ol, 4-methyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 81-81-2 | 2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 822-16-2 | Octadecanoic acid, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 83-44-3 | Cholan-24-oic acid, 3,12-dihydroxy-, (3.alpha.,5.beta.,12.alpha.)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 83682-78-4 | 1-Propanaminium, 3,3',3"-[phosphinylidynetris(oxy)]tris[N-(3-aminopropyl)-2-hydroxy-N,N-dimethyl-, N,N',N" - tri-C6-18 acyl derivs. trichlorides | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 83863-64-3 | Spiro[5.5]undecan-3-one, 7,9-dimethyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 83-88-5 | Riboflavin | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 84082-80-4 | St.-John's-wort, Hypericum perforatum, ext. | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 84082-82-6 | Willow, Salix alba, Extract | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 84282-44-0 | 2-Nonynoic acid, 2-methylpropyl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 84625-29-6 | Capsicum annuum, ext. | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 84681-91-4 | Bicyclo[3.2.1]octan-8-ol, 1,5,8-trimethyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 84696-15-1 | Ginger, ext. | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| *84696-21-9/ 84776-24-9 | Hydrocotyle asiatica, ext. | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| *84696-47-9/ 84603-93-0 | Rose, Rosa canina, ext | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 84775-78-0 | Ascophyllum nodosum, ext. | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 84776-23-8 | Calendula officinalis, ext. | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 84776-67-0 | Lily, Lilium candidum, ext. | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 84787-68-8 | Primrose, Primula veris, ext. | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 84787-69-9 | Rubus fruticosus, ext. | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 84-80-0 | 1,4-Naphthalenedione, 2-methyl-3-[(2E,7R,11R)-3,7,11,15-tetramethyl-2-hexadecen-1-yl]- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 84929-61-3 | Carrot, ext. | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 84988-65-8 | Harpagophytum procumbens, ext. | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 85049-30-5 | Bentonite, sodian | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 85351-04-8 | Octanenitrile, 3-methyl-. | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 85351-07-1 | Dodecanenitrile, 3-methyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 85507-69-3 | Aloe vera, ext | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 860-22-0 | 1H-Indole-5-sulfonic acid, 2-(1,3-dihydro-3-oxo-5-sulfo-2H-indol-2-ylidene)-2,3-dihydro-3-oxo-, sodium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 868-14-4 | Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, potassium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 868-18-8 | Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, sodium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 86893-19-8 | Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, ether with methyl D-glucopyranoside 2,6-di-(9Z)-9-octadecenoate (2:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 87-28-5 | Benzoic acid, 2-hydroxy-, 2-hydroxyethyl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 87-69-4 | Butanedioic acid, 2,3-dihydroxy- (2R,3R)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 886-86-2 | Benzoic acid, 3-amino-, ethyl ester, methanesulfonate (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 89079-92-5 | 1-Oxaspiro[4.5]deca-3,6-diene, 2,7-dimethyl-10-(1-methylethyl)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 89-57-6 | Benzoic acid, 5-amino-2-hydroxy- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 89-65-6 | D-erythro-Hex-2-enonic acid, .gamma.lactone | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| *89957-91-5/ 85049-52-1 | Bergamot, ext. | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9000-01-5 | Gum arabic | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9000-05-9 | Gum benzoin | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9000-07-1 | Carrageenan | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9000-11-7 | Cellulose, carboxymethyl ether | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9000-29-7 | Guaiacum (resin) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9000-30-0 | Guar gum | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9000-36-6 | Karaya gum | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9000-40-2 | Carob gum | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9000-59-3 | Shellac | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9000-65-1 | Gum tragacanth | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9000-69-5 | Pectin | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9000-70-8 | Gelatins | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9000-71-9 | Caseins | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9001-32-5 | Fibrinogens | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9001-42-7 | Glucosidase, .alpha.- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9001-54-1 | Hyaluronidase | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9002-18-0 | Agar | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 90028-66-3 | Evening primrose, Oenothera biennis, ext. | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9002-92-0 | Poly(oxy-1,2-ethanediyl), .alpha.-dodecyl-.omega.-hydroxy- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9003-05-8 | 2-Propenamide, homopolymer | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9003-13-8 | Poly[oxy(methyl-1,2-ethanediyl)], .alpha.-butyl-.omega.-hydroxy- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9003-39-8 | 2-Pyrrolidinone, 1-ethenyl-, homopolymer | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9004-32-4 | Cellulose, carboxymethyl ether, sodium salt | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9004-34-6 | Cellulose | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9004-54-0 | Dextran | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9004-62-0 | Cellulose, 2-hydroxyethyl ether | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9004-64-2 | Cellulose, 2-hydroxypropyl ether | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9004-65-3 | Cellulose, 2-hydroxypropyl methyl ether | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9004-67-5 | Cellulose, methyl ether | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9004-82-4 | Poly(oxy-1,2-ethanediyl), .alpha.-sulfo-.omega.-(dodecyloxy)-, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9004-99-3 | Poly(oxy-1,2-ethanediyl),.alpha.-(1-oxooctadecyl)-.omega.-hydroxy- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9005-00-9 | Poly(oxy-1,2-ethanediyl), .alpha.-octadecyl-.omega.-hydroxy- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9005-25-8 | Starch | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9005-27-0 | Starch, 2-hydroxyethyl ether | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9005-32-7 | Alginic Acid | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9005-34-9 | Alginic acid, ammonium salt | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9005-35-0 | Alginic acid, calcium salt | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9005-36-1 | Alginic acid, potassium salt | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9005-37-2 | Alginic acid, ester with 1,2-propanediol | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9005-38-3 | Alginic acid, sodium salt | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9005-49-6 | Heparin | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9005-65-6 | Sorbitan, mono-(9Z)-9-octadecenoate, poly(oxy-1,2-ethanediyl) derivs. | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9005-67-8 | Sorbitan, monooctadecanoate, poly(oxy-1,2-ethanediyl) derivs | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9005-71-4 | Sorbitan, trioctadecanoate, poly(oxy-1,2-ethanediyl) derivs. | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9005-79-2 | Glycogen | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9006-65-9 | Dimethicone | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9007-49-2 | Deoxyribonucleic acids | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| *9011-14-7/ 143476-91-9 | 2-Propenoic acid, 2-methyl-, methyl ester, homopolymer | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9014-01-1 | Subtilisin | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9016-45-9 | Poly(oxy-1,2-ethanediyl), .alpha.-(nonylphenyl)-.omega.-hydroxy- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 90320-37-9 | Almond, sweet, ext. | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9041-08-1 | Heparin, sodium salt | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9049-05-2 | Carrageenan, calcium salt | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 9054-89-1 | Dismutase, superoxide | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 90-80-2 | D-Gluconic acid, .delta.-lactone | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 91031-88-8 | Fatty acids, coco, esters with sucrose | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 91482-37-0 | 5,9-Undecadien-2-ol, 6,10-dimethyl-, 2-acetate | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 91-53-2 | Quinoline, 6-ethoxy-1,2-dihydro-2,2,4-trimethyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 915-67-3 | 2,7-Naphthalenedisulfonic acid, 3-hydroxy-4-[2-(4-sulfo-1-naphthalenyl)diazenyl]-, sodium salt (1:3) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 91-64-5 | 2H-1-Benzopyran-2-one | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 91744-66-0 | Glycerides, palm-oil mono-, di- and tri-, hydrogenated | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 92044-87-6 | Fatty acids, coco, 2-ethylhexyl esters | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 92113-40-1 | Fats and Glyceridic oils, animal | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 92129-90-3 | Whey | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 921-53-9 | Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, potassium salt (1:2) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 93-60-7 | 3-Pyridinecarboxylic acid, methyl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 94-13-3 | Benzoic acid, 4-hydroxy-, propyl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 94-36-0 | Peroxide, dibenzoyl | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 94441-92-6 | .beta.-Alanine, N-(2-carboxyethyl)-N-(2-ethylhexyl)-, sodium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 95-25-0 | 2(3H)-Benzoxazolone, 5-chloro- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 95-38-5 | 1H-Imidazole-1-ethanol, 2-(8-heptadecen-1-yl)-4,5-dihydro- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 95461-64-6 | Octadecanoic acid, pentaester with decaglycerol | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 95912-86-0 | Fatty acids, C8-10, C12-18-alky esters | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 97592-64-8 | L-Asparagine, N-[3-(diethylamino)propyl]-, N2-(C8-18 and C18-unsatd. alkyl) derivs., monosodium salts | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 97-67-6 | Butanedioic acid, 2-hydroxy-, (2S)- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 97862-72-1 | Fatty acids, C10-30, esters with lanolin alcohols | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 98-92-0 | 3-Pyridinecarboxamide | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 99-20-7 | .alpha.-D-Glucopyranoside, .alpha. -D-glucopyranosyl | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 996-31-6 | Propanoic acid, 2-hydroxy-, potassium salt (1:1) | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 99-76-3 | Benzoic acid, 4-hydroxy-, methyl ester | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 99-97-8 | Benzenamine, N,N,4-trimethyl- | On DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10025-69-1 | Tin chloride (SnCl2), dihydrate | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10025-70-4 | Strontium chloride (SrCl2), hexahydrate | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10028-24-7 | Phosphoric acid, disodium salt, dihydrate | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10031-30-8 | Phosphoric acid, calcium salt, hydrate (2:1:1) | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10035-04-8 | Calcium chloride (CaCl2), dihydrate | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10049-21-5 | Phosphoric acid, monosodium salt, monohydrate | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10101-41-4 | Sulfuric acid, calcium salt (1:1), dihydrate | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10101-89-0 | Phosphoric acid, sodium salt, hydrate (1:3:12) | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10213-79-3 | Silicic acid (H2SiO3), disodium salt, pentahydrate | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 10486-00-7 | Perboric acid (HBO(O2)), sodium salt, tetrahydrate | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 12389-15-0 | Iron, bis(D-gluconato-.kappaO1,.kappa.O2)-, hydrate (1:2) | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 13472-36-1 | Diphosphoric acid, sodium salt, hydrate (1:4:10) | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 14168-73-1 | Sulfuric acid magnesium salt (1:1), monohydrate | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 14434-22-1 | Ferrate(4-), hexakis(cyano-.kappa.C)-, sodium, hydrate (1:4:10), (OC-6-11)- | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 15091-98-2 | Triphosphoric acid, pentasodium salt, hexahydrate | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 15244-36-7 | Sulfuric acid, manganese(2+) salt (1:1), hydrate | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 23389-33-5 | Carbonic acid, magnesium salt (1:1), hydrate | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 23411-34-9 | Calciate(2-), [[N,N'-1,2-ethanediylbis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']-, disodium, hydrate, (OC-6-21)- | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 41372-22-9 | Propanoic acid, 2-hydroxy-, calcium salt (2:1), hydrate | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 5743-12-4 | 1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-, hydrate (1:1) | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 5743-28-2 | L-Ascorbic acid, calcium salt (2:1), dihydrate | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| *5743-47-5/ 63690-56-2/ 156733-79-8 | Propanoic acid, 2-hydroxy-, calcium salt, hydrate(2:1:5) | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 5785-44-4 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, calcium salt (2:3), tetrahydrate | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 5968-11-6 | Carbonic acid disodium salt, monohydrate | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 6100-05-6 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, potassium salt, hydrate (1:3:1) | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 6106-24-7 | Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, sodium salt, hydrate (1:2:2) | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 6131-90-4 | Acetic acid, sodium salt, hydrate (1:1:3) | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 6132-02-1 | Carbonic acid sodium salt (1:2), hydrate (1:10) | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 6132-04-3 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, sodium salt, hydrate (1:3:2) | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 62974-97-4 | Calcium hydroxide phosphate (Ca10(OH)2(PO4)6), hydrate | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 63524-04-9 | D-erythro-Hex-2-enonic acid, .gamma.-lactone, sodium salt, hydrate (1:1:1) | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 6381-59-5 | Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, potassium sodium salt, hydrate (1:1:1:4) | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 6381-79-9 | Carbonic acid, dipotassium salt, hydrate (2:3) | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 64044-51-5 | D-glucose. 4-.ortho.-.beta.-D-galactopyranosyl-, hydrate (1:1) | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7048-04-6 | L-Cysteine, hydrochloride, hydrate (1:1:1) | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 74978-16-8 | Aluminum magnesium hydroxide sulfate (Al5Mg10(OH)31(SO4)2), hydrate | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7727-73-3 | Sulfuric acid sodium salt (1:2), hydrate (1:10) | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7782-63-0 | Sulfuric acid, iron(2+) salt (1:1), heptahydrate | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7784-24-9 | Sulfuric acid, aluminum potassium salt (2:1:1), dodecahydrate | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7784-31-8 | Sulfuric acid, aluminum salt (3:2), octadecahydrate | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
| 7791-18-6 | Magnesium chloride (MgCl2), hexahydrate | Anhydrous form on DSL | Removed from R-ICL to avoid redundancy with DSL | Removed from R-ICL |
Page details
- Date modified: